{"meta":{"query_hash":"1fe60c4b3c46","filters":{"venue":"Critical Reviews in Oncology/Hematology"},"cohort_total":164,"direct_labels_cover":1,"predictions_cover":164,"exported":164,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1fe60c4b3c46","api":"https://metacan.xera.ac/api/v1/cohort?venue=Critical+Reviews+in+Oncology%2FHematology"},"results":[{"id":"W1969110349","doi":"10.1016/j.critrevonc.2013.04.003","title":"CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Monoclonal antibody; Multiple myeloma; Immune system; Haematopoiesis; Immunology; Receptor; Biology; Autoimmunity; Cancer research; Antibody; Medicine; Cell biology; Stem cell; Genetics","score_opus":0.1524543527778546,"score_gpt":0.44352341900849934,"score_spread":0.29106906623064477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969110349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031553977,0.987062,0.00004836384,0.0019072656,0.00043281473,0.008675594,0.000039064253,0.00005383993,0.0014655418],"genre_scores_gemma":[0.0011135852,0.9830011,0.006363093,0.00093419506,0.000120527075,0.0075096856,0.00045355794,0.00013549654,0.0003687186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9882933,0.0036539226,0.0042758896,0.0015432952,0.0004521517,0.0017814519],"domain_scores_gemma":[0.9922926,0.005062725,0.0005199832,0.001357885,0.00025521906,0.00051159185],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0022536723,0.0011141475,0.009834872,0.0015027416,0.00008124706,0.0000316586,0.0006627213,0.0021526422,0.0017570137],"category_scores_gemma":[0.01066193,0.0008443154,0.0009143619,0.0016684224,0.00086074707,0.00017432169,0.00033600343,0.0025004558,0.0027620427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020244607,0.002155134,0.0062457,0.025858581,0.00017424911,0.0011355879,0.0002039233,4.723797e-8,0.000028870374,0.0035489812,0.0029791305,0.9574674],"study_design_scores_gemma":[0.004254589,0.00063193374,0.0017667831,0.040002704,0.0002617544,0.00038681785,0.00008274335,0.00014661704,0.000013944145,0.001576192,0.95026946,0.000606435],"about_ca_topic_score_codex":0.0002020011,"about_ca_topic_score_gemma":0.0003520205,"teacher_disagreement_score":0.9568609,"about_ca_system_score_codex":0.0019006287,"about_ca_system_score_gemma":0.0015770191,"threshold_uncertainty_score":0.9998008},"labels":[],"label_agreement":null},{"id":"W1971705000","doi":"10.1016/j.critrevonc.2011.06.001","title":"Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Temsirolimus; Medicine; Tolerability; Everolimus; Oncology; Bevacizumab; Renal cell carcinoma; Clinical trial; Internal medicine; Combination therapy; Targeted therapy; Discovery and development of mTOR inhibitors; Intensive care medicine; Cancer; Adverse effect; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.2091943021318495,"score_gpt":0.4524947061415655,"score_spread":0.243300404009716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971705000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006748292,0.9846438,0.00021485426,0.0011074691,0.0006208883,0.008570834,0.000056352466,0.000031369444,0.0046869586],"genre_scores_gemma":[0.0019599884,0.9879485,0.004363766,0.0019187629,0.00006662239,0.0033971276,0.000109627275,0.00010638522,0.0001292287],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98835844,0.003563731,0.0053067934,0.0012175263,0.00047910478,0.00107442],"domain_scores_gemma":[0.989105,0.0071719433,0.00092670816,0.0015599,0.0007247502,0.0005117174],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002862613,0.0010965653,0.010657558,0.0004844859,0.00009955136,0.000022909806,0.00078125176,0.00070034387,0.0006164569],"category_scores_gemma":[0.019332895,0.00059863675,0.0013375999,0.0009782359,0.0010006251,0.00015066596,0.0003958202,0.0016204607,0.0004234724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015745968,0.002292479,0.00018060597,0.5067128,0.00015339168,0.0015995946,0.0002343246,2.192701e-8,0.000003700972,0.0659196,0.0029732971,0.4197727],"study_design_scores_gemma":[0.0015540185,0.0070154816,0.000059594462,0.13046706,0.011150926,0.0022964594,0.00016755208,0.0000029999712,0.000039693405,0.0012862132,0.84516305,0.0007969788],"about_ca_topic_score_codex":0.000050310016,"about_ca_topic_score_gemma":0.000043086722,"teacher_disagreement_score":0.8421897,"about_ca_system_score_codex":0.0015061167,"about_ca_system_score_gemma":0.0022004095,"threshold_uncertainty_score":0.9996465},"labels":[],"label_agreement":null},{"id":"W1980534817","doi":"10.1016/j.critrevonc.2005.08.002","title":"Cancer screening: The importance of outcome measures","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Outcome (game theory); Cancer; Cancer screening; Disease; MEDLINE; Intensive care medicine; Family medicine; Pathology; Internal medicine","score_opus":0.23187728914333075,"score_gpt":0.50424701748236,"score_spread":0.2723697283390293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980534817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009726287,0.9907953,0.00037401466,0.002775749,0.00071454095,0.0019831862,0.000017137767,0.00005253226,0.0032777935],"genre_scores_gemma":[0.00025664532,0.9945352,0.0016127711,0.0012190517,0.0004729592,0.0016278407,0.000014875019,0.00006213182,0.00019853844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400604,0.0011799276,0.003028929,0.00076771434,0.0003405927,0.00067682366],"domain_scores_gemma":[0.99508,0.0028016162,0.0007991505,0.00089435925,0.00021154482,0.00021336359],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023938515,0.0006002551,0.00701698,0.0003192024,0.00008691497,0.00000948113,0.00048428198,0.0011181515,0.00042692482],"category_scores_gemma":[0.008717583,0.00036317995,0.0011677534,0.0008335723,0.0008452674,0.00005200387,0.00018523599,0.001935321,0.00007271895],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015844179,0.00014548724,0.0013382034,0.011516299,0.00009030181,0.000103441394,0.00003089525,1.535764e-7,1.4227913e-7,0.0032372533,0.0021347546,0.9812446],"study_design_scores_gemma":[0.00040947477,0.00068113237,0.000075700074,0.022975255,0.001498315,0.0017811704,0.000019540286,0.000010404452,0.0000021942037,0.00011500671,0.9721492,0.00028264063],"about_ca_topic_score_codex":0.00004999351,"about_ca_topic_score_gemma":0.0007844273,"teacher_disagreement_score":0.980962,"about_ca_system_score_codex":0.00055949815,"about_ca_system_score_gemma":0.000723554,"threshold_uncertainty_score":0.99988204},"labels":[],"label_agreement":null},{"id":"W1988787726","doi":"10.1016/j.critrevonc.2014.10.007","title":"Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Pleiotrophin; Midkine; Angiogenesis; Angiogenin; Cancer research; Basic fibroblast growth factor; Haematopoiesis; Growth factor; Immunology; Vascular endothelial growth factor; Chronic lymphocytic leukemia; Placental growth factor; Medicine; Angiopoietin; Biology; Internal medicine; Leukemia; Stem cell; Cell biology; Receptor; VEGF receptors","score_opus":0.10254896086678436,"score_gpt":0.46684396905452313,"score_spread":0.36429500818773874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988787726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060477745,0.9893747,0.00009330536,0.00044093048,0.00094289903,0.0051677693,0.00003278465,0.00010942638,0.0037776844],"genre_scores_gemma":[0.0003686839,0.99587727,0.0004030429,0.00016587318,0.0005290341,0.0017897806,0.00008116052,0.00027115655,0.0005140216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98457843,0.0039732084,0.0052372958,0.0023961335,0.0007949013,0.0030200134],"domain_scores_gemma":[0.9851252,0.01047154,0.00070391916,0.0024701892,0.00021738373,0.0010118133],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0038227658,0.0017231009,0.016089557,0.001603986,0.00011170037,0.00005413894,0.001463202,0.0041296813,0.001826767],"category_scores_gemma":[0.01296689,0.0013113279,0.002187272,0.0020972276,0.0018365687,0.00014345904,0.00082856853,0.003497786,0.0028525766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010225864,0.00034462087,0.00005404417,0.24271351,0.00021043525,0.0053409524,0.00011584324,9.944156e-7,0.0000012636425,0.025913054,0.010361408,0.7148416],"study_design_scores_gemma":[0.0068160496,0.0008395031,0.0000013811795,0.1470619,0.0010509563,0.006570317,0.00004295665,0.00018955619,0.0000035908283,0.00069629983,0.8358968,0.0008306865],"about_ca_topic_score_codex":0.00018682083,"about_ca_topic_score_gemma":0.0006694287,"teacher_disagreement_score":0.8255354,"about_ca_system_score_codex":0.21538065,"about_ca_system_score_gemma":0.09389165,"threshold_uncertainty_score":0.99955153},"labels":[],"label_agreement":null},{"id":"W1989665858","doi":"10.1016/j.critrevonc.2013.01.006","title":"The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"Medical Research Council; Beatrice Hunter Cancer Research Institute","keywords":"Prostate cancer; Estrogen therapy; Androgen deprivation therapy; Estrogen; Medicine; Internal medicine; Androgen; Castration; Oncology; Endocrinology; Gynecology; Cancer; Hormone","score_opus":0.16639744115831975,"score_gpt":0.4974359483198989,"score_spread":0.3310385071615791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989665858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025997672,0.9596218,0.0000023187022,0.0036119572,0.00022529106,0.010132152,0.00010543454,0.000011654884,0.00029171884],"genre_scores_gemma":[0.0047294796,0.9864522,0.000028057562,0.00022401956,0.0000511319,0.00826873,0.00011130392,0.000043404765,0.00009165968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557096,0.0017269751,0.0014527056,0.00051871024,0.0002142948,0.0005163852],"domain_scores_gemma":[0.9922515,0.0059932424,0.0005222425,0.0007745699,0.00029695468,0.00016147814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010677144,0.00044421217,0.0027496614,0.00020952808,0.00010565784,0.000012354973,0.0004486655,0.0004036888,0.000094160234],"category_scores_gemma":[0.0036803614,0.00018965517,0.00030608088,0.00058351946,0.00071721047,0.000025872405,0.00010912591,0.00076076086,0.000120393204],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004199821,0.0005179503,0.0033789321,0.006373188,0.00020078955,0.000012246718,0.000075293865,1.0244372e-7,0.000012437047,0.006555249,0.0021795847,0.98027426],"study_design_scores_gemma":[0.0016767122,0.012823968,0.00035338453,0.022365237,0.0004685126,0.00006835423,0.00003634311,0.00000199479,0.00056708447,0.00016791957,0.9612325,0.00023801708],"about_ca_topic_score_codex":0.000026455553,"about_ca_topic_score_gemma":0.00002967034,"teacher_disagreement_score":0.9800362,"about_ca_system_score_codex":0.00043334544,"about_ca_system_score_gemma":0.0005350088,"threshold_uncertainty_score":0.7733913},"labels":[],"label_agreement":null},{"id":"W1993986934","doi":"10.1016/j.critrevonc.2009.09.005","title":"Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Geriatric oncology; Comorbidity; Geriatrics; Gerontology; Life expectancy; Activities of daily living; Androgen deprivation therapy; Cancer; Physical therapy; Population; Internal medicine; Psychiatry; Environmental health","score_opus":0.16781836514551474,"score_gpt":0.514269838172044,"score_spread":0.34645147302652923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993986934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013123284,0.96403,0.00013547485,0.015061445,0.00053063396,0.019888598,0.00022893344,0.000008390523,0.000103351675],"genre_scores_gemma":[0.00004360891,0.9661767,0.00707565,0.0007509627,0.00013035125,0.025624694,0.000057373145,0.000046487698,0.00009416326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995146,0.00032846897,0.003059219,0.00065587234,0.00018873836,0.0006216958],"domain_scores_gemma":[0.9925138,0.005418143,0.0007187618,0.00072017056,0.0005403669,0.000088811765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001940251,0.00052082195,0.0049922955,0.00015584852,0.00005861745,0.0000068175395,0.0004286802,0.00042899515,0.000050901024],"category_scores_gemma":[0.0014824846,0.00024495966,0.0008647111,0.00041546123,0.00057388976,0.0000327761,0.00012716473,0.00038977244,0.000005526174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029720474,0.0006501173,0.000041945146,0.09856414,0.00031493092,0.00005466136,0.00006172829,6.389272e-7,1.08867646e-7,0.021762434,0.0053736684,0.87287843],"study_design_scores_gemma":[0.0023039116,0.00118759,0.000032940236,0.10038856,0.0036192997,0.00010563758,0.00016996195,0.000042460284,0.000010116286,0.0010029083,0.89095026,0.00018635693],"about_ca_topic_score_codex":0.000039823004,"about_ca_topic_score_gemma":0.0003019957,"teacher_disagreement_score":0.8855766,"about_ca_system_score_codex":0.0004839461,"about_ca_system_score_gemma":0.0008692085,"threshold_uncertainty_score":0.9989165},"labels":[],"label_agreement":null},{"id":"W2000337004","doi":"10.1016/j.critrevonc.2005.10.002","title":"Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Oncology; Meta-analysis; Randomized controlled trial; Regimen; Internal medicine; Adverse effect; Radiation therapy; Clinical trial; Adjuvant; Stage (stratigraphy); Cancer; Surgery","score_opus":0.07913791823205374,"score_gpt":0.45831428217309583,"score_spread":0.3791763639410421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000337004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.3911746e-7,0.96123874,0.00021076933,0.0030080946,0.00072166143,0.033037025,0.00016944787,0.000074625714,0.0015386818],"genre_scores_gemma":[0.000003839363,0.9367826,0.0024627359,0.0047610328,0.00028531434,0.054729864,0.00044571905,0.00019080388,0.00033811096],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9901568,0.0015480773,0.0050513255,0.0015841917,0.00031162892,0.0013479566],"domain_scores_gemma":[0.9903938,0.0059015006,0.001339824,0.0015367327,0.0004010326,0.00042706841],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019968771,0.0013411759,0.023322035,0.00039336094,0.00011797907,0.00002532089,0.00067059306,0.0013069335,0.00027614183],"category_scores_gemma":[0.0030066683,0.00090846757,0.0023857295,0.0007989834,0.00034686422,0.0000454777,0.0001424062,0.0011558282,0.00016672928],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027125574,0.0011187036,0.00003229303,0.8626387,0.0003145531,0.0004004024,0.00001931827,1.735068e-8,1.4121093e-7,0.0011873796,0.06661948,0.06764189],"study_design_scores_gemma":[0.0013348539,0.00048691814,0.0000013806986,0.503364,0.011331106,0.0005735803,0.0000029127477,0.000012648232,0.0000015828913,0.000040642943,0.4824681,0.00038222357],"about_ca_topic_score_codex":0.00006864004,"about_ca_topic_score_gemma":0.00019612917,"teacher_disagreement_score":0.4158486,"about_ca_system_score_codex":0.0030544968,"about_ca_system_score_gemma":0.0020256415,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W2001748120","doi":"10.1016/j.critrevonc.2004.05.001","title":"Exercise issues in older cancer survivors","year":2004,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Aging","keywords":"Medicine; Cancer; Gerontology; Cancer survivor; Sports medicine; Cancer survivorship; Population; Physical therapy; Older people; Survivorship curve; Internal medicine","score_opus":0.08199993426541416,"score_gpt":0.47648314449728313,"score_spread":0.39448321023186894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001748120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010200132,0.98779607,0.000014622025,0.0024822757,0.0027000702,0.0035446628,0.00003386615,0.0000699829,0.0033482579],"genre_scores_gemma":[0.000044958793,0.9929775,0.00031977106,0.00096196786,0.00031378103,0.004534849,0.000097756296,0.00013385917,0.00061555905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926454,0.0013139462,0.0029963881,0.0014039817,0.00032678398,0.0013134985],"domain_scores_gemma":[0.99634993,0.001612494,0.0003648986,0.0010697499,0.0001602873,0.00044263757],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016273807,0.0010189535,0.011843437,0.0008271969,0.000051114366,0.000019739879,0.0005737123,0.0023345046,0.0020066868],"category_scores_gemma":[0.0026958808,0.0008114532,0.0011127846,0.0013925311,0.00074069423,0.00009110003,0.00025286403,0.0024956719,0.00070108764],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038586826,0.0006262181,0.0002609488,0.11956882,0.00003555888,0.0020069748,0.0003471099,6.113575e-8,5.930484e-8,0.009821334,0.002081018,0.86521333],"study_design_scores_gemma":[0.0006666924,0.00014590922,0.00001734871,0.22804502,0.0008216634,0.00070116326,0.00008497345,5.6491166e-7,0.0000012211096,0.0005943313,0.7684102,0.00051091315],"about_ca_topic_score_codex":0.0023823967,"about_ca_topic_score_gemma":0.021989362,"teacher_disagreement_score":0.8647024,"about_ca_system_score_codex":0.001984943,"about_ca_system_score_gemma":0.0023410013,"threshold_uncertainty_score":0.9998056},"labels":[],"label_agreement":null},{"id":"W2002497392","doi":"10.1016/j.critrevonc.2010.02.010","title":"Difficulties in decision making regarding chemotherapy for older cancer patients: A census of cancer physicians","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Division of Graduate Education; Université de Montréal; McGill University","keywords":"Medicine; Cancer; Geriatric oncology; Family medicine; General partnership; Gerontology; Chemotherapy; Social support; Internal medicine; Psychology","score_opus":0.06441616133795885,"score_gpt":0.47200247292678754,"score_spread":0.4075863115888287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002497392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003254726,0.99026656,0.00022904629,0.0011281773,0.0018893274,0.0056981174,0.00017863624,0.00003209549,0.0002525895],"genre_scores_gemma":[0.00030645818,0.9845017,0.008202871,0.0011137174,0.0003116413,0.005278823,0.00008581951,0.00013741915,0.000061525534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940131,0.00048905547,0.003124681,0.001077023,0.00029784974,0.0009982937],"domain_scores_gemma":[0.99189156,0.005937522,0.0008905414,0.0007029102,0.00044057856,0.00013687859],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000843621,0.00079557917,0.008729446,0.00055558776,0.000055978267,0.000011121336,0.00049410714,0.0017863438,0.00017193054],"category_scores_gemma":[0.009675959,0.00060789974,0.000988308,0.0006799478,0.00066708284,0.000077530174,0.00015399136,0.0017382705,0.000014369581],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013404718,0.0010086201,0.00088899967,0.04567946,0.00007145603,0.000047928144,0.00023065199,1.4233808e-7,0.000001953215,0.0015686847,0.004192748,0.94617534],"study_design_scores_gemma":[0.0028680214,0.00026116273,0.00024173125,0.21717139,0.0006869707,0.00007244889,0.000036175672,0.00001658556,0.000008146652,0.00029011685,0.7779364,0.00041083441],"about_ca_topic_score_codex":0.000049115057,"about_ca_topic_score_gemma":0.0010585412,"teacher_disagreement_score":0.9457645,"about_ca_system_score_codex":0.0010956707,"about_ca_system_score_gemma":0.0006130414,"threshold_uncertainty_score":0.99963725},"labels":[],"label_agreement":null},{"id":"W2009230593","doi":"10.1016/j.critrevonc.2004.11.002","title":"Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences","year":2004,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; Perforin; Hepatosplenomegaly; Cytotoxic T cell; Missense mutation; Pathogenesis; Medicine; Disease; Biology; Mutation; Immune system; CD8; Gene; Genetics; Internal medicine","score_opus":0.05908053155043523,"score_gpt":0.43244267741001585,"score_spread":0.3733621458595806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009230593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011277014,0.9902301,0.000005970529,0.0006343977,0.00011272382,0.005060235,0.00000915384,0.00003064624,0.003804048],"genre_scores_gemma":[0.0005206044,0.9941363,0.00026206704,0.0010440929,0.000046265635,0.0037780995,0.00007119699,0.000084452484,0.000056955916],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9918191,0.0016631947,0.003856243,0.0011345401,0.00048871286,0.0010382377],"domain_scores_gemma":[0.99607635,0.0015052479,0.00071590126,0.0012344638,0.00018277728,0.00028526084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020611784,0.0008877483,0.0117075555,0.00084169564,0.000060282415,0.000008925366,0.0007462094,0.0010958568,0.00077830657],"category_scores_gemma":[0.008175848,0.0005956025,0.0008191307,0.0015595778,0.0016588954,0.000094867064,0.00020919558,0.0016061808,0.0004231463],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008883646,0.0012403891,0.00017947551,0.31691632,0.00010569543,0.000628887,0.00027791783,6.0773374e-8,1.3808938e-7,0.0044727824,0.00068625546,0.67540324],"study_design_scores_gemma":[0.0015093033,0.0015687712,0.000025099826,0.5646278,0.0006255725,0.004124782,0.00013540678,6.5723015e-7,0.0000048518677,0.00014654918,0.42677242,0.0004587594],"about_ca_topic_score_codex":0.00005970691,"about_ca_topic_score_gemma":0.000019615438,"teacher_disagreement_score":0.67494446,"about_ca_system_score_codex":0.0013839776,"about_ca_system_score_gemma":0.0037035665,"threshold_uncertainty_score":0.9996495},"labels":[],"label_agreement":null},{"id":"W2009447754","doi":"10.1016/s1040-8428(01)00218-9","title":"Iron chelators as therapeutic agents for the treatment of cancer","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Australian Research Council; National Health and Medical Research Council; Medical Research Council Canada; National Medical Research Council; Heart Research Institute","keywords":"Chelation; Chemistry; Pharmacology; In vivo; In vitro; Deferoxamine; Deferiprone; Intracellular; Cancer; Cancer research; Medicine; Biochemistry; Biology; Internal medicine","score_opus":0.1316043607119331,"score_gpt":0.48144355978300624,"score_spread":0.34983919907107314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009447754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000105852105,0.98853093,0.000026681417,0.0026628992,0.001043958,0.00564246,0.00002555546,0.000021592936,0.002035363],"genre_scores_gemma":[0.000034743065,0.993854,0.00015084654,0.0008983997,0.00013756967,0.0039533987,0.000029351531,0.00007323745,0.0008684772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960098,0.0005639053,0.0019336834,0.00062522537,0.0001589976,0.000708358],"domain_scores_gemma":[0.995125,0.003462315,0.00042543336,0.0007010522,0.00009393564,0.00019224186],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000492791,0.0006273262,0.005948567,0.00019884283,0.000094167954,0.000005860611,0.0003045158,0.0015178112,0.0010445669],"category_scores_gemma":[0.0011972752,0.00032412927,0.0014339593,0.0004103974,0.00078709,0.000020104582,0.000041693576,0.0006213144,0.0002316553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003671502,0.0012708165,0.000041323878,0.021723345,0.0003181105,0.00009533731,0.00015221797,1.0497331e-7,1.3027758e-7,0.010915985,0.0019485014,0.9634974],"study_design_scores_gemma":[0.0012277572,0.00169247,0.0000034014706,0.016689615,0.005662012,0.000503198,0.00006155677,0.000021461718,0.0000017189939,0.0002958412,0.9735951,0.00024587094],"about_ca_topic_score_codex":0.000037222537,"about_ca_topic_score_gemma":0.000029308663,"teacher_disagreement_score":0.9716466,"about_ca_system_score_codex":0.0006910232,"about_ca_system_score_gemma":0.00057341164,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W2012142584","doi":"10.1016/j.critrevonc.2009.04.005","title":"Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative study","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"National Cancer Institute; McGill University","keywords":"Cancer; Geriatric oncology; Medicine; Qualitative research; Geriatrics; Family medicine; Grounded theory; Older people; Gerontology; Health care; Internal medicine; Psychiatry","score_opus":0.09402092157403291,"score_gpt":0.5330545663960128,"score_spread":0.4390336448219799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012142584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9451788,0.04963096,0.000019939473,0.002236737,0.0004456658,0.0020077808,0.000023101104,0.000009947118,0.0004470637],"genre_scores_gemma":[0.98782396,0.009279334,0.0011441594,0.0012406782,0.00007638409,0.00040249858,0.000006444844,0.00001377695,0.000012778411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994953,0.0014688042,0.0023374243,0.00058883405,0.00023289573,0.00041905555],"domain_scores_gemma":[0.9967804,0.0018542266,0.00035008343,0.0003717098,0.00047894267,0.000164619],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009344671,0.0002509818,0.00254459,0.00022663144,0.000021303498,0.0000029131506,0.00019568908,0.00036088773,0.00015591968],"category_scores_gemma":[0.008880705,0.00021086451,0.00013151285,0.00051993236,0.00093155954,0.00008326489,0.00008848381,0.0005068892,0.0000033010551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034595004,0.004063823,0.8073123,0.00089610595,0.00002429253,0.000117552525,0.10924998,1.3995282e-7,0.00002665676,0.0023380362,0.0004394916,0.07518566],"study_design_scores_gemma":[0.010825356,0.006032709,0.903453,0.0050257803,0.0002612329,0.000017152683,0.06877593,0.000012904207,0.00021411102,0.0008553863,0.0041316818,0.00039476893],"about_ca_topic_score_codex":0.0005491296,"about_ca_topic_score_gemma":0.005793897,"teacher_disagreement_score":0.09614067,"about_ca_system_score_codex":0.00029717133,"about_ca_system_score_gemma":0.00033185823,"threshold_uncertainty_score":0.9994679},"labels":[],"label_agreement":null},{"id":"W2012173045","doi":"10.1016/j.critrevonc.2014.11.002","title":"Biologicals, platelet apoptosis and human diseases: An outlook","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Platelet; Medicine; Hemostasis; Apoptosis; Thrombosis; Pathophysiology; Immunology; Inflammation; Pharmacology; Cancer research; Bioinformatics; Internal medicine; Biology","score_opus":0.09548755128177946,"score_gpt":0.46330080389559064,"score_spread":0.36781325261381115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012173045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044953494,0.9936373,0.000024271198,0.00047016251,0.0002812814,0.0025569953,0.00006177625,0.00008950515,0.0024291768],"genre_scores_gemma":[0.00041377303,0.99521464,0.00078003947,0.0012897355,0.0001480168,0.00124549,0.0007036182,0.00007803793,0.0001266333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99350965,0.0017545738,0.0021867128,0.0014061288,0.0001615574,0.0009814049],"domain_scores_gemma":[0.9959041,0.0019787091,0.000394911,0.00089890166,0.00007210379,0.00075130677],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00083933596,0.00095499103,0.011397809,0.00039455915,0.0001542783,0.000027582028,0.00036965284,0.0018781954,0.00039372264],"category_scores_gemma":[0.003376584,0.0006340605,0.0007250243,0.00032014452,0.0010748925,0.00008153975,0.00024543144,0.0011584164,0.0004888368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030825155,0.0018195062,0.00029904174,0.026963266,0.00016158777,0.0018001937,0.00002375174,2.8226839e-9,4.092622e-7,0.039343785,0.0018659533,0.9276917],"study_design_scores_gemma":[0.001200956,0.0017240619,0.000017818345,0.017132923,0.0019657484,0.0033321148,0.000018878518,0.000001511199,6.588333e-7,0.0030216135,0.97106206,0.0005216777],"about_ca_topic_score_codex":0.000013150826,"about_ca_topic_score_gemma":0.00001864132,"teacher_disagreement_score":0.9691961,"about_ca_system_score_codex":0.0002671498,"about_ca_system_score_gemma":0.00027066396,"threshold_uncertainty_score":0.9996111},"labels":[],"label_agreement":null},{"id":"W2017989710","doi":"10.1016/j.critrevonc.2007.08.002","title":"Neoadjuvant treatment for pancreatic cancer—A review","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Neoadjuvant therapy; Pancreatic cancer; Adjuvant therapy; Disease; Surgery; Population; Cancer; Oncology; Chemotherapy; Internal medicine; Breast cancer","score_opus":0.30927968592112004,"score_gpt":0.585018553739542,"score_spread":0.275738867818422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017989710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013905706,0.97324264,0.00032524858,0.0035531812,0.00070825464,0.015159268,0.00008724367,0.00007243361,0.0068503357],"genre_scores_gemma":[4.3813773e-7,0.9670692,0.0064558634,0.0036337618,0.00052194064,0.020179177,0.00030438617,0.00014210786,0.0016931421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899148,0.0017178147,0.0044788793,0.001537227,0.0003581596,0.001993119],"domain_scores_gemma":[0.9863595,0.01048565,0.00072543474,0.00136862,0.00035436574,0.0007064823],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004090232,0.0012611697,0.021954317,0.0006765982,0.00015222472,0.000012928836,0.00056542066,0.0021677678,0.0013379145],"category_scores_gemma":[0.013764712,0.00084082905,0.002172206,0.0009286116,0.0010473633,0.000058592526,0.00017203201,0.0014624301,0.0008404043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087400724,0.00089101784,0.00012300568,0.20540339,0.0003112575,0.001003102,0.00001974051,2.6628693e-9,1.0023508e-7,0.0063929725,0.018102402,0.7676656],"study_design_scores_gemma":[0.0014056143,0.002084816,0.0000036919962,0.2487012,0.008897374,0.003179561,0.000010005683,0.000009277794,4.498941e-7,0.00025265792,0.7350086,0.0004467293],"about_ca_topic_score_codex":0.000054409225,"about_ca_topic_score_gemma":0.00011352952,"teacher_disagreement_score":0.7672189,"about_ca_system_score_codex":0.003376277,"about_ca_system_score_gemma":0.004261963,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W2024714098","doi":"10.1016/j.critrevonc.2007.06.001","title":"Cognitive function after chemotherapy in adults with solid tumours","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cognition; Medicine; Chemotherapy; Cognitive impairment; Cancer; Confounding; Etiology; Incidence (geometry); Oncology; Internal medicine; Clinical psychology; Psychiatry","score_opus":0.06126936250480111,"score_gpt":0.44898116214656203,"score_spread":0.38771179964176095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024714098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087007815,0.98508346,0.00032530972,0.00096338266,0.0006443558,0.006119974,0.000025483114,0.00006879711,0.006682257],"genre_scores_gemma":[0.00094610284,0.9895226,0.00040074877,0.003813332,0.0003241069,0.0045865583,0.000106949665,0.0001359716,0.00016362514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934806,0.0010147531,0.0025062838,0.0013542502,0.00032973997,0.0013143339],"domain_scores_gemma":[0.99474984,0.0036307538,0.0004903794,0.00043730185,0.0003757283,0.0003159659],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014728593,0.0010601804,0.008331131,0.0010358177,0.000060560265,0.000010923127,0.00018975176,0.001563082,0.0007191588],"category_scores_gemma":[0.0040832413,0.000775761,0.000627212,0.0012977854,0.0013810039,0.000100000434,0.0001294332,0.0026998392,0.0006536694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032845747,0.0013001758,0.000974851,0.034329623,0.0002680235,0.0033101663,0.00020611593,8.2529175e-9,3.9472543e-8,0.0007015242,0.00093386654,0.95469105],"study_design_scores_gemma":[0.0046987804,0.0029698806,0.0005778478,0.24529183,0.0024480356,0.0033064275,0.00021854445,0.000001381888,0.0000012759364,0.00017904014,0.73967475,0.0006321902],"about_ca_topic_score_codex":0.000012476292,"about_ca_topic_score_gemma":0.00036850185,"teacher_disagreement_score":0.9540588,"about_ca_system_score_codex":0.0012142132,"about_ca_system_score_gemma":0.0009071708,"threshold_uncertainty_score":0.9997331},"labels":[],"label_agreement":null},{"id":"W2025490583","doi":"10.1016/s1040-8428(03)00095-7","title":"The importance of parenting concerns among patients with cancer","year":2003,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Family Support in Illness","field":"Social Sciences","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Cancer; Childhood cancer; Quality of life (healthcare); Medicine; Cancer treatment; Psychology; Family medicine; Nursing","score_opus":0.10138859431815475,"score_gpt":0.4596896178503047,"score_spread":0.35830102353215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025490583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009123334,0.9788634,0.000012471086,0.00025041023,0.0018711191,0.0024453003,0.000029984658,0.000024862802,0.016411182],"genre_scores_gemma":[0.00017914697,0.99715835,0.00023249762,0.00023917279,0.000113108166,0.0017671576,0.000022673074,0.00005388487,0.00023403698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911407,0.0038502503,0.002566891,0.0007668647,0.00047729586,0.0011979773],"domain_scores_gemma":[0.9897439,0.007529269,0.0014122011,0.0007057833,0.00037336623,0.00023548825],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003604679,0.0005342897,0.004578561,0.00012348976,0.00046743776,0.00003487832,0.001170697,0.0010172406,0.0004107311],"category_scores_gemma":[0.011221173,0.00033097793,0.0004466957,0.0009028149,0.0048713894,0.00014293699,0.00017401442,0.0011073283,0.00004156617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008214981,0.00023850444,0.10318458,0.0078060217,0.00006864224,0.00006535024,0.00044626938,4.7495607e-8,1.9462165e-9,0.1963552,0.0043823714,0.6874448],"study_design_scores_gemma":[0.00020220698,0.00006306197,0.00015576674,0.015725248,0.000346516,0.0000071656314,0.00029973363,2.2277072e-7,6.311661e-8,0.0007403541,0.982103,0.00035665472],"about_ca_topic_score_codex":0.00019464723,"about_ca_topic_score_gemma":0.009834121,"teacher_disagreement_score":0.9777206,"about_ca_system_score_codex":0.0007327902,"about_ca_system_score_gemma":0.0022820116,"threshold_uncertainty_score":0.9999142},"labels":[],"label_agreement":null},{"id":"W2027012209","doi":"10.1016/j.critrevonc.2007.04.011","title":"Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Garron Family Cancer Centre","keywords":"Monoclonal antibody; Epitope; Paratope; Cetuximab; Recombinant DNA; Antibody; Antigen; Immunogenicity; Computational biology; Medicine; Biology; Immunology; Genetics; Gene","score_opus":0.22997501949382906,"score_gpt":0.499674365523765,"score_spread":0.26969934602993595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027012209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108129614,0.9920439,0.0005488483,0.0007508646,0.00065132586,0.0037822793,0.00034548613,0.000009854299,0.0017593093],"genre_scores_gemma":[0.00015569017,0.9896594,0.008307086,0.00014415749,0.00022114131,0.0007634377,0.00014513322,0.00004122331,0.0005626845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952208,0.0010302635,0.0022746425,0.0005703494,0.0002800267,0.0006239355],"domain_scores_gemma":[0.9915574,0.006727102,0.000635314,0.00058330677,0.00033800898,0.00015885272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013258641,0.00050266564,0.0052283634,0.0003283372,0.00013652533,0.000004487217,0.0003276963,0.0010521531,0.00024517282],"category_scores_gemma":[0.0044174874,0.00027763066,0.0010023761,0.0006267232,0.0011043672,0.000037108883,0.00014407907,0.000958444,0.00000876839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048639078,0.0008138565,0.0019553215,0.06466352,0.00048342845,0.000023191476,0.00008038577,6.2936687e-7,0.000040510524,0.25513303,0.001630646,0.67468905],"study_design_scores_gemma":[0.00072886894,0.00082187844,0.00014737355,0.016677992,0.001780731,0.00034647406,0.000022453165,0.000019745557,0.0000674755,0.0057515684,0.9734374,0.0001980158],"about_ca_topic_score_codex":0.000105159335,"about_ca_topic_score_gemma":0.0002815574,"teacher_disagreement_score":0.97180676,"about_ca_system_score_codex":0.0004956044,"about_ca_system_score_gemma":0.0015438393,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W2028588327","doi":"10.1016/j.critrevonc.2010.10.004","title":"Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Weight loss; Anorexia; Cancer cachexia; Cancer; Medicine; Psychosocial; Bioinformatics; Internal medicine; Obesity; Biology; Psychiatry","score_opus":0.10541733335297397,"score_gpt":0.46813371465139136,"score_spread":0.3627163812984174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028588327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010250354,0.98986185,0.0000050431067,0.002342903,0.00042474372,0.006404229,0.00009237707,0.000028192111,0.0008304042],"genre_scores_gemma":[0.000017877854,0.9879714,0.0004733237,0.0050957925,0.000111375695,0.00605621,0.0001213963,0.0000761631,0.0000764645],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99092126,0.0030563585,0.0040568467,0.0008755817,0.00025509467,0.0008348403],"domain_scores_gemma":[0.99475455,0.0026293239,0.0012243821,0.000634137,0.00036715178,0.00039045067],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029917127,0.0007629733,0.013988596,0.0006722893,0.000051775245,0.000007673213,0.00030222003,0.0014276947,0.00025986403],"category_scores_gemma":[0.004777122,0.00050111423,0.00042594384,0.0015069129,0.0007349407,0.00008900107,0.00012566875,0.0023304147,0.000015974842],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003389766,0.00053244014,0.0014109602,0.95366776,0.00013408762,0.00138003,0.0001958613,1.4017689e-9,6.900371e-8,0.008163112,0.0023965,0.032085277],"study_design_scores_gemma":[0.0008078302,0.00020516067,0.000027200109,0.6537298,0.0017652404,0.0019972334,0.00000982847,0.0000011038073,1.4178755e-7,0.00018656587,0.34100902,0.00026085245],"about_ca_topic_score_codex":0.00006678179,"about_ca_topic_score_gemma":0.00086335297,"teacher_disagreement_score":0.33861253,"about_ca_system_score_codex":0.0012967589,"about_ca_system_score_gemma":0.0014274939,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W2029225153","doi":"10.1016/s1040-8428(00)00087-1","title":"Overview of autologous stem cell transplantation","year":2000,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Stem cell; Multiple myeloma; Transplantation; Bone marrow; Autologous stem-cell transplantation; Surgery; Immunology; Biology","score_opus":0.1334675622002062,"score_gpt":0.44358331696603615,"score_spread":0.31011575476583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029225153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000204842,0.97843,0.0002927915,0.00020573167,0.00048388576,0.003375304,0.00008189757,0.00006932541,0.017040635],"genre_scores_gemma":[0.00007458894,0.9956749,0.002483335,0.00031607755,0.000073125215,0.00078251533,0.00028645885,0.00010216752,0.00020683512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910761,0.00224899,0.004450245,0.0010290006,0.0003524144,0.00084323203],"domain_scores_gemma":[0.99360687,0.004379193,0.0007004789,0.0008744373,0.00011617181,0.00032286043],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014738187,0.000860237,0.010383158,0.00067048095,0.000047850506,0.000008232414,0.00043698435,0.0021079262,0.0011649926],"category_scores_gemma":[0.00029711358,0.00069677597,0.0012114098,0.0008415786,0.0005887084,0.00007747015,0.000035516525,0.0013535669,0.0010181539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059649326,0.00051477656,0.00001925502,0.2841687,0.000044752625,0.0014729917,0.00016964778,4.8682153e-8,0.0000014566082,0.0077639883,0.0003415906,0.70544314],"study_design_scores_gemma":[0.00097619224,0.00054209697,0.000010472382,0.11406176,0.0037533923,0.011537326,0.000024612806,0.0000039823503,0.00004574698,0.00023535467,0.86836135,0.0004477264],"about_ca_topic_score_codex":0.000008065621,"about_ca_topic_score_gemma":0.000013768492,"teacher_disagreement_score":0.86801976,"about_ca_system_score_codex":0.00036321016,"about_ca_system_score_gemma":0.0011685962,"threshold_uncertainty_score":0.9997597},"labels":[],"label_agreement":null},{"id":"W2036568229","doi":"10.1016/j.critrevonc.2009.03.001","title":"Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant therapy; Adjuvant; Clinical trial; Cancer; Internal medicine; Metastatic breast cancer; Randomized controlled trial; Disease","score_opus":0.052923977268484586,"score_gpt":0.46855957400646975,"score_spread":0.41563559673798517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036568229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013834889,0.9878528,0.000009654425,0.0016880606,0.0016886472,0.007054444,0.0013463239,0.000034394743,0.00031182155],"genre_scores_gemma":[0.00005880843,0.99291974,0.0013461834,0.0013445448,0.00016358035,0.003609026,0.00037049456,0.00007825235,0.00010936544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950963,0.0005905368,0.0024040677,0.0008424703,0.00023682532,0.0008297641],"domain_scores_gemma":[0.99656653,0.0011969705,0.00063605345,0.00054753595,0.00066308293,0.00038980987],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004486878,0.0007232198,0.009228635,0.00028840487,0.00009569347,0.0000057688208,0.00022052061,0.0013896114,0.00045057968],"category_scores_gemma":[0.0010352657,0.00043429167,0.0009216131,0.00054590235,0.0003038285,0.000050862465,0.00004583188,0.00081767124,0.000030684943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016590955,0.0010259487,0.00036536297,0.05476326,0.00011873542,0.00010300065,0.00007458265,3.1839615e-9,1.4446615e-8,0.0011726383,0.00410759,0.93660975],"study_design_scores_gemma":[0.003756642,0.0048528565,0.00023955191,0.04147483,0.0012292453,0.000559441,0.00003081059,2.3864888e-7,0.000001617191,0.00014648376,0.9474097,0.00029856674],"about_ca_topic_score_codex":0.000042215448,"about_ca_topic_score_gemma":0.0004210495,"teacher_disagreement_score":0.94330215,"about_ca_system_score_codex":0.00122097,"about_ca_system_score_gemma":0.0026427484,"threshold_uncertainty_score":0.9999068},"labels":[],"label_agreement":null},{"id":"W2036755924","doi":"10.1016/j.critrevonc.2013.05.007","title":"Geographic differences in approach to advanced gastric cancer: Is there a standard approach?","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Irinotecan; Cancer; Internal medicine; Oncology; Chemotherapy; Disease; Colorectal cancer","score_opus":0.10869819486598088,"score_gpt":0.42253776119236824,"score_spread":0.3138395663263874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036755924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005650657,0.9764485,0.0007041712,0.0014516312,0.0005289575,0.007664964,0.00004016765,0.00006564293,0.013039511],"genre_scores_gemma":[0.00014215895,0.9746682,0.01194841,0.0016523892,0.00016226259,0.010817385,0.00006255026,0.00008855909,0.0004580998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99260956,0.0010664318,0.0027313642,0.0016656107,0.00044533686,0.0014816934],"domain_scores_gemma":[0.99670124,0.0011530666,0.00047557763,0.0010204362,0.00013895037,0.00051070645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012166235,0.0011008948,0.011016233,0.0016238212,0.000071390794,0.000040979572,0.00086632086,0.0011090393,0.0006139819],"category_scores_gemma":[0.0018574215,0.00077297166,0.00097066414,0.002546714,0.0005378236,0.000107817315,0.00044175028,0.0019060683,0.00021432714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059166425,0.00064010336,0.0045978227,0.047858007,0.000121604906,0.0001337778,0.00009920298,1.3315433e-7,3.5540193e-8,0.007289011,0.0064429543,0.93275815],"study_design_scores_gemma":[0.0012836604,0.00061206135,0.00045153435,0.02476012,0.0010903093,0.00039635858,0.0001595777,0.000018629627,9.302904e-8,0.0003394877,0.9702843,0.00060386467],"about_ca_topic_score_codex":0.000086022286,"about_ca_topic_score_gemma":0.00006461355,"teacher_disagreement_score":0.9638414,"about_ca_system_score_codex":0.0009712069,"about_ca_system_score_gemma":0.0007457969,"threshold_uncertainty_score":0.99947214},"labels":[],"label_agreement":null},{"id":"W2042675162","doi":"10.1016/s1040-8428(02)00007-0","title":"Copper and carcinogenesis","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Trace Elements in Health","field":"Nursing","cited_by":352,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kootenay Association for Science & Technology","funders":"","keywords":"Deoxyribose; Reactive oxygen species; Chemistry; Copper; Carcinogenesis; Radical; Catalysis; DNA damage; Redox; Reactive intermediate; Metal; DNA; Biochemistry; Inorganic chemistry; Organic chemistry","score_opus":0.17513654691434463,"score_gpt":0.4877557359682859,"score_spread":0.31261918905394126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042675162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005005454,0.98743373,0.000013295235,0.0024231274,0.003264027,0.0028715543,0.000035203073,0.00009042151,0.0038636432],"genre_scores_gemma":[0.000029497536,0.9933317,0.0030648103,0.0017245004,0.0003178256,0.0012770366,0.00003015882,0.00014223187,0.000082248924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891271,0.0042307526,0.0033744492,0.001473341,0.00025235582,0.0015420133],"domain_scores_gemma":[0.9904685,0.007389247,0.0005398657,0.0010486641,0.00008628113,0.00046743886],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021416747,0.00097254926,0.00864828,0.00057948934,0.0001810529,0.000032026426,0.00069665676,0.002079175,0.00070363126],"category_scores_gemma":[0.008203262,0.0008164385,0.0005608889,0.00064529775,0.0010445482,0.00010789257,0.00032825378,0.0019876389,0.0012796432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010434222,0.0002836544,0.00013231202,0.050692398,0.000023050232,0.0002683096,0.00007679846,6.286112e-9,7.578661e-8,0.013428015,0.016995782,0.91808915],"study_design_scores_gemma":[0.0003614214,0.0004046287,0.000007179645,0.026796762,0.0008240986,0.0025717258,0.000022269698,0.0000035013454,7.0747893e-7,0.00068497454,0.9677188,0.00060393714],"about_ca_topic_score_codex":0.0000191431,"about_ca_topic_score_gemma":0.000099649376,"teacher_disagreement_score":0.950723,"about_ca_system_score_codex":0.0010436529,"about_ca_system_score_gemma":0.00023845359,"threshold_uncertainty_score":0.99949795},"labels":[],"label_agreement":null},{"id":"W2043247151","doi":"10.1016/s1040-8428(01)00139-1","title":"Ethics of rural health care","year":2001,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jessie Ball duPont Fund","keywords":"Outreach; Confidentiality; Rural area; Medicine; Health care; Alliance; Nursing; Economic Justice; Quarter (Canadian coin); Family medicine; Political science; Law","score_opus":0.1608137104597912,"score_gpt":0.5248876162937445,"score_spread":0.36407390583395327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043247151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012911615,0.98205703,0.00015134957,0.0050327075,0.0007195843,0.002949257,0.0000142704885,0.00004713386,0.009027367],"genre_scores_gemma":[0.0000087916715,0.99226177,0.002600441,0.00394566,0.00021414108,0.00045088833,0.0002157364,0.000065585366,0.00023700214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99182004,0.0031678402,0.003194126,0.0005709777,0.0003052925,0.0009417165],"domain_scores_gemma":[0.993149,0.004636667,0.0006916176,0.000972539,0.00020053728,0.00034963136],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0031112698,0.0006444442,0.010332189,0.0005820048,0.00007671491,0.0000069607386,0.0005014449,0.0018589665,0.0003577233],"category_scores_gemma":[0.012466852,0.0004938967,0.0010423297,0.00086640613,0.00080956443,0.000039655668,0.00027422106,0.003092692,0.0003778955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015720172,0.00026444253,0.000110782814,0.18105355,0.000052371066,0.00032495876,0.00032941214,5.6439697e-9,1.7256477e-8,0.050279416,0.009824565,0.7577448],"study_design_scores_gemma":[0.000493135,0.0005969994,0.00000806202,0.091969706,0.0007883649,0.0003761715,0.0003737632,8.599937e-7,1.1313235e-7,0.0003870186,0.90472674,0.0002790792],"about_ca_topic_score_codex":0.000021946405,"about_ca_topic_score_gemma":0.0000693082,"teacher_disagreement_score":0.89490217,"about_ca_system_score_codex":0.0007843409,"about_ca_system_score_gemma":0.0021657217,"threshold_uncertainty_score":0.99975127},"labels":[],"label_agreement":null},{"id":"W2046364242","doi":"10.1016/j.critrevonc.2012.07.003","title":"The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; St. Paul's Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Lenalidomide; Thalidomide; Myelodysplastic syndromes; Guideline; Medicine; Intensive care medicine; Oncology; Internal medicine; Multiple myeloma; Pathology; Bone marrow","score_opus":0.2543962427450863,"score_gpt":0.5526891098308602,"score_spread":0.29829286708577385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046364242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024726487,0.9831931,0.00018739431,0.006059077,0.0016028446,0.00800046,0.000047542908,0.00001922546,0.0008656142],"genre_scores_gemma":[0.000053639676,0.98859024,0.0064323097,0.0010908456,0.00045919072,0.0029168893,0.000048152022,0.00010818938,0.00030054475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98584926,0.005809718,0.005732829,0.00095928257,0.00039434058,0.0012545547],"domain_scores_gemma":[0.93594664,0.059693716,0.0014684204,0.0018880321,0.00053882075,0.00046435432],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009398698,0.0008315257,0.008494353,0.00021553652,0.00025916565,0.000024041668,0.0008167462,0.0014993297,0.000084560306],"category_scores_gemma":[0.0766605,0.0003967963,0.0016929511,0.00046819,0.0027095145,0.00010188888,0.0005235496,0.0012632634,0.000120089644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004861048,0.0011606985,0.00006696161,0.015696969,0.0007014752,0.0002580831,0.000059593625,2.7067372e-8,5.905703e-7,0.012241197,0.010297573,0.95903075],"study_design_scores_gemma":[0.0028892453,0.0014449727,0.000019533089,0.011944477,0.0062770504,0.010473545,0.00007354883,0.000027741236,0.0000014401144,0.00036360772,0.96620196,0.00028285163],"about_ca_topic_score_codex":0.000018101846,"about_ca_topic_score_gemma":0.000020519969,"teacher_disagreement_score":0.95874786,"about_ca_system_score_codex":0.0015597156,"about_ca_system_score_gemma":0.0030206947,"threshold_uncertainty_score":0.99984837},"labels":[],"label_agreement":null},{"id":"W2049829884","doi":"10.1016/j.critrevonc.2014.07.004","title":"Reproductive factors and non-Hodgkin lymphoma: A systematic review","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universitat de Barcelona","keywords":"Etiology; Medicine; Estrogen; Lymphoma; Hormone; Hodgkin lymphoma; Oncology; Bioinformatics; Gynecology; Internal medicine; Biology","score_opus":0.07690594790914243,"score_gpt":0.45548752257723996,"score_spread":0.3785815746680975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049829884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006050432,0.98685324,0.00007056816,0.000893225,0.00085290405,0.009759843,0.000022991115,0.000060996477,0.0014801958],"genre_scores_gemma":[0.000044083703,0.9943376,0.0004001584,0.0017175017,0.00024748498,0.0029049453,0.00008074012,0.00012174255,0.00014571976],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98981297,0.0025197598,0.004556173,0.0018269997,0.00031577324,0.00096833945],"domain_scores_gemma":[0.9914042,0.0047534234,0.0011759453,0.001906547,0.00020795087,0.00055198674],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003625238,0.0012394703,0.025102163,0.0004822674,0.000093596216,0.000022620985,0.00045876368,0.0014477144,0.0001872365],"category_scores_gemma":[0.032249738,0.00077826873,0.0014370589,0.00077921076,0.0009213911,0.000083306964,0.00031217127,0.0012476915,0.00039893773],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009637739,0.00024837657,0.00004668861,0.8521126,0.00013907987,0.00028404375,0.00005413356,5.351047e-10,4.5897867e-8,0.0027451776,0.0038279835,0.14053224],"study_design_scores_gemma":[0.00029821057,0.00030807412,0.0000058882583,0.48680678,0.0049979403,0.0028014444,0.000016787793,6.2814433e-7,2.6627214e-7,0.00009911909,0.504313,0.0003518536],"about_ca_topic_score_codex":0.000036006593,"about_ca_topic_score_gemma":0.000033545566,"teacher_disagreement_score":0.500485,"about_ca_system_score_codex":0.0009489078,"about_ca_system_score_gemma":0.00088921067,"threshold_uncertainty_score":0.9998486},"labels":[],"label_agreement":null},{"id":"W2053115200","doi":"10.1016/j.critrevonc.2011.05.009","title":"Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Zoledronic acid; Medicine; Bone marrow; Cancer; Breast cancer; Multiple myeloma; Cancer research; Tumor progression; Oncology; Cancer cell; Tumor microenvironment; Internal medicine","score_opus":0.12128708839131158,"score_gpt":0.5000773647743756,"score_spread":0.378790276383064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053115200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025609508,0.9948452,0.00029738175,0.00030809618,0.0011660858,0.0028397355,0.00004099898,0.00002830303,0.00044856683],"genre_scores_gemma":[0.00091090996,0.988013,0.009102486,0.00020054153,0.000045264587,0.0014875517,0.0001043148,0.00006597042,0.000069917616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941688,0.00088875345,0.0032646253,0.000693895,0.0002402753,0.00074365584],"domain_scores_gemma":[0.99674207,0.00084015116,0.0013274599,0.00048280272,0.00026829046,0.00033923078],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012278098,0.00057398604,0.0077404943,0.0003608486,0.00005938588,0.0000024213864,0.00021099033,0.0016449738,0.00073353556],"category_scores_gemma":[0.002419653,0.00040048218,0.00074122084,0.000478072,0.0005395633,0.000055354474,0.00014451725,0.0011136753,0.000071364826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016520219,0.001343263,0.000084994375,0.08340213,0.000140038,0.00047162117,0.000030482233,1.26277975e-8,0.000012064475,0.016285973,0.0008825762,0.89718163],"study_design_scores_gemma":[0.0012572509,0.0013448044,0.00000915811,0.07658789,0.0030576927,0.0019845278,0.000024051942,0.0000067868773,0.00032236121,0.002396072,0.91269153,0.00031786415],"about_ca_topic_score_codex":0.00014672146,"about_ca_topic_score_gemma":0.000058976868,"teacher_disagreement_score":0.91180897,"about_ca_system_score_codex":0.00037314728,"about_ca_system_score_gemma":0.001460428,"threshold_uncertainty_score":0.99984473},"labels":[],"label_agreement":null},{"id":"W2058243111","doi":"10.1016/j.critrevonc.2009.03.005","title":"Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Rehabilitation Institute; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Toronto Rehabilitation Institute; University Health Network; Cancer Research Institute","keywords":"Testosterone (patch); Prostate cancer; Cognition; Hormone; Androgen; Androgen deprivation therapy; Internal medicine; Affect (linguistics); Medicine; Psychology; Endocrinology; Oncology; Cancer; Neuroscience","score_opus":0.059537684602260964,"score_gpt":0.4201733202279859,"score_spread":0.360635635625725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058243111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049436,0.04521647,0.000049572976,0.021158734,0.0001386108,0.005216277,0.000020693165,0.00005290491,0.023203144],"genre_scores_gemma":[0.9925744,0.0050403452,0.00042795786,0.0010840374,0.000068937465,0.00049832684,0.000006302763,0.000016257205,0.00028341427],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99757487,0.0005255474,0.0007460566,0.00054161967,0.00017413046,0.0004378047],"domain_scores_gemma":[0.9984463,0.00091106823,0.00012516737,0.00024066312,0.00017614466,0.00010067674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082861545,0.000281852,0.0021008542,0.00021018383,0.000039430844,0.0000027552899,0.00007776596,0.00022165618,0.00006848089],"category_scores_gemma":[0.0025296668,0.00015407678,0.00008158701,0.00030723517,0.0006154578,0.000049962517,0.00003301005,0.00047650357,0.000019830572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01808065,0.005980466,0.28002593,0.0049064523,0.0002955458,0.002906683,0.005663503,0.000002445147,0.010604719,0.006721492,0.002360384,0.66245174],"study_design_scores_gemma":[0.029240143,0.06932582,0.7784249,0.027537433,0.0015049501,0.0028135523,0.003489138,0.00023038487,0.06375612,0.005539677,0.016603824,0.0015340252],"about_ca_topic_score_codex":0.000015474656,"about_ca_topic_score_gemma":0.00012789851,"teacher_disagreement_score":0.6609177,"about_ca_system_score_codex":0.00013415483,"about_ca_system_score_gemma":0.00014679215,"threshold_uncertainty_score":0.62830687},"labels":[],"label_agreement":null},{"id":"W2059330989","doi":"10.1016/j.critrevonc.2010.04.003","title":"Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study","year":2010,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Grip strength; Logistic regression; Toxicity; Geriatric oncology; Prospective cohort study; Proportional hazards model; Performance status; Internal medicine; Cancer; Gerontology; Physical therapy","score_opus":0.08229290768159514,"score_gpt":0.4132758791085545,"score_spread":0.33098297142695937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059330989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847747,0.0018697574,0.00003301167,0.002839352,0.00082032266,0.008868601,0.0003584663,0.000055747347,0.00038001325],"genre_scores_gemma":[0.9914863,0.00063918706,0.0017730809,0.00090962293,0.00017196083,0.004886025,0.000057346122,0.000040066396,0.000036392677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955428,0.0006329403,0.0016248005,0.0012406118,0.00022335925,0.00073546084],"domain_scores_gemma":[0.9929431,0.0054049487,0.00039504506,0.00065229234,0.0002742192,0.00033038892],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011077123,0.00045994815,0.002206996,0.00016529766,0.00009679929,0.000019714194,0.00018679914,0.00039240633,0.00011209071],"category_scores_gemma":[0.03342557,0.00037171794,0.00011904531,0.00027729882,0.0005489063,0.00013672092,0.00014038295,0.0008633061,0.000010269182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001708658,0.012283588,0.974008,0.00026340786,0.00009490217,0.0003356213,0.0016230211,1.9306651e-7,0.00005972677,0.0001671599,0.0007121861,0.008743542],"study_design_scores_gemma":[0.026074693,0.0067620776,0.9619601,0.0011691381,0.00031163066,0.0000264725,0.0006530282,0.00013766816,0.00015498849,0.00076478114,0.0016967452,0.00028871952],"about_ca_topic_score_codex":0.0016206459,"about_ca_topic_score_gemma":0.067536704,"teacher_disagreement_score":0.06591606,"about_ca_system_score_codex":0.00070037396,"about_ca_system_score_gemma":0.0002433751,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W2059784303","doi":"10.1016/j.critrevonc.2015.01.007","title":"Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Society for Radiation Oncology; American Association for Cancer Research","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Oncology; Adjuvant; Targeted therapy; Adjuvant therapy; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Nursing","score_opus":0.13091745782011374,"score_gpt":0.5000722111753172,"score_spread":0.3691547533552034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059784303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06534654,0.92871124,6.757248e-8,0.0002593237,0.0002774319,0.004890038,0.00031343367,0.0000160377,0.00018587374],"genre_scores_gemma":[0.008789579,0.9867787,0.000039108254,0.00012607628,0.0001404587,0.0037809992,0.000230345,0.00006281425,0.000051955067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953696,0.0013395615,0.0016612441,0.00077983603,0.00014377746,0.00070596224],"domain_scores_gemma":[0.99794525,0.0008803517,0.00041744942,0.00036543547,0.00010310487,0.00028838514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003975707,0.0008169693,0.0071257465,0.0007462354,0.000021649757,0.000006472569,0.000102021644,0.0010146899,0.0011495252],"category_scores_gemma":[0.00013601812,0.00053168356,0.0005863947,0.0006300013,0.00034830393,0.00010928134,0.000047104277,0.00046191475,0.000062606035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005209515,0.0026393156,0.20517991,0.0017787578,0.0002316017,0.00023228291,0.00042410693,3.7709626e-8,0.0000013229842,0.00004523116,0.00018268908,0.7887638],"study_design_scores_gemma":[0.024324916,0.018215531,0.31836915,0.02179665,0.0024224024,0.00092781923,0.000009698037,0.000019785939,0.00000418712,0.00012548745,0.6128882,0.0008961544],"about_ca_topic_score_codex":0.008062962,"about_ca_topic_score_gemma":0.0036146175,"teacher_disagreement_score":0.78786767,"about_ca_system_score_codex":0.005817023,"about_ca_system_score_gemma":0.0010871036,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2060481687","doi":"10.1016/j.critrevonc.2014.08.001","title":"Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Benchmarking; Renal cell carcinoma; Medicine; Oncology; Clinical endpoint; Internal medicine; Progression-free survival; Clinical trial; Overall survival; Randomized controlled trial","score_opus":0.12207618892468768,"score_gpt":0.48118485976249337,"score_spread":0.3591086708378057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060481687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016201149,0.9798839,0.0027880569,0.00026626792,0.00072954857,0.012713915,0.000065961365,0.000021789638,0.00191044],"genre_scores_gemma":[0.0050162324,0.9722683,0.017914267,0.00019336397,0.00013995165,0.0030742504,0.0012382253,0.00009530963,0.000060143575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96511,0.022185469,0.009621447,0.001610198,0.0006172626,0.00085564447],"domain_scores_gemma":[0.9295937,0.064803116,0.0035300604,0.0012471784,0.0003620601,0.00046391497],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03774944,0.0010302338,0.032538787,0.0011335706,0.00006079966,0.0000169084,0.00040669978,0.0016126619,0.00023484493],"category_scores_gemma":[0.061016627,0.0006476629,0.0033335618,0.0008532969,0.0010686982,0.00008373969,0.0002976317,0.0013387924,0.000010366229],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09120545,0.0048580733,0.012032521,0.10346564,0.0034020147,0.0016487018,0.00021036997,0.00000549534,0.000007428289,0.012930294,0.0008594007,0.7693746],"study_design_scores_gemma":[0.35199076,0.0120364465,0.003167781,0.0764266,0.07527365,0.0007794591,0.00007228989,0.0006010493,0.000027859716,0.0024178969,0.47500122,0.0022049833],"about_ca_topic_score_codex":0.000020970667,"about_ca_topic_score_gemma":0.00006577256,"teacher_disagreement_score":0.76716965,"about_ca_system_score_codex":0.000630237,"about_ca_system_score_gemma":0.0012854823,"threshold_uncertainty_score":0.99968344},"labels":[],"label_agreement":null},{"id":"W2066047258","doi":"10.1016/j.critrevonc.2012.02.004","title":"Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Sunitinib; Axitinib; Bevacizumab; Medicine; Angiogenesis; Vascular endothelial growth factor; Sorafenib; Fibroblast growth factor; Lung cancer; Cancer research; Oncology; Platelet-derived growth factor receptor; Growth factor; Pharmacology; Internal medicine; Chemotherapy; Cancer; VEGF receptors; Receptor; Hepatocellular carcinoma","score_opus":0.12314918485587871,"score_gpt":0.5226966903665233,"score_spread":0.3995475055106446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066047258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046298046,0.99214983,0.00002102356,0.0025594246,0.0018174584,0.002249624,0.000058341524,0.00004995635,0.0010480732],"genre_scores_gemma":[0.00007886884,0.9937591,0.0031905195,0.0011273607,0.0007284948,0.00074948184,0.00021849843,0.0000612662,0.00008639556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952987,0.0011884008,0.0018952386,0.0008374068,0.00011705614,0.0006632306],"domain_scores_gemma":[0.9970131,0.0015173747,0.00030527933,0.0005035447,0.00009511692,0.0005655863],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009397522,0.0005681438,0.0053524366,0.0003017171,0.00013755987,0.000015955937,0.00013144778,0.0013120286,0.00035283156],"category_scores_gemma":[0.0013953792,0.0004020015,0.00062463613,0.00038404236,0.0007034647,0.000092151065,0.00016868873,0.001011902,0.0002758432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010771108,0.0006554184,0.0015587274,0.008490537,0.0003574903,0.00025433305,0.00004778708,6.093277e-10,3.486893e-8,0.0074669337,0.0022458315,0.9789121],"study_design_scores_gemma":[0.0010624531,0.00022923957,0.00071163336,0.0065512923,0.007623776,0.0030835574,0.000024648052,0.0000020286736,6.127492e-8,0.0001284954,0.98028463,0.00029818417],"about_ca_topic_score_codex":0.00000808203,"about_ca_topic_score_gemma":0.000029263201,"teacher_disagreement_score":0.978614,"about_ca_system_score_codex":0.00025545352,"about_ca_system_score_gemma":0.0004554056,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W2068016036","doi":"10.1016/j.critrevonc.2013.12.003","title":"A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Discovery and development of mTOR inhibitors; Biology","score_opus":0.13347212915148227,"score_gpt":0.4518256693344538,"score_spread":0.3183535401829715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068016036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029863333,0.98373216,0.0010774303,0.00035774734,0.00097035355,0.0102405185,0.00018008696,0.00004318684,0.0030998948],"genre_scores_gemma":[0.0037351097,0.95585304,0.026405148,0.000095358526,0.00023785622,0.012723894,0.00030832467,0.0001965687,0.00044467344],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896294,0.0021771442,0.0046977242,0.0016223387,0.00037593264,0.0014974735],"domain_scores_gemma":[0.97835904,0.017968113,0.0008275241,0.001532083,0.0005011109,0.0008121239],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012127695,0.0014412745,0.013712392,0.00079241226,0.00011400605,0.000026928317,0.000540187,0.0013778908,0.00045412278],"category_scores_gemma":[0.005729985,0.0010168647,0.002744404,0.0005693101,0.0011402449,0.00010384432,0.00020722793,0.0010431561,0.000985092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004105157,0.011816721,0.00007831189,0.54616416,0.00054771267,0.004101444,0.0004235048,5.583258e-7,0.0002430621,0.027229382,0.008736408,0.40024823],"study_design_scores_gemma":[0.0047728526,0.013360227,0.000006521866,0.044161323,0.017781712,0.0104863085,0.00027022508,0.00009025896,0.0004025956,0.00026853336,0.9073331,0.0010663669],"about_ca_topic_score_codex":0.000044850327,"about_ca_topic_score_gemma":0.000010539791,"teacher_disagreement_score":0.89859664,"about_ca_system_score_codex":0.0018063034,"about_ca_system_score_gemma":0.0022925888,"threshold_uncertainty_score":0.9999185},"labels":[],"label_agreement":null},{"id":"W2070432051","doi":"10.1016/j.critrevonc.2010.05.004","title":"Potential drug interactions in elderly cancer patients","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Concomitant; Contraindication; Medicine; Drug; Cancer; Intensive care medicine; Drug interaction; Internal medicine; Pharmacology; Alternative medicine; Pathology","score_opus":0.2005661983127204,"score_gpt":0.557114383883131,"score_spread":0.35654818557041057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070432051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015435288,0.9841289,0.000013097864,0.002959553,0.004438925,0.003026922,0.000036040914,0.000034832738,0.0052073714],"genre_scores_gemma":[0.00048739108,0.9947793,0.00058504706,0.001858966,0.00028788674,0.0014683474,0.00013008421,0.000069202135,0.00033376113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934698,0.0016301681,0.0028028972,0.00090686145,0.00026393117,0.0009263708],"domain_scores_gemma":[0.99400747,0.004250944,0.00056418194,0.0005705271,0.00015626938,0.00045059863],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010405286,0.00067902496,0.006004738,0.0006067799,0.00007080286,0.000021173571,0.00041089626,0.0007748605,0.0019928229],"category_scores_gemma":[0.008258173,0.0005117947,0.000832181,0.0006070804,0.00046204944,0.00020585771,0.0002411799,0.005244261,0.00087015965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070211216,0.0019695722,0.0026235029,0.018163577,0.000049266877,0.000525918,0.000048989215,2.5891769e-8,3.4286586e-7,0.0026447482,0.003112154,0.9707917],"study_design_scores_gemma":[0.0011890358,0.00020890086,0.000071932955,0.024838805,0.0012596677,0.0005382557,0.000011752058,0.00001956,7.0041466e-7,0.00025750432,0.97121054,0.0003933554],"about_ca_topic_score_codex":0.00006589637,"about_ca_topic_score_gemma":0.0006465191,"teacher_disagreement_score":0.9703983,"about_ca_system_score_codex":0.0006345703,"about_ca_system_score_gemma":0.0007729764,"threshold_uncertainty_score":0.9999078},"labels":[],"label_agreement":null},{"id":"W2071995956","doi":"10.1016/j.critrevonc.2010.07.007","title":"Peripheral T-cell lymphoma – Not otherwise specified","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; CD5; International Prognostic Index; CD8; Not Otherwise Specified; Medicine; Pathology; Lymph node; B symptoms; Bone marrow; Cytotoxic T cell; Generalized lymphadenopathy; T cell; Biology; Immunology; Diffuse large B-cell lymphoma; Immune system","score_opus":0.0986027842196142,"score_gpt":0.43288626105203254,"score_spread":0.3342834768324183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071995956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038659928,0.95753664,0.000012676252,0.001497559,0.0016383943,0.0033829669,0.00003715363,0.00008548563,0.03577049],"genre_scores_gemma":[0.000105663945,0.9894032,0.0035968185,0.0023924983,0.0005766406,0.0027707568,0.00013071255,0.0001522931,0.00087143935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927229,0.0012242359,0.002948834,0.0014967519,0.0003201959,0.0012870505],"domain_scores_gemma":[0.99382097,0.0032849147,0.0005388285,0.0015346141,0.00013585135,0.00068484887],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010787268,0.0012271164,0.010917283,0.0004191805,0.00010837398,0.000036140304,0.0005800984,0.0028523523,0.0020476454],"category_scores_gemma":[0.0030086234,0.00086363894,0.0018331537,0.0005535887,0.0009200052,0.00006920716,0.00025517287,0.0012636652,0.0035540997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007159432,0.004142976,0.00006981566,0.020242061,0.00007862611,0.0043293606,0.000044870645,2.3992732e-9,0.0000013330163,0.021978913,0.0056549716,0.9433855],"study_design_scores_gemma":[0.0033645495,0.0007403184,0.000026410968,0.017727682,0.0019089445,0.0069085313,0.000015793337,0.0000018416162,0.000019094561,0.00019724468,0.96845305,0.00063655624],"about_ca_topic_score_codex":0.000016141252,"about_ca_topic_score_gemma":0.00008338322,"teacher_disagreement_score":0.96279806,"about_ca_system_score_codex":0.0016261148,"about_ca_system_score_gemma":0.0017717038,"threshold_uncertainty_score":0.9993814},"labels":[],"label_agreement":null},{"id":"W2072037526","doi":"10.1016/j.critrevonc.2012.02.005","title":"Anaplastic large cell lymphoma, ALK-positive","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; CD30; Medicine; Lymphoma; CHOP; Internal medicine; Oncology; International Prognostic Index; Large cell; Chemotherapy; Autologous stem-cell transplantation; Vincristine; Pathology; Cancer research; Cyclophosphamide; Diffuse large B-cell lymphoma; Cancer; Adenocarcinoma","score_opus":0.0786741343386865,"score_gpt":0.42814028940004256,"score_spread":0.34946615506135603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072037526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000074684754,0.96812326,0.00005459175,0.0005224791,0.0012638372,0.0032200355,0.000106305626,0.00006526389,0.026636774],"genre_scores_gemma":[0.00045897078,0.9927591,0.0013363045,0.0014947031,0.00040225632,0.0027066348,0.00039525307,0.00011808016,0.0003287011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922154,0.0017940131,0.0026665332,0.0012355717,0.00029401644,0.0017944569],"domain_scores_gemma":[0.9910871,0.0063729254,0.00053213374,0.0010385411,0.00014487209,0.0008244592],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001277102,0.0011837181,0.0105069205,0.0005158386,0.00012679191,0.000020995194,0.00040513615,0.0020451015,0.000901501],"category_scores_gemma":[0.0027705152,0.00083847996,0.0015138029,0.00064384344,0.00053467706,0.00009897523,0.00035147657,0.000788432,0.0062984615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000460339,0.009321378,0.00023982678,0.03520036,0.00017954728,0.003738858,0.000062306084,1.9538946e-9,6.451448e-8,0.035573646,0.0061065517,0.9095314],"study_design_scores_gemma":[0.003478855,0.001032053,0.00005303802,0.033860974,0.0059802462,0.006173156,0.000020478219,0.0000018021784,0.0000041658477,0.00016041649,0.9486441,0.0005907027],"about_ca_topic_score_codex":0.000011269871,"about_ca_topic_score_gemma":0.000042490312,"teacher_disagreement_score":0.94253755,"about_ca_system_score_codex":0.002108809,"about_ca_system_score_gemma":0.0013409368,"threshold_uncertainty_score":0.9994066},"labels":[],"label_agreement":null},{"id":"W2072606968","doi":"10.1016/j.critrevonc.2007.04.014","title":"A comprehensive systematic review of testicular germ cell tumor surveillance","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Germ cell; Germ; Medicine; Biology; Cell biology; Genetics","score_opus":0.09061410456637124,"score_gpt":0.45929676956395243,"score_spread":0.3686826649975812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072606968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017839341,0.98791754,0.000059516355,0.00014001243,0.00033221956,0.009731249,0.00007674332,0.000052760894,0.001688195],"genre_scores_gemma":[0.000023103563,0.9937455,0.0022007646,0.0019018311,0.00006313912,0.001696517,0.0002104526,0.000099459336,0.000059218444],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.989582,0.0027265996,0.005276397,0.0010408079,0.00044810475,0.00092607934],"domain_scores_gemma":[0.98588693,0.009539576,0.0018868123,0.0015768933,0.0005567815,0.00055301655],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017914872,0.0010489057,0.02047834,0.00041347407,0.000047704114,0.0000083256455,0.0004787008,0.00074976514,0.00030249005],"category_scores_gemma":[0.027533222,0.000710516,0.002127835,0.0009748023,0.00068875385,0.000037075944,0.0002189014,0.0010021959,0.0008783958],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000119465185,0.0013428676,0.00007814001,0.9532762,0.00019331499,0.0062216436,0.00000515019,4.0938914e-9,1.3454763e-7,0.0017750235,0.0008665411,0.03622899],"study_design_scores_gemma":[0.00046697716,0.0003670612,0.0000071847912,0.6037794,0.006386105,0.0061397324,0.0000046252385,0.0000014691291,5.1306574e-7,0.000044125805,0.3824998,0.0003029865],"about_ca_topic_score_codex":0.0000075932917,"about_ca_topic_score_gemma":0.0000028823242,"teacher_disagreement_score":0.38163328,"about_ca_system_score_codex":0.00057427405,"about_ca_system_score_gemma":0.0013243486,"threshold_uncertainty_score":0.9998995},"labels":[],"label_agreement":null},{"id":"W2073309188","doi":"10.1016/j.critrevonc.2011.02.005","title":"Consensus on the utility of bone markers in the malignant bone disease setting","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Waterloo; Centre Hospitalier de l’Université de Montréal","funders":"Cancer Research UK","keywords":"Disease; Medicine; Pathology","score_opus":0.16574590685762466,"score_gpt":0.45947597047575384,"score_spread":0.29373006361812914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073309188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011332259,0.97672504,0.000002255453,0.00940608,0.0003260358,0.0052108043,0.000057731504,0.000016506167,0.0081422],"genre_scores_gemma":[0.0036973597,0.99034023,0.0003518471,0.003755631,0.00004036458,0.0016684628,0.000050708197,0.000042004587,0.000053415544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98897356,0.0058245603,0.0032045136,0.00079204293,0.00025118652,0.00095416635],"domain_scores_gemma":[0.9845966,0.01279688,0.0007001135,0.001426221,0.00009553765,0.0003846413],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057679033,0.0006307715,0.0060824496,0.0002711081,0.00009738151,0.0000054339853,0.00035230536,0.00076353946,0.0004801379],"category_scores_gemma":[0.019649921,0.00030540855,0.0008026184,0.0005420903,0.0013546831,0.000016047543,0.00014136062,0.0017771767,0.0002482939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046465328,0.002289545,0.0009595524,0.057675745,0.000075024174,0.0055120406,0.0001199455,1.3428182e-9,3.644272e-8,0.05643282,0.011100655,0.86537],"study_design_scores_gemma":[0.0008492693,0.00049770187,0.00066604547,0.051464655,0.0013241507,0.0024086514,0.000073679264,0.0000056132876,2.4395308e-7,0.0018812278,0.9406106,0.00021818394],"about_ca_topic_score_codex":0.000058082296,"about_ca_topic_score_gemma":0.00007921842,"teacher_disagreement_score":0.92950994,"about_ca_system_score_codex":0.00024806734,"about_ca_system_score_gemma":0.0014377686,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W2073595456","doi":"10.1016/j.critrevonc.2008.07.015","title":"Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia","year":2008,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Myeloid leukemia; Cognition; Pediatrics; Adverse effect; Gerontology; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.04108414178077232,"score_gpt":0.38816088368181106,"score_spread":0.34707674190103877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073595456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94750077,0.036320616,0.00014591755,0.008473401,0.00016093427,0.0024490773,0.000023408336,0.00004092607,0.004884933],"genre_scores_gemma":[0.952372,0.033457376,0.0068008155,0.0044024508,0.00008503791,0.0026882505,0.00002628134,0.000056259385,0.00011149232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938219,0.001370988,0.002270333,0.0009288439,0.00048710566,0.0011208302],"domain_scores_gemma":[0.9941695,0.0037353134,0.00024854057,0.0009359282,0.00034344546,0.00056729926],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017872463,0.0004578293,0.0035053436,0.00049407815,0.000055605924,0.0000048941843,0.0004041642,0.000830879,0.0009981823],"category_scores_gemma":[0.010801783,0.00034870824,0.00026641678,0.0009381767,0.0019637474,0.0001608376,0.00026873263,0.0015648312,0.00021022325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008556122,0.0028270506,0.9234686,0.003995612,0.00016845745,0.0139754405,0.002397174,8.9473997e-7,0.00013539384,0.0077758436,0.015524472,0.021174947],"study_design_scores_gemma":[0.033418417,0.004778109,0.8989829,0.008986744,0.00039685078,0.0080402605,0.0011693563,0.00023077602,0.0021554295,0.0018077572,0.038521625,0.0015117712],"about_ca_topic_score_codex":0.00025621327,"about_ca_topic_score_gemma":0.00073085376,"teacher_disagreement_score":0.024862297,"about_ca_system_score_codex":0.0013063321,"about_ca_system_score_gemma":0.0021845517,"threshold_uncertainty_score":0.99991506},"labels":[],"label_agreement":null},{"id":"W2073945008","doi":"10.1016/j.critrevonc.2013.06.003","title":"Malnutrition assessment in patients with cancers of the head and neck: A call to action and consensus","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Nutrition Society; Alberta Health Services","keywords":"Malnutrition; Medicine; Action (physics); Head and neck; Call to action; Head and neck cancer; Intensive care medicine; Head (geology); Internal medicine; Surgery; Radiation therapy; Biology","score_opus":0.1476131765603573,"score_gpt":0.5086713834653993,"score_spread":0.361058206905042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073945008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045934985,0.98434114,0.000012384076,0.005426135,0.00025623883,0.004924207,0.000016865199,0.000008799755,0.00042070175],"genre_scores_gemma":[0.0011274428,0.9912226,0.00503683,0.001581695,0.000033454104,0.0009387127,0.000018688117,0.000022563154,0.000018021845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968739,0.000839419,0.0012976631,0.00045708226,0.00014935354,0.00038255606],"domain_scores_gemma":[0.99814767,0.000927399,0.00027550408,0.00028412443,0.00013821638,0.00022707299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006069468,0.00028764183,0.003124518,0.00028648248,0.000047052148,0.000006445238,0.0000844353,0.00046950206,0.000040348114],"category_scores_gemma":[0.001017079,0.00018103737,0.00009448005,0.0003616009,0.00042831092,0.000026671965,0.0000874757,0.00093633815,0.00000728401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013998225,0.0006788295,0.024688778,0.105857514,0.000028277589,0.00005197928,0.00006351894,2.6243368e-8,6.196081e-7,0.007258915,0.002833087,0.8583985],"study_design_scores_gemma":[0.0027186815,0.0010836947,0.009306489,0.1100923,0.0002944236,0.00046775685,0.00003795194,0.000005310349,5.5229583e-7,0.0002533979,0.87553865,0.00020077833],"about_ca_topic_score_codex":0.00007810964,"about_ca_topic_score_gemma":0.0003656328,"teacher_disagreement_score":0.8727056,"about_ca_system_score_codex":0.00076719414,"about_ca_system_score_gemma":0.0007024305,"threshold_uncertainty_score":0.73824894},"labels":[],"label_agreement":null},{"id":"W2074862947","doi":"10.1016/j.critrevonc.2012.12.010","title":"Erythropoiesis-stimulating agents (ESAs): Do they still have a role in chemotherapy-induced anemia (CIA)?","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Juravinski Hospital; Regional Municipality of Durham; University of Toronto; Health Sciences Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Ottawa Hospital","funders":"Public Health Agency of Canada","keywords":"Medicine; Anemia; Erythropoiesis; Chemotherapy; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.10825598706274397,"score_gpt":0.4510804286726588,"score_spread":0.3428244416099148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074862947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057660363,0.9788083,0.000007812676,0.0022488558,0.00058224564,0.005663714,0.000017021148,0.000098041804,0.011997405],"genre_scores_gemma":[0.0019548084,0.98846686,0.0047826706,0.0014764986,0.00032903597,0.0022910852,0.0001338228,0.0002072866,0.00035795913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99009186,0.0020255952,0.003967754,0.0017801559,0.00041733004,0.00171732],"domain_scores_gemma":[0.9934925,0.0035805616,0.00075956224,0.0013975785,0.0001829632,0.0005868649],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0013923306,0.0014895246,0.011078344,0.0007233811,0.00010983808,0.000046285855,0.0006250141,0.0027667235,0.001963064],"category_scores_gemma":[0.0053365943,0.0011020583,0.0012340288,0.0005939159,0.00067420816,0.00011516278,0.0003405072,0.0027485734,0.001643365],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000495394,0.0018492205,0.0006610762,0.029547073,0.00012635135,0.002163297,0.00056473335,1.4015737e-7,0.0000089295945,0.003768038,0.0029096203,0.95835197],"study_design_scores_gemma":[0.002810836,0.0010846809,0.000042241787,0.07155506,0.00094215025,0.003081629,0.00036475944,0.000029928055,0.000010272711,0.0014847727,0.9176925,0.0009011627],"about_ca_topic_score_codex":0.00013413365,"about_ca_topic_score_gemma":0.00017587873,"teacher_disagreement_score":0.9574508,"about_ca_system_score_codex":0.0019154596,"about_ca_system_score_gemma":0.0010328875,"threshold_uncertainty_score":0.9997854},"labels":[],"label_agreement":null},{"id":"W2076179156","doi":"10.1016/j.critrevonc.2008.01.005","title":"Conformal radiotherapy for hepatocellular carcinoma","year":2008,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; University of Michigan","keywords":"Medicine; Hepatocellular carcinoma; Radiation therapy; Toxicity; Carcinoma; Oncology; Limiting; Internal medicine","score_opus":0.20987471570514496,"score_gpt":0.4231530574531787,"score_spread":0.21327834174803376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076179156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005802451,0.98624974,0.00051939656,0.0007432879,0.0007680277,0.009322902,0.000056845016,0.000088148074,0.0021936372],"genre_scores_gemma":[0.0002051831,0.98275673,0.0077548656,0.00095309835,0.0004909351,0.006767414,0.0005782594,0.00017681194,0.00031667005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928792,0.0010992229,0.003105682,0.0012291025,0.00025749303,0.0014292704],"domain_scores_gemma":[0.9941411,0.003539358,0.00049517065,0.001033003,0.0001972761,0.0005941067],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010248562,0.00119749,0.011317258,0.00065192796,0.0001606212,0.000019742796,0.0004838296,0.002389286,0.00047010515],"category_scores_gemma":[0.0024600776,0.00091415993,0.0027413655,0.00057692506,0.0008272481,0.00009478584,0.00011404087,0.0012991731,0.00044428694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012245218,0.0008473008,0.00609975,0.04276123,0.00025905523,0.004630904,0.00009207691,2.460078e-9,5.627041e-7,0.013579607,0.00972018,0.92188686],"study_design_scores_gemma":[0.0021190732,0.0016442399,0.000005123098,0.013212191,0.0017186018,0.013380147,0.000009877382,0.0002054836,0.000009195526,0.00012878289,0.96689034,0.0006769782],"about_ca_topic_score_codex":0.000010464048,"about_ca_topic_score_gemma":0.0000043282657,"teacher_disagreement_score":0.9571701,"about_ca_system_score_codex":0.0009812774,"about_ca_system_score_gemma":0.0018147904,"threshold_uncertainty_score":0.9993309},"labels":[],"label_agreement":null},{"id":"W2078205539","doi":"10.1016/s1040-8428(01)00126-3","title":"The use of Shiga-like toxin 1 in cancer therapy","year":2001,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"University of Toronto","keywords":"Shiga toxin; Cancer research; Biology; Context (archaeology); Immunotoxin; Immunology; Antibody; Monoclonal antibody; Gene","score_opus":0.18327446621127189,"score_gpt":0.434008883629548,"score_spread":0.25073441741827607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078205539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029899738,0.99271196,0.00005473408,0.00062156754,0.0034756572,0.0025838949,0.00006478124,0.0000335379,0.00042396842],"genre_scores_gemma":[0.000022516808,0.99510396,0.00033634866,0.00077645486,0.00005541683,0.0023563232,0.0000676516,0.00008521978,0.0011961256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886015,0.0051365276,0.0037295565,0.0010041994,0.000081760925,0.0014464295],"domain_scores_gemma":[0.98873687,0.008935329,0.0008555255,0.0012842986,0.000119469405,0.00006853482],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022245739,0.0009133786,0.0070304563,0.0004743133,0.00018671068,0.000027221236,0.0013808776,0.002818076,0.0013380301],"category_scores_gemma":[0.0038130106,0.00057699444,0.0009585189,0.0009941043,0.001681773,0.00013743069,0.00038748502,0.0026955197,0.00058535393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079421,0.0006132317,0.000030917472,0.0022667493,0.00013090008,0.000114155584,0.00007486829,1.3171613e-7,0.00006594014,0.037753865,0.0076095467,0.95126027],"study_design_scores_gemma":[0.0008578714,0.00041349724,0.000006545704,0.0139712,0.00018677674,0.0006160398,0.00003456264,6.6704285e-7,0.000055004006,0.0007393818,0.9826199,0.00049858756],"about_ca_topic_score_codex":0.00018839649,"about_ca_topic_score_gemma":0.0010080251,"teacher_disagreement_score":0.97501034,"about_ca_system_score_codex":0.0004620532,"about_ca_system_score_gemma":0.0008711971,"threshold_uncertainty_score":0.9996681},"labels":[],"label_agreement":null},{"id":"W2079589100","doi":"10.1016/j.critrevonc.2009.08.005","title":"Treatment for metastatic malignant melanoma: Old drugs and new strategies","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Directorate for Biological Sciences","keywords":"Medicine; Dacarbazine; Melanoma; Metastatic melanoma; Immunotherapy; Clinical trial; Oncology; Chemotherapy; First line; Refractory (planetary science); Cancer; Internal medicine; Cancer research","score_opus":0.2065223788696071,"score_gpt":0.5077436865363419,"score_spread":0.3012213076667348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079589100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044869766,0.9841579,0.00029632088,0.00283585,0.00027188179,0.007293915,0.000031662614,0.000047182082,0.0050607664],"genre_scores_gemma":[0.0000058854184,0.98492956,0.0076865335,0.0005449544,0.0002647508,0.002278531,0.00013012832,0.00009562528,0.004064003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367136,0.0013505723,0.0023039877,0.0012145459,0.0002456964,0.0012138634],"domain_scores_gemma":[0.9916978,0.0063453726,0.00030988193,0.0008691831,0.00011982726,0.00065796723],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014039814,0.00094256684,0.010305129,0.0005316427,0.00008205358,0.000051132418,0.00032877046,0.000940182,0.0009891624],"category_scores_gemma":[0.002576615,0.0006295028,0.0010857088,0.0004330041,0.0006468871,0.00008316277,0.000109334156,0.00086124276,0.00018076389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011643591,0.00057482865,0.0000021395026,0.026195848,0.00020137643,0.00091802306,0.00010757585,8.797837e-9,0.00000287248,0.09290206,0.0023214018,0.8766574],"study_design_scores_gemma":[0.0024835332,0.004129028,7.893671e-7,0.017285371,0.0027044232,0.006316675,0.000114725044,0.000006565182,0.0000046674427,0.009013466,0.95751715,0.00042358818],"about_ca_topic_score_codex":0.000040025603,"about_ca_topic_score_gemma":0.00006321073,"teacher_disagreement_score":0.9551958,"about_ca_system_score_codex":0.0010137906,"about_ca_system_score_gemma":0.0028716412,"threshold_uncertainty_score":0.99992406},"labels":[],"label_agreement":null},{"id":"W2088100021","doi":"10.1016/j.critrevonc.2009.10.006","title":"Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Toronto; Jewish General Hospital","funders":"Jewish General Hospital; McGill University","keywords":"Medicine; Emergency department; Prospective cohort study; Cancer; Odds ratio; Health care; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.028648932510621613,"score_gpt":0.3904657639378036,"score_spread":0.36181683142718196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088100021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94772166,0.0073644742,0.000249701,0.03347962,0.00087160093,0.009494622,0.00008417993,0.000040898154,0.0006932477],"genre_scores_gemma":[0.99086624,0.0040721893,0.0010371014,0.0021273806,0.00014054577,0.0015761489,0.000041108433,0.000021848493,0.00011741693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959431,0.000758792,0.0016802488,0.0007745927,0.00032846926,0.00051476783],"domain_scores_gemma":[0.99788636,0.00062333,0.00026544335,0.0005084146,0.00049786025,0.00021860252],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008841579,0.00032518152,0.0012747573,0.00021387148,0.00007843596,0.000010321897,0.00020753243,0.00017804261,0.0001512946],"category_scores_gemma":[0.011580465,0.00019147898,0.00006719297,0.00067325233,0.00014244225,0.00016000212,0.00011815618,0.00042727945,0.000019206633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013219718,0.013949342,0.93400425,0.00035025022,0.000073251664,0.00022414705,0.0044124033,0.000010076694,0.00007491964,0.0038416404,0.022025654,0.019712081],"study_design_scores_gemma":[0.0078076073,0.010865079,0.96901107,0.00095423457,0.00016367462,0.000031382904,0.00026885004,0.000053003387,0.00018004523,0.0010151011,0.009408235,0.00024174723],"about_ca_topic_score_codex":0.00016091384,"about_ca_topic_score_gemma":0.0038315805,"teacher_disagreement_score":0.043144606,"about_ca_system_score_codex":0.00034283154,"about_ca_system_score_gemma":0.00017399865,"threshold_uncertainty_score":0.9967454},"labels":[],"label_agreement":null},{"id":"W2088500044","doi":"10.1016/j.critrevonc.2012.07.006","title":"Treatment of metastatic cervical cancer: Future directions involving targeted agents","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Clinical trial; Disease; Oncology; Targeted therapy; Chemotherapy; Cancer; Radiation therapy; Internal medicine; Intensive care medicine","score_opus":0.13359325886132045,"score_gpt":0.5007791000466785,"score_spread":0.367185841185358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088500044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010283648,0.9918747,0.000018500401,0.0012569006,0.0019185365,0.0031631724,0.00015217387,0.000044730397,0.0015610316],"genre_scores_gemma":[0.00007924489,0.99135786,0.002643693,0.00022759866,0.0004740405,0.0045421086,0.00033751864,0.000075348325,0.00026259382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951636,0.0010791699,0.0021142673,0.00067869143,0.00019608703,0.00076816697],"domain_scores_gemma":[0.9968289,0.0014368687,0.0005083465,0.00063821924,0.00016059571,0.00042702822],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029701306,0.0007035907,0.007258649,0.00044811136,0.0001005467,0.000007621445,0.00018676,0.0007341097,0.0013939077],"category_scores_gemma":[0.00065769575,0.0004672997,0.0010703651,0.00075580995,0.00037632856,0.00007764136,0.00006941371,0.0005299101,0.00018789167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019921456,0.002608208,0.00034538013,0.026913479,0.0007666945,0.0003136079,0.00033257634,2.7850566e-8,2.817577e-7,0.007656937,0.00077625504,0.96026665],"study_design_scores_gemma":[0.0010859759,0.0007058558,0.000054174187,0.012139895,0.014409612,0.0011904495,0.00007967103,0.0000037923176,0.0000017769115,0.000119645876,0.96992517,0.0002839922],"about_ca_topic_score_codex":0.00011957263,"about_ca_topic_score_gemma":0.00025993894,"teacher_disagreement_score":0.96914893,"about_ca_system_score_codex":0.002141775,"about_ca_system_score_gemma":0.0014687179,"threshold_uncertainty_score":0.99977785},"labels":[],"label_agreement":null},{"id":"W2093173796","doi":"10.1016/j.critrevonc.2010.08.004","title":"Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Geriatric oncology; Depression (economics); Malnutrition; Cancer; Geriatric Depression Scale; Geriatrics; Population; Activities of daily living; Internal medicine; Physical therapy; Cognition; Psychiatry; Depressive symptoms","score_opus":0.07266032070785503,"score_gpt":0.458234214218081,"score_spread":0.385573893510226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093173796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015667323,0.97743756,0.00008515677,0.00036764913,0.0005451538,0.0053746775,0.000042424912,0.000024167293,0.00045586826],"genre_scores_gemma":[0.003595602,0.9893186,0.004379786,0.0005978139,0.00006957908,0.0018471543,0.00009442159,0.000071141665,0.000025916965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323297,0.0013496018,0.0031183737,0.0010493055,0.0005100765,0.0007397064],"domain_scores_gemma":[0.9871934,0.010020088,0.0010586338,0.0007660109,0.0007337856,0.00022809285],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00073553005,0.0007877725,0.006678975,0.0010529592,0.00004968824,0.00001203178,0.00044466957,0.0014785783,0.00013671521],"category_scores_gemma":[0.0053257467,0.00055590353,0.00034951672,0.0015011044,0.0007096753,0.00009926425,0.00011815664,0.002576244,0.000093010276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025719492,0.001538372,0.0021956244,0.02140559,0.000053445117,0.00024923187,0.00007366088,0.0000046924442,0.0000024539786,0.0020304096,0.00019123651,0.9719981],"study_design_scores_gemma":[0.0061292765,0.005396645,0.010704552,0.09145614,0.0014940766,0.00063836237,0.000022423581,0.000019339248,0.000003803591,0.0005288985,0.8828999,0.00070660573],"about_ca_topic_score_codex":0.00004524412,"about_ca_topic_score_gemma":0.00021294625,"teacher_disagreement_score":0.9712915,"about_ca_system_score_codex":0.0009224891,"about_ca_system_score_gemma":0.0020526024,"threshold_uncertainty_score":0.9998177},"labels":[],"label_agreement":null},{"id":"W2093960755","doi":"10.1016/j.critrevonc.2008.07.019","title":"Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach","year":2008,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cancer Research UK","keywords":"Multidisciplinary approach; Medicine; Prostate cancer; Docetaxel; Disease; Multidisciplinary team; Cancer; Palliative care; Intensive care medicine; Oncology; Family medicine; Medical physics; Gynecology; Internal medicine; Nursing","score_opus":0.15436456547267305,"score_gpt":0.5045686602154852,"score_spread":0.3502040947428121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093960755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025258096,0.9743324,0.00015975803,0.009701083,0.000131803,0.013208771,0.00006990142,0.000035301582,0.0023584685],"genre_scores_gemma":[0.000004340436,0.9283732,0.02449989,0.00017209457,0.00011082092,0.045715556,0.00035316066,0.000076519624,0.00069438777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958849,0.00094130577,0.0012459408,0.0009642225,0.00014732625,0.000816282],"domain_scores_gemma":[0.99521583,0.0035218426,0.000293239,0.00056173524,0.00014354858,0.0002638203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005985487,0.0006822947,0.005384536,0.00023216907,0.00034105885,0.000018027464,0.00021635508,0.00048170047,0.000032193555],"category_scores_gemma":[0.00061579957,0.0003187525,0.0004824732,0.00036940828,0.0016400279,0.00008073484,0.00015480146,0.00065566343,0.000009583441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011232182,0.00074758887,0.000014571985,0.009785922,0.00028963241,0.00016921108,0.0012780818,2.879116e-7,1.7432629e-7,0.0026561366,0.0022440725,0.9816911],"study_design_scores_gemma":[0.009137979,0.0016049766,7.2337286e-7,0.021328347,0.0009189958,0.0021601366,0.0004130847,0.00012842476,0.000002401703,0.00011454781,0.9638758,0.00031460606],"about_ca_topic_score_codex":0.00002299892,"about_ca_topic_score_gemma":0.000026460975,"teacher_disagreement_score":0.98137647,"about_ca_system_score_codex":0.0011619378,"about_ca_system_score_gemma":0.0013361976,"threshold_uncertainty_score":0.99992645},"labels":[],"label_agreement":null},{"id":"W2096582651","doi":"10.1016/j.critrevonc.2006.06.006","title":"Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Androgen deprivation therapy; Prostate cancer; Medicine; Sexual function; Adverse effect; Quality of life (healthcare); Disease; Bone mineral; Oncology; Sexual dysfunction; Randomized controlled trial; Internal medicine; Cancer; Physical therapy; Osteoporosis","score_opus":0.04513563591893599,"score_gpt":0.4416818956491786,"score_spread":0.3965462597302426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096582651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000682176,0.97592664,0.000018752668,0.00057144917,0.00011571815,0.022754682,0.000026409423,0.0000225671,0.0004955811],"genre_scores_gemma":[0.000059277096,0.9827062,0.00039787818,0.00034507926,0.000049401944,0.015816968,0.00034487533,0.00009247545,0.00018783673],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920253,0.0025804306,0.0031350737,0.00095519033,0.00041199848,0.00089197495],"domain_scores_gemma":[0.9945392,0.0031278734,0.0009115845,0.0008784723,0.00031556602,0.00022730627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017385872,0.0008856147,0.012218687,0.0007327702,0.00004287168,0.000020679528,0.00038619014,0.0006273007,0.000025082389],"category_scores_gemma":[0.0021859533,0.0005037871,0.0005877904,0.0018605285,0.00049382064,0.000117022966,0.00010451506,0.0012862715,0.000033345586],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010882711,0.00065767195,0.000804613,0.7254144,0.00021520354,0.0042771064,0.000081427665,2.808722e-8,0.0000012414338,0.00015136503,0.0003737125,0.26791438],"study_design_scores_gemma":[0.003192248,0.0014856706,0.00008319392,0.956965,0.0025055392,0.002331355,0.000005306192,0.0000031958384,0.000021554533,0.0000697818,0.032946832,0.00039029063],"about_ca_topic_score_codex":0.000018818051,"about_ca_topic_score_gemma":0.000069603455,"teacher_disagreement_score":0.2675241,"about_ca_system_score_codex":0.0009489212,"about_ca_system_score_gemma":0.0017045867,"threshold_uncertainty_score":0.9997414},"labels":[],"label_agreement":null},{"id":"W2096984260","doi":"10.1016/j.critrevonc.2004.12.004","title":"Multi-dysfunctional pathophysiology in ITP","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology of the People's Republic of China; University of Calgary","keywords":"Autoantibody; Immunology; Pathophysiology; Medicine; Megakaryocytopoiesis; Disease; Platelet; Thrombopoietin; Antibody; Biology; Haematopoiesis; Stem cell; Internal medicine","score_opus":0.11643709893329297,"score_gpt":0.46576395480221006,"score_spread":0.3493268558689171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096984260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002619899,0.99319005,0.000041448777,0.0010315656,0.0007406613,0.0024168564,0.000030408819,0.000042921623,0.0024798678],"genre_scores_gemma":[0.000025919295,0.9896667,0.00567163,0.0018956542,0.00019663556,0.0018279919,0.00032363285,0.00007641375,0.00031544018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935463,0.0013599753,0.0026125766,0.0012191314,0.00016856851,0.0010934517],"domain_scores_gemma":[0.9962746,0.0023282676,0.0003379833,0.000671818,0.000080168174,0.00030716372],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082017126,0.00085379515,0.0099429535,0.00071157166,0.000055647273,0.000007662569,0.00031493758,0.0021379518,0.00090347364],"category_scores_gemma":[0.0043746945,0.00064083876,0.00093321473,0.00065497484,0.0005953637,0.000071272116,0.00018932407,0.0019532505,0.002503765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052665146,0.0027740002,0.00013353875,0.011675951,0.000082374725,0.007868023,0.00002064673,6.734527e-8,4.860537e-7,0.005144078,0.0019971721,0.970251],"study_design_scores_gemma":[0.0021594462,0.00049147103,0.000056333254,0.019423736,0.000682913,0.005399076,0.000011412092,0.000018630855,1.3184174e-7,0.00079513685,0.9705456,0.00041610343],"about_ca_topic_score_codex":0.000013379867,"about_ca_topic_score_gemma":0.0001613604,"teacher_disagreement_score":0.9698349,"about_ca_system_score_codex":0.0009103163,"about_ca_system_score_gemma":0.0009775845,"threshold_uncertainty_score":0.9996043},"labels":[],"label_agreement":null},{"id":"W2112249236","doi":"10.1016/j.critrevonc.2013.03.002","title":"Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Meta-analysis; Medicine; Oncology; Outcome (game theory); Internal medicine; Cancer","score_opus":0.31325222125291924,"score_gpt":0.5481715933611923,"score_spread":0.23491937210827302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112249236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001611733,0.98246026,0.000011178112,0.0016026822,0.0005028376,0.015007829,0.00006764708,0.000055565073,0.00027588228],"genre_scores_gemma":[0.00003402267,0.9816401,0.0030698413,0.0030886687,0.0000779343,0.011753242,0.000035773424,0.00008685678,0.00021357444],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9778537,0.008276927,0.010185976,0.0020019086,0.00043746308,0.001244019],"domain_scores_gemma":[0.97743154,0.018339118,0.0015593272,0.0015872213,0.00026268727,0.0008201119],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00852933,0.0012702676,0.05557453,0.0013697069,0.000052221647,0.000030116347,0.00044879946,0.002003874,0.0017430012],"category_scores_gemma":[0.06138367,0.0008074596,0.005170797,0.0026045246,0.0011580297,0.00007604914,0.0005164623,0.0026016869,0.00014262015],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021205427,0.00034776673,0.0017319563,0.9501436,0.025539355,0.00032355095,0.000021895428,1.1562157e-8,1.35757015e-8,0.0007000173,0.0009005844,0.020270098],"study_design_scores_gemma":[0.00077325903,0.00050371984,0.000026255551,0.080073595,0.6647174,0.0007935665,0.000013301014,0.000005076951,4.1580293e-8,0.00009766986,0.25246727,0.0005288437],"about_ca_topic_score_codex":0.00015540996,"about_ca_topic_score_gemma":0.00051484304,"teacher_disagreement_score":0.8700699,"about_ca_system_score_codex":0.0009096698,"about_ca_system_score_gemma":0.00096766226,"threshold_uncertainty_score":0.99969935},"labels":[],"label_agreement":null},{"id":"W2124808968","doi":"10.1016/j.critrevonc.2006.09.006","title":"Pharmacogenetics of paclitaxel metabolism","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paclitaxel; Pharmacogenetics; Medicine; Pharmacology; Chemotherapy; Drug metabolism; Drug; Oncology; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3217679777041367,"score_gpt":0.5847237841736879,"score_spread":0.2629558064695512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124808968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030525513,0.97285783,0.00013334537,0.00032989116,0.006168138,0.00309624,0.00053872314,0.0000862192,0.016759088],"genre_scores_gemma":[0.000117487274,0.99298686,0.0021658686,0.0014241819,0.00096303603,0.0015152737,0.0002158629,0.00020438555,0.00040705866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98078656,0.008850924,0.006185522,0.0016357872,0.00042446007,0.0021167675],"domain_scores_gemma":[0.9886417,0.007374404,0.0017181183,0.0011003632,0.00034723934,0.00081816793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0050774594,0.0017081171,0.012139378,0.0011511227,0.00018707683,0.000022121474,0.001995857,0.0039426307,0.0022814837],"category_scores_gemma":[0.0032906616,0.001478582,0.0021305596,0.0014923757,0.0021438268,0.00011518102,0.0007536408,0.0047147814,0.0010885607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005743074,0.0017396336,0.000042855943,0.020131115,0.00031691053,0.00050073105,0.000077382785,0.0000032537343,0.00003867196,0.03898011,0.01722283,0.9208891],"study_design_scores_gemma":[0.0016356165,0.00013635693,0.0000052087626,0.003939641,0.0053825644,0.0007173029,0.000013722442,0.000053043645,0.00022445568,0.0025395667,0.98420835,0.0011441765],"about_ca_topic_score_codex":0.00001940254,"about_ca_topic_score_gemma":0.000022008711,"teacher_disagreement_score":0.9669855,"about_ca_system_score_codex":0.00032452878,"about_ca_system_score_gemma":0.0013014995,"threshold_uncertainty_score":0.9996892},"labels":[],"label_agreement":null},{"id":"W2131932756","doi":"10.1016/j.critrevonc.2011.03.003","title":"Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital","funders":"University of Melbourne; Amgen","keywords":"Medicine; Neutropenia; Antibiotics; Febrile neutropenia; Incidence (geometry); Intensive care medicine; Clinical trial; Internal medicine; Chemotherapy","score_opus":0.1792675953964135,"score_gpt":0.4809735508662515,"score_spread":0.301705955469838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131932756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002028951,0.9931185,0.00021384927,0.00025244366,0.00025496213,0.0045963507,0.000027132777,0.000031175514,0.0013026602],"genre_scores_gemma":[0.0009069302,0.99507874,0.00069505326,0.00007384732,0.000076943514,0.002931263,0.00005234931,0.000060045037,0.00012483468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932536,0.00069868675,0.004794653,0.00055297563,0.0001266883,0.00057338853],"domain_scores_gemma":[0.9903642,0.004263945,0.0040281583,0.00066937,0.0005469418,0.0001273626],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015464557,0.0004829179,0.008655547,0.00023351656,0.00009785001,0.0000030986428,0.00020045172,0.0005591969,0.000110230525],"category_scores_gemma":[0.013815268,0.000264485,0.0008594991,0.000852913,0.0007038615,0.000027198903,0.0000392369,0.0005071234,0.0000059920776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002485189,0.0036705695,0.0011349719,0.038575973,0.0014273715,0.00035321337,0.0004355972,2.2853092e-7,0.000019445724,0.017912986,0.0012903208,0.9349308],"study_design_scores_gemma":[0.0010860134,0.004605393,0.00008786193,0.04284143,0.0061341776,0.0019292007,0.000048441845,0.0000052267687,0.00017451991,0.00016902533,0.94265383,0.00026489428],"about_ca_topic_score_codex":0.000037439,"about_ca_topic_score_gemma":0.00019939526,"teacher_disagreement_score":0.9413635,"about_ca_system_score_codex":0.0006010623,"about_ca_system_score_gemma":0.0015179515,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W2141368398","doi":"10.1016/j.critrevonc.2007.07.003","title":"The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults","year":2007,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Toronto Rehabilitation Institute; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; Toronto Rehabilitation Institute","keywords":"Medicine; Myeloid leukemia; Quality of life (healthcare); Activities of daily living; Performance status; Internal medicine; Palliative care; Gerontology; Chemotherapy; Oncology; Physical therapy","score_opus":0.06820022062710904,"score_gpt":0.4493297000785055,"score_spread":0.3811294794513964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141368398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631372,0.03244512,0.000035085428,0.0017915892,0.000081084545,0.0011744432,0.000021691347,0.000007433933,0.0013063407],"genre_scores_gemma":[0.9620291,0.03718693,0.00028502548,0.00028988157,0.000037355338,0.00009723629,0.00001302997,0.000014761586,0.000046684443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662805,0.00069388474,0.0013748402,0.00041478564,0.0002167021,0.0006717201],"domain_scores_gemma":[0.9922288,0.0067163706,0.00018603727,0.00032654696,0.00018571717,0.00035650897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025782504,0.0002414111,0.001605315,0.00023600821,0.000048860817,0.0000038038954,0.000083450344,0.0003638181,0.00010145535],"category_scores_gemma":[0.008261404,0.00014224093,0.00015092456,0.0003078048,0.0008376979,0.000046520436,0.000099566314,0.00054097216,0.000012237148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030622758,0.0040062694,0.55733526,0.0032461016,0.00069822255,0.000953378,0.0021343909,0.0000024329897,0.005072733,0.12023011,0.0036190697,0.2720793],"study_design_scores_gemma":[0.013204508,0.0057505737,0.97331524,0.001140702,0.00011052828,0.0005813646,0.0005226202,0.00028667354,0.0014557362,0.0009882607,0.00241285,0.00023096302],"about_ca_topic_score_codex":0.0002228224,"about_ca_topic_score_gemma":0.000260978,"teacher_disagreement_score":0.41597998,"about_ca_system_score_codex":0.0014118262,"about_ca_system_score_gemma":0.0011516537,"threshold_uncertainty_score":0.9890269},"labels":[],"label_agreement":null},{"id":"W2145906267","doi":"10.1016/s1040-8428(08)70003-9","title":"Understanding and meeting the needs of the older population: a global challenge","year":2008,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Migration, Aging, and Tourism Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Waterloo","funders":"","keywords":"Livelihood; Population ageing; Relevance (law); Economic growth; Older people; Population; Development economics; Gerontology; Political science; Sociology; Economics; Geography; Medicine; Demography","score_opus":0.16626104376205575,"score_gpt":0.4084801668687963,"score_spread":0.24221912310674054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145906267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48422697,0.21458493,0.0020916802,0.1636458,0.0022333532,0.0023185392,0.0000059663917,0.000083127896,0.13080963],"genre_scores_gemma":[0.98309016,0.01604222,0.00016016037,0.0005137241,0.00010848846,0.00003491095,3.1099123e-7,0.0000035079072,0.000046527926],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9979528,0.0010131213,0.00045550097,0.00014215393,0.00014956247,0.00028684398],"domain_scores_gemma":[0.9983551,0.0012726691,0.00012093095,0.00015223984,0.00005106522,0.00004800106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013494573,0.00009966691,0.00045846537,0.00003336658,0.0007692214,0.0000076023157,0.00020516304,0.00015140284,0.00003714155],"category_scores_gemma":[0.0036979988,0.00005920306,0.000077832854,0.00037132137,0.0015506783,0.000062381674,0.00009631117,0.00016971013,0.0000037880343],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029247208,0.000043007112,0.07914304,0.000050623523,0.0000062476847,0.000005227802,0.06267728,1.7799282e-7,2.7899654e-7,0.8553432,0.0020061287,0.0007218695],"study_design_scores_gemma":[0.0015271744,0.00024163305,0.21315023,0.0017805648,0.00022044971,0.00040609826,0.05456214,0.00010709372,0.00000831978,0.51018506,0.21718062,0.00063058623],"about_ca_topic_score_codex":0.00090778054,"about_ca_topic_score_gemma":0.013801613,"teacher_disagreement_score":0.4988632,"about_ca_system_score_codex":0.00017373667,"about_ca_system_score_gemma":0.000098681885,"threshold_uncertainty_score":0.7701624},"labels":[],"label_agreement":null},{"id":"W2146532066","doi":"10.1016/j.critrevonc.2014.01.007","title":"Detection methods of circulating tumor cells in cutaneous melanoma: A systematic review","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Melanoma; Medicine; Circulating tumor cell; Malignancy; Disease; Oncology; Peripheral blood; Biomarker; Primary tumor; Stage (stratigraphy); Cancer; Internal medicine; Pathology; Cancer research; Metastasis; Biology","score_opus":0.08296916132267225,"score_gpt":0.4777881327860845,"score_spread":0.39481897146341227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146532066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013391251,0.9881784,0.0015371683,0.0001343383,0.00076593965,0.0076901596,0.000014090266,0.000029880626,0.0016487271],"genre_scores_gemma":[0.000036539048,0.9833641,0.013039004,0.00086191844,0.00009332172,0.0024561307,0.000022095337,0.000091223636,0.00003568459],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9831901,0.007950232,0.006732799,0.001028885,0.00027659987,0.000821345],"domain_scores_gemma":[0.9880623,0.008390179,0.0018190786,0.0012471395,0.00019057798,0.00029068725],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007522023,0.0008187464,0.023530534,0.0006913035,0.000036065485,0.000007972599,0.00042126878,0.00090373395,0.00022586572],"category_scores_gemma":[0.025485145,0.0006084145,0.0016574606,0.0012188235,0.00038317515,0.000040187922,0.00017983733,0.0016097698,0.00018184593],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000775201,0.00018546273,8.3072814e-7,0.6598648,0.000057708832,0.0007415049,0.000016602151,2.6391307e-8,0.000009803085,0.0008268859,0.00007471226,0.33821395],"study_design_scores_gemma":[0.0002659947,0.0002949985,5.97472e-8,0.57536393,0.0050923782,0.013545578,0.000011382646,0.0000116301535,0.000028760898,0.00010997402,0.40500546,0.00026984565],"about_ca_topic_score_codex":0.00002833221,"about_ca_topic_score_gemma":0.00007878557,"teacher_disagreement_score":0.40493074,"about_ca_system_score_codex":0.0009479254,"about_ca_system_score_gemma":0.00072519935,"threshold_uncertainty_score":0.9996367},"labels":[],"label_agreement":null},{"id":"W2164110159","doi":"10.1016/j.critrevonc.2005.04.006","title":"Management of patients with higher risk myelodysplastic syndromes","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; University of Southern California","keywords":"Myelodysplastic syndromes; Medicine; International Prognostic Scoring System; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Azacitidine; Disease; Radiation therapy; Intensive care medicine; Bone marrow","score_opus":0.0678892869649371,"score_gpt":0.4310722778615204,"score_spread":0.36318299089658335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164110159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003233078,0.9864408,0.000087674845,0.00035035715,0.00041474417,0.0043278923,0.000063313346,0.000043803797,0.008239097],"genre_scores_gemma":[0.00008020436,0.9879546,0.009406045,0.00016627605,0.00010929322,0.0013075005,0.00017660516,0.00012896804,0.00067047955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926134,0.0016425119,0.0028326148,0.0011658492,0.0005613767,0.0011843019],"domain_scores_gemma":[0.9938041,0.00348778,0.00073748844,0.0012580776,0.00027390136,0.00043867464],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0013546534,0.00089027995,0.009250625,0.0007341489,0.00006376631,0.000009781396,0.00069666596,0.0013046885,0.001825904],"category_scores_gemma":[0.0020437264,0.0005843128,0.00066855823,0.0010617287,0.0012309526,0.00007720042,0.00048701337,0.0023730719,0.001140986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013454421,0.0011229989,0.0005496523,0.08047049,0.00044836657,0.00197775,0.000010962724,5.530304e-8,6.178171e-9,0.014737466,0.0030655658,0.89748216],"study_design_scores_gemma":[0.0020014974,0.0010969668,0.00047245773,0.06568984,0.0038880587,0.00066321046,0.000008755959,0.000002229112,1.2259713e-7,0.0001434998,0.9256131,0.0004202714],"about_ca_topic_score_codex":0.000004678958,"about_ca_topic_score_gemma":0.0000061037736,"teacher_disagreement_score":0.9225475,"about_ca_system_score_codex":0.001539225,"about_ca_system_score_gemma":0.0008159895,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W2168814113","doi":"10.1016/j.critrevonc.2006.11.009","title":"Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Paclitaxel; Regimen; Chemotherapy; Oncology; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Cancer; Cisplatin","score_opus":0.19755678368570986,"score_gpt":0.5193243633535761,"score_spread":0.3217675796678663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168814113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063197534,0.9706904,0.00005464987,0.017345496,0.0010481625,0.0072846166,0.00026605686,0.00007595247,0.0031714474],"genre_scores_gemma":[0.0001349033,0.98334837,0.003675889,0.004711923,0.00032998342,0.0071367323,0.00022797646,0.00016865724,0.0002655417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99171025,0.00091209245,0.0036260665,0.0017999329,0.0003965886,0.0015550536],"domain_scores_gemma":[0.99332315,0.0040679886,0.00059180235,0.0012003895,0.00016854769,0.00064812624],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012840055,0.0014362168,0.012295552,0.0007308415,0.00010849655,0.000029393812,0.00034703102,0.0020260527,0.0031660662],"category_scores_gemma":[0.0019093922,0.0010737715,0.0010993769,0.0009410751,0.00078827795,0.00008843064,0.00011397479,0.0015239558,0.00014459112],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056661316,0.0026131263,0.00046358112,0.015872182,0.00036982098,0.0076284697,0.00017886079,5.1177625e-7,2.9581278e-7,0.015693722,0.001009381,0.9556034],"study_design_scores_gemma":[0.0078338785,0.0036863624,0.000031297033,0.036803238,0.0013540945,0.001434082,0.00005508573,0.000003760412,0.000026084024,0.00038911976,0.94768894,0.00069404213],"about_ca_topic_score_codex":0.00039657252,"about_ca_topic_score_gemma":0.0048163915,"teacher_disagreement_score":0.9549094,"about_ca_system_score_codex":0.0067246747,"about_ca_system_score_gemma":0.0037766572,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W2213935416","doi":"10.1016/j.critrevonc.2015.12.008","title":"Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Università Bocconi; Helsinn","keywords":"Anorexia; Cachexia; Quality of life (healthcare); Medicine; Resource (disambiguation); Cancer cachexia; Cancer; Intensive care medicine; Gerontology; Internal medicine; Nursing; Computer science","score_opus":0.3282251994536354,"score_gpt":0.5772138258584952,"score_spread":0.24898862640485986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2213935416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051947307,0.98667085,0.0000044489097,0.0043651103,0.00018457594,0.007893231,0.000078708596,0.000031508975,0.00071962154],"genre_scores_gemma":[0.00021272733,0.9953161,0.00031228154,0.0026382133,0.000033922162,0.001294552,0.00010036146,0.000055215605,0.000036656187],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98179597,0.007460784,0.008879337,0.0007593389,0.00043516344,0.000669428],"domain_scores_gemma":[0.98980635,0.0046738945,0.0032549629,0.0010324102,0.00040180283,0.0008305855],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01001849,0.00066060526,0.023337843,0.0005462451,0.00005433816,0.000004608249,0.00030202916,0.0010138659,0.0003166551],"category_scores_gemma":[0.023362055,0.00045670572,0.0010370482,0.0009580338,0.0007714635,0.000043263597,0.00011679552,0.0014640822,0.000052557367],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006293409,0.00054106535,0.00018170779,0.9436959,0.00017722181,0.00006707418,0.000072457566,1.4839229e-8,4.7125756e-8,0.007814369,0.0044823857,0.042904817],"study_design_scores_gemma":[0.0010248852,0.0013734113,0.00006774542,0.8525231,0.0013879495,0.002032983,0.000028832184,0.000003040593,2.978268e-8,0.00037612842,0.14092305,0.0002588555],"about_ca_topic_score_codex":0.000120775054,"about_ca_topic_score_gemma":0.000030352992,"teacher_disagreement_score":0.13644066,"about_ca_system_score_codex":0.00126055,"about_ca_system_score_gemma":0.003593068,"threshold_uncertainty_score":0.99978846},"labels":[],"label_agreement":null},{"id":"W2292869747","doi":"10.1016/j.critrevonc.2016.03.002","title":"Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Biomarker; Meta-analysis; Oncology; Internal medicine; Cancer; Head and neck cancer; Diagnostic biomarker; Biomarker discovery; Pathology; Proteomics; Biology","score_opus":0.15278933483028087,"score_gpt":0.49711508965559925,"score_spread":0.34432575482531835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292869747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014475858,0.9846105,0.00017400792,0.0072553176,0.000031434207,0.0072436733,0.000534959,0.00002051553,0.00012812526],"genre_scores_gemma":[0.000033852455,0.98805875,0.0008802004,0.0028973932,0.00002843246,0.007858217,0.000063526626,0.000044923836,0.00013472466],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918809,0.0020450125,0.0042662686,0.0010142939,0.00020240422,0.000591151],"domain_scores_gemma":[0.97620517,0.020809498,0.0014076942,0.00087954226,0.00030008017,0.00039802823],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025964046,0.00076900574,0.031536218,0.00081665866,0.000064233434,0.000013634032,0.00024951182,0.00073171017,0.00097080256],"category_scores_gemma":[0.048888877,0.00043546932,0.0041249148,0.001198942,0.0007469094,0.00007807083,0.00016003252,0.00042351583,0.00003569654],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006510666,0.00017022833,0.00001588958,0.9285264,0.036716457,0.000092156464,0.000008623575,2.133048e-9,1.1689534e-7,0.002918043,0.001032457,0.03051312],"study_design_scores_gemma":[0.00031933436,0.00014541757,0.0000013930361,0.34740534,0.5301746,0.00052146864,0.0000056075237,0.00000231006,4.3049172e-7,0.00014556121,0.121040344,0.00023817047],"about_ca_topic_score_codex":0.000011784295,"about_ca_topic_score_gemma":0.00008819908,"teacher_disagreement_score":0.581121,"about_ca_system_score_codex":0.00019662525,"about_ca_system_score_gemma":0.00042592298,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2333897154","doi":"10.1016/s1040-8428(13)70021-0","title":"IIIB.1 Adjuvant chemotherapy in elderly patients: an analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup JBR.10","year":2006,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Axitinib; Medicine; Proteinuria; Discontinuation; Internal medicine; Adverse effect; Hazard ratio; Renal cell carcinoma; Urology; Gastroenterology; Renal function; Oncology; Kidney; Confidence interval; Sunitinib","score_opus":0.10382160704737768,"score_gpt":0.46543353735548804,"score_spread":0.36161193030811034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333897154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787823,0.016672982,0.00009311953,0.0017937559,0.00035674084,0.00094889005,0.000047291134,0.0000059162526,0.0012990072],"genre_scores_gemma":[0.99487793,0.0026090208,0.0012458711,0.00083973544,0.000068626796,0.00018500422,0.00011961647,0.000013305642,0.000040868734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421257,0.001382049,0.0032623315,0.00050272164,0.0003028896,0.00033744978],"domain_scores_gemma":[0.9963169,0.0024158994,0.0005129799,0.00028681994,0.00029523924,0.00017215013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033805252,0.00023916479,0.003850901,0.00042290692,0.000019428351,0.0000031041118,0.00014068035,0.00032665546,0.0003791791],"category_scores_gemma":[0.0060821264,0.00018321835,0.00029395535,0.0005880603,0.00059187616,0.00008165642,0.00004646697,0.00030772286,0.0000011818325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014328525,0.005041233,0.8884856,0.00069098175,0.00049144437,0.00022962505,0.00010828606,0.000010149665,0.00019038269,0.022862775,0.0034425594,0.077014074],"study_design_scores_gemma":[0.01353727,0.0049079084,0.93234694,0.0014060144,0.001862218,0.00007245468,0.000103650345,0.000913977,0.00050747173,0.0020502151,0.041886467,0.0004053939],"about_ca_topic_score_codex":0.025084851,"about_ca_topic_score_gemma":0.39102116,"teacher_disagreement_score":0.3659363,"about_ca_system_score_codex":0.0006498328,"about_ca_system_score_gemma":0.0008859017,"threshold_uncertainty_score":0.98140717},"labels":[],"label_agreement":null},{"id":"W2394579054","doi":"10.1016/j.critrevonc.2016.05.011","title":"The role of aspirin in colorectal cancer chemoprevention","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Upper River Valley Hospital; Dalhousie University; Memorial University of Newfoundland","funders":"","keywords":"Aspirin; Medicine; Disease; Colorectal cancer; Cyclooxygenase; Cancer; Intensive care medicine; Low dose aspirin; Clinical trial; Cancer prevention; Oncology; Internal medicine; Bioinformatics; Biology","score_opus":0.03925139523658195,"score_gpt":0.4389904786052342,"score_spread":0.39973908336865227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394579054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030093148,0.992634,0.00000563758,0.0004163255,0.00096525304,0.0027505255,0.000011784876,0.000017714774,0.0028978258],"genre_scores_gemma":[0.0003804305,0.99635303,0.00009402237,0.0000968513,0.00026174446,0.0026619462,0.000016197873,0.000052340474,0.00008345097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940897,0.0018163099,0.0025007694,0.0005884637,0.00021553991,0.0007891873],"domain_scores_gemma":[0.9936627,0.0049804673,0.00057452655,0.00047656396,0.00011286348,0.00019283981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029987895,0.000506373,0.005681892,0.00031114186,0.000054039658,0.000005649224,0.00038154406,0.0012703792,0.00026323317],"category_scores_gemma":[0.006865111,0.00028040138,0.0007444219,0.00046581012,0.0008226961,0.000046910136,0.0001675981,0.0011413591,0.0002858777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006650684,0.00022293041,0.00044636638,0.021145133,0.000042243555,0.0002017909,0.000027056507,3.489052e-9,0.00001815535,0.020207405,0.00042822777,0.95719415],"study_design_scores_gemma":[0.00063817383,0.000307106,0.00003685963,0.08061596,0.00034391772,0.0004915097,0.000013084345,0.000003335764,0.00012821337,0.0013941386,0.9158018,0.00022590024],"about_ca_topic_score_codex":0.0000148613435,"about_ca_topic_score_gemma":0.00021809264,"teacher_disagreement_score":0.9569683,"about_ca_system_score_codex":0.00072727853,"about_ca_system_score_gemma":0.0012296628,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2397619099","doi":"10.1016/j.critrevonc.2016.04.019","title":"Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Tolerability; Medicine; Internal medicine; Oncology; Refractory (planetary science); Anaplastic large-cell lymphoma; Lymphoma; Clinical trial; Hodgkin lymphoma; Adverse effect","score_opus":0.09861715029883955,"score_gpt":0.4469495262259395,"score_spread":0.3483323759270999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397619099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000623369,0.98349786,0.000003145099,0.004692972,0.00087962026,0.008932247,0.0005398712,0.00007312834,0.0013188501],"genre_scores_gemma":[0.00010481176,0.98515064,0.00153156,0.0028002171,0.00017267127,0.0044206115,0.005697832,0.000105568855,0.000016109952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847715,0.005794456,0.005581587,0.002173741,0.0005457544,0.0011329906],"domain_scores_gemma":[0.9863053,0.006440399,0.0015645318,0.0049118255,0.0003055902,0.00047235822],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035100586,0.0011256961,0.011542408,0.00035621822,0.000068126516,0.0000335153,0.0019405447,0.0014816667,0.0016499531],"category_scores_gemma":[0.018148648,0.0005965956,0.00084950787,0.0010668625,0.0010774746,0.0002511393,0.0010818706,0.0009850501,0.00048189546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000686229,0.009362604,0.00029280994,0.035530448,0.00019501304,0.0010056674,0.000032507407,8.816152e-10,1.15104356e-7,0.0018224003,0.044123113,0.9075667],"study_design_scores_gemma":[0.0027159043,0.0012112989,0.00010936594,0.2538318,0.0017335307,0.00064054265,0.000015574125,0.0000028520851,9.3621907e-7,0.00019046696,0.7391776,0.00037012243],"about_ca_topic_score_codex":0.0001323114,"about_ca_topic_score_gemma":0.00022397537,"teacher_disagreement_score":0.9071966,"about_ca_system_score_codex":0.001489824,"about_ca_system_score_gemma":0.0027968094,"threshold_uncertainty_score":0.9998146},"labels":[],"label_agreement":null},{"id":"W2406868600","doi":"10.1016/j.critrevonc.2010.04.010","title":"Editorial","year":2010,"lang":"en","type":"editorial","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"European Society for Medical Oncology; European School of Oncology","keywords":"Medicine; Quality of life (healthcare); Prospective cohort study; Cohort; Activities of daily living; Mental health; Cancer; Gerontology; Internal medicine; Physical therapy; Psychiatry","score_opus":0.030418805447440956,"score_gpt":0.4148811962739988,"score_spread":0.3844623908265578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406868600","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016460555,0.029432245,0.000032179636,0.0027620397,0.94241935,0.0012589085,0.000079558704,0.00008003188,0.0239192],"genre_scores_gemma":[0.000023045965,0.021801531,0.0023597088,0.0017799657,0.9719887,0.0006121573,0.00056677015,0.00010018292,0.00076798623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402964,0.0007141196,0.0021159502,0.0012683641,0.00072454923,0.0011474025],"domain_scores_gemma":[0.9882874,0.008957385,0.00036058007,0.0012240554,0.00056076393,0.00060981204],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0022420525,0.00074016105,0.0048395693,0.00038466533,0.00009615496,0.000025195166,0.00060738256,0.008144884,0.0028123758],"category_scores_gemma":[0.057092205,0.0006368612,0.00061346416,0.00029317374,0.0011474016,0.000112109155,0.0002664515,0.009086936,0.0012412746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045784406,0.00040303727,0.000048394617,0.001845884,0.00004003384,0.00063575344,0.00005138856,1.2237408e-8,0.00007298949,0.002417485,0.9734192,0.020607958],"study_design_scores_gemma":[0.0028277973,0.0009155863,0.000004859354,0.0014157462,0.00030632745,0.00023560911,0.000014649697,0.0000048632483,0.00003354392,0.0009173666,0.9928236,0.0005000549],"about_ca_topic_score_codex":0.000040103223,"about_ca_topic_score_gemma":0.00027098323,"teacher_disagreement_score":0.054850154,"about_ca_system_score_codex":0.0009001348,"about_ca_system_score_gemma":0.004492685,"threshold_uncertainty_score":0.9996083},"labels":[],"label_agreement":null},{"id":"W2517435317","doi":"10.1016/j.critrevonc.2012.06.004","title":"Anaplastic large cell lymphoma, ALK-negative","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Lymphoma; Medicine; CD30; Internal medicine; Pathology; Large cell; B symptoms; Oncology; Cancer; Adenocarcinoma; Lung cancer","score_opus":0.09508870384681826,"score_gpt":0.4356182006152879,"score_spread":0.3405294967684696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517435317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008255017,0.9698819,0.000040983505,0.000494587,0.0012648337,0.0032730738,0.00008109551,0.000068803536,0.024886467],"genre_scores_gemma":[0.0005000917,0.9918701,0.00208195,0.0012651845,0.0003771635,0.0032418505,0.00021197817,0.00011574539,0.0003359279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921189,0.0018298184,0.0027628308,0.0012276433,0.00030079146,0.0017599987],"domain_scores_gemma":[0.9891354,0.008240627,0.0005887255,0.0010772691,0.00014585134,0.0008121579],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013085348,0.0011917283,0.010806844,0.00052064384,0.0001237672,0.000019753475,0.0004244943,0.0019839506,0.0012164923],"category_scores_gemma":[0.004979442,0.0008293617,0.0014692823,0.0007061145,0.000602789,0.000101866215,0.0003509621,0.00081168074,0.0065667764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042726173,0.008934933,0.00021658167,0.0419957,0.00017516414,0.0026943528,0.000075008254,2.8697413e-9,4.755194e-8,0.033241708,0.00620163,0.90642214],"study_design_scores_gemma":[0.0038625577,0.0009711641,0.00003034199,0.029750742,0.0051788418,0.00421523,0.000025727564,0.0000024331803,0.0000044234785,0.0003621955,0.95501107,0.00058528275],"about_ca_topic_score_codex":0.000012839322,"about_ca_topic_score_gemma":0.000060820603,"teacher_disagreement_score":0.94880944,"about_ca_system_score_codex":0.0020754389,"about_ca_system_score_gemma":0.0014361906,"threshold_uncertainty_score":0.99969655},"labels":[],"label_agreement":null},{"id":"W2518785689","doi":"10.1016/j.critrevonc.2016.09.001","title":"Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Neurocognitive; Neuropsychology; Medicine; Adverse effect; Clinical psychology; Pediatrics; Psychiatry; Cognition; Internal medicine","score_opus":0.04423018214970691,"score_gpt":0.4246406758221332,"score_spread":0.3804104936724263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518785689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023167374,0.9866804,0.000119473516,0.0024729897,0.0006364556,0.008386517,0.00017812962,0.00011828313,0.0011760677],"genre_scores_gemma":[0.00019126163,0.9855621,0.0006809801,0.010953475,0.00020695808,0.0018935185,0.00020766922,0.00016648161,0.00013757996],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9850475,0.0062653553,0.0046288557,0.0020114402,0.00068457314,0.0013622623],"domain_scores_gemma":[0.9803312,0.014986867,0.0015648924,0.0016845221,0.0005049055,0.0009276475],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020803672,0.0016153927,0.017319502,0.0006436661,0.00008307367,0.000015997684,0.00081019395,0.0019917423,0.00021001276],"category_scores_gemma":[0.046078373,0.0009616646,0.0015680892,0.0021432238,0.0011062009,0.00013892689,0.0004027745,0.0021557354,0.00040501246],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064736285,0.002941172,0.00013571141,0.28551298,0.00096721307,0.009848799,0.00046689354,5.2150963e-8,0.0000044388967,0.0022498465,0.009271866,0.68795365],"study_design_scores_gemma":[0.0028893435,0.0049466146,0.00032448227,0.67473686,0.006047893,0.0066779954,0.000007419795,3.2199773e-7,0.0000036125266,0.00012422365,0.30350885,0.0007323641],"about_ca_topic_score_codex":0.0000036843019,"about_ca_topic_score_gemma":0.000023088603,"teacher_disagreement_score":0.6872213,"about_ca_system_score_codex":0.0016770097,"about_ca_system_score_gemma":0.0017725945,"threshold_uncertainty_score":0.99965936},"labels":[],"label_agreement":null},{"id":"W2528978902","doi":"10.1016/j.critrevonc.2016.09.003","title":"A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bone marrow; Neoplasm; Haematopoiesis; Disease; Plasmacytoid dendritic cell; Leukemia; Stem cell; Complete remission; Cancer research; Immunology; Dendritic cell; Oncology; Pathology; Chemotherapy; Internal medicine; Biology; Immune system","score_opus":0.13979330534355452,"score_gpt":0.4921211483401748,"score_spread":0.35232784299662023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528978902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002390255,0.98005575,0.0005976275,0.00274102,0.00057391485,0.0095886225,0.00037428061,0.000050947307,0.0060154265],"genre_scores_gemma":[0.000024947502,0.9850236,0.0026962424,0.0010219009,0.00022548964,0.009718027,0.00016269925,0.0001791694,0.000947925],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889365,0.002660751,0.004595639,0.0015573573,0.0004572784,0.0017924669],"domain_scores_gemma":[0.96252584,0.033934496,0.0005319126,0.00134848,0.00094548974,0.0007137589],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0017364593,0.001303832,0.015052042,0.0007443856,0.00012254827,0.000019680003,0.0006297707,0.0014816191,0.0012894562],"category_scores_gemma":[0.05652658,0.00087006507,0.0024163534,0.0006012946,0.002386689,0.00009065968,0.0002546941,0.000912008,0.00075343717],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012642429,0.0013697429,0.000009538851,0.55116,0.0001395319,0.0007771348,0.000042227923,8.158602e-9,0.0000027809572,0.033866044,0.0033831724,0.4091234],"study_design_scores_gemma":[0.0013616232,0.0027460658,1.038715e-7,0.31332606,0.0019611914,0.009216773,0.000027443855,0.0000105444,0.000017446682,0.0014259916,0.66945934,0.00044743068],"about_ca_topic_score_codex":0.000009404413,"about_ca_topic_score_gemma":0.000029676161,"teacher_disagreement_score":0.6660761,"about_ca_system_score_codex":0.002596988,"about_ca_system_score_gemma":0.0056364336,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W2561725509","doi":"10.1016/j.critrevonc.2016.12.009","title":"Salivary biomarkers in the diagnosis of breast cancer: A review","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Biomarker; Medicine; Oncology; Cancer; Internal medicine; Saliva; Stage (stratigraphy); Biology","score_opus":0.10194319096818653,"score_gpt":0.4640668575290022,"score_spread":0.3621236665608156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561725509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.588093e-7,0.9720427,0.000015646769,0.018395703,0.00055629405,0.0035253086,0.00015136448,0.000018982351,0.005293144],"genre_scores_gemma":[0.000011685623,0.98789334,0.00015147633,0.0054917615,0.00014980478,0.006167058,0.00006446337,0.000046187324,0.000024222738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930063,0.002498033,0.0028407138,0.0007321456,0.00024004589,0.0006827504],"domain_scores_gemma":[0.99138993,0.0068009417,0.00050865306,0.0009989646,0.00012051288,0.00018097326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00245854,0.0005951474,0.0075242887,0.00043854702,0.00004834545,0.0000053206786,0.0005624477,0.0008584899,0.0020933924],"category_scores_gemma":[0.0056785364,0.00030288802,0.0011124355,0.0012597867,0.00080286217,0.000058609203,0.00014037818,0.0009240052,0.00024099571],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031886357,0.000733286,0.0015513757,0.11585196,0.00011409969,0.00034062323,0.0000196722,7.1353445e-10,3.028249e-8,0.007793452,0.059294477,0.8142691],"study_design_scores_gemma":[0.00047235333,0.00016325463,0.000084873194,0.28035894,0.0013898293,0.0030754774,0.000018377907,1.5928659e-7,4.1037794e-8,0.00035336602,0.71387845,0.00020486409],"about_ca_topic_score_codex":0.00006955188,"about_ca_topic_score_gemma":0.00007814579,"teacher_disagreement_score":0.81406426,"about_ca_system_score_codex":0.00029781857,"about_ca_system_score_gemma":0.0010358819,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W2586486297","doi":"10.1016/j.critrevonc.2017.02.003","title":"Enzastaurin: A lesson in drug development","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Cancer Society","keywords":"Medicine; Drug development; Drug; Clinical trial; Pharmacology; MAPK/ERK pathway; Oncology; Kinase; Internal medicine; Biology","score_opus":0.17130075587845123,"score_gpt":0.466556597083607,"score_spread":0.2952558412051558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586486297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051587045,0.98687357,0.000100084806,0.0001670166,0.0009176754,0.0014729727,0.000015134807,0.00001379138,0.010388176],"genre_scores_gemma":[0.00010266044,0.99426913,0.002460832,0.00027257783,0.00026004564,0.0016260745,0.00023824781,0.000073932526,0.00069650245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936832,0.0015069207,0.0022895883,0.001321094,0.00015148227,0.0010477229],"domain_scores_gemma":[0.9973873,0.0004438938,0.0005506818,0.0012930813,0.000069247144,0.00025581688],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021620772,0.0007951297,0.0049118837,0.0003277453,0.00012165692,0.000031266838,0.0012142195,0.0017022493,0.00009362741],"category_scores_gemma":[0.0044786185,0.00067338615,0.0005437759,0.00016205951,0.00046943888,0.000007856973,0.00074801105,0.0010371865,0.00051390583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018327572,0.0003500547,0.00005137097,0.013031782,0.00003385931,0.00065498316,0.00006258023,2.0143446e-8,0.000008729504,0.008380668,0.004577222,0.9728304],"study_design_scores_gemma":[0.0004260929,0.00014770342,0.0000065342256,0.014408067,0.000093784314,0.0007824697,0.000014129262,4.025366e-7,0.000074947806,0.00020686234,0.9832155,0.00062351226],"about_ca_topic_score_codex":0.000013187131,"about_ca_topic_score_gemma":0.0007780526,"teacher_disagreement_score":0.9786383,"about_ca_system_score_codex":0.00026770946,"about_ca_system_score_gemma":0.0016533884,"threshold_uncertainty_score":0.99959373},"labels":[],"label_agreement":null},{"id":"W2589167545","doi":"10.1016/j.critrevonc.2017.02.020","title":"Adjuvant nodal radiotherapy in the era of sentinel node biopsy staging of breast cancer: A review of published guidelines and prospective trials and their implications on clinical practice","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sentinel node; Medicine; Breast cancer; Radiation therapy; Adjuvant radiotherapy; Biopsy; Adjuvant; Clinical Practice; Oncology; Cancer; NODAL; Medical physics; General surgery; Internal medicine; Family medicine","score_opus":0.20305275812832801,"score_gpt":0.5545317272133716,"score_spread":0.3514789690850436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589167545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055602704,0.9778147,0.000048480906,0.0191242,0.00015613616,0.002186967,0.00037493472,0.0000029021676,0.0002361311],"genre_scores_gemma":[0.00035360947,0.99509317,0.0016567673,0.001445441,0.00016820699,0.0012000814,0.000052400188,0.000028251905,0.0000020991683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912321,0.0035450729,0.003974151,0.00081591436,0.000113488655,0.00031928642],"domain_scores_gemma":[0.99082303,0.004870241,0.0025976205,0.0010202967,0.0006183943,0.00007038731],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077514397,0.0004843011,0.00707371,0.000114524846,0.000059620004,0.000012008535,0.00053054193,0.00052179984,0.00001291765],"category_scores_gemma":[0.03295452,0.00027502084,0.00055846106,0.00022874652,0.0013334373,0.00001692335,0.00024222165,0.0005761499,4.4240602e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018262635,0.000787132,0.0042641466,0.036987428,0.0004940735,0.000009465193,0.00007467517,2.3370179e-8,0.000015217458,0.0034302082,0.0019794458,0.95177555],"study_design_scores_gemma":[0.0017935025,0.00037056743,0.0032668435,0.1156723,0.0016251871,0.0015561575,0.000099535515,0.0000012750213,0.000011672075,0.0003263659,0.8749083,0.0003682484],"about_ca_topic_score_codex":0.00006853085,"about_ca_topic_score_gemma":0.000024371984,"teacher_disagreement_score":0.9514073,"about_ca_system_score_codex":0.000071522256,"about_ca_system_score_gemma":0.0007172822,"threshold_uncertainty_score":0.9999702},"labels":[],"label_agreement":null},{"id":"W2593675800","doi":"10.1016/j.critrevonc.2017.02.026","title":"A comprehensive review of immunotherapies in prostate cancer","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; Princess Margaret Cancer Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; Immunotherapy; Clinical trial; Cancer; Disease; Oncology; Immune system; Cancer immunotherapy; Internal medicine; Immunology","score_opus":0.25979385975926067,"score_gpt":0.5697634065239928,"score_spread":0.30996954676473215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593675800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033427152,0.9872759,7.865412e-7,0.0035000646,0.0004290555,0.0064620473,0.00006517669,0.000017060009,0.0022465643],"genre_scores_gemma":[0.0000030946644,0.99304575,0.0003396275,0.000930994,0.00007348461,0.004994674,0.00010863547,0.00007036716,0.0004333681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934209,0.0016125808,0.0029443132,0.0008381021,0.0002807195,0.0009033588],"domain_scores_gemma":[0.9955382,0.0019199249,0.00082071027,0.0011766499,0.00034299924,0.0002015197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014488222,0.0006949021,0.01225175,0.00055206136,0.00006287096,0.000010742271,0.0005856502,0.00072050875,0.0006216016],"category_scores_gemma":[0.0036423053,0.00046272165,0.00093125366,0.00053011224,0.0015398879,0.00008020511,0.00027107625,0.0016212908,0.00015849009],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006596743,0.00032877046,0.00010181431,0.40178704,0.000104345105,0.00092950696,0.00004794598,1.8436732e-9,4.9432e-7,0.00082217983,0.0016827647,0.59412915],"study_design_scores_gemma":[0.00081773597,0.00028329124,0.0000128724905,0.41435468,0.00045396408,0.00052221614,0.000010289196,2.7211215e-7,0.000001567338,0.00013778037,0.58321583,0.00018949299],"about_ca_topic_score_codex":0.000074739684,"about_ca_topic_score_gemma":0.000047225687,"teacher_disagreement_score":0.59393966,"about_ca_system_score_codex":0.0009006013,"about_ca_system_score_gemma":0.0027063142,"threshold_uncertainty_score":0.99978244},"labels":[],"label_agreement":null},{"id":"W2594173744","doi":"10.1016/j.critrevonc.2012.07.005","title":"Active surveillance for low-risk prostate cancer","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Overdiagnosis; Prostate cancer; Medicine; Cancer; Asymptomatic; Disease; Gynecology; Internal medicine; Intensive care medicine; Family medicine; Oncology","score_opus":0.10824038319028571,"score_gpt":0.4795322791321462,"score_spread":0.37129189594186046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594173744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011056958,0.98579514,0.00004284216,0.0014922624,0.0015700185,0.00939014,0.0007826568,0.000052087944,0.00086377695],"genre_scores_gemma":[0.000056596196,0.96746373,0.0012346626,0.0007160738,0.0004750929,0.02942634,0.00034306225,0.00012589469,0.00015851783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993707,0.0011778247,0.0023707408,0.0011620051,0.00018030242,0.0014021416],"domain_scores_gemma":[0.9911178,0.006473839,0.0008544231,0.00078597374,0.0002607012,0.0005073102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015327366,0.00091713155,0.009168381,0.000265883,0.00010923148,0.000014659333,0.0002892293,0.0011826188,0.00037796065],"category_scores_gemma":[0.005622648,0.000642437,0.001161817,0.0004476559,0.0005751746,0.00009026481,0.00015601979,0.0012314942,0.0003326548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012669775,0.0009823376,0.0009614797,0.05942482,0.00025907613,0.00016899664,0.000079350066,2.4316636e-8,7.378678e-8,0.0038285528,0.003939075,0.93022954],"study_design_scores_gemma":[0.0014127706,0.0007292763,0.00005441979,0.04095589,0.0027341447,0.00046165535,0.000014431825,0.0000019511542,0.000006260217,0.00043348467,0.95269895,0.0004967614],"about_ca_topic_score_codex":0.000033517234,"about_ca_topic_score_gemma":0.00017862185,"teacher_disagreement_score":0.94875985,"about_ca_system_score_codex":0.001947995,"about_ca_system_score_gemma":0.0015070471,"threshold_uncertainty_score":0.9996027},"labels":[],"label_agreement":null},{"id":"W2595537928","doi":"10.1016/j.critrevonc.2017.03.002","title":"Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transferrin saturation; Ferritin; Pathological; Hematopoietic stem cell; Stem cell; Haematopoiesis; Transplantation; Anemia; Internal medicine; Iron deficiency; Gastroenterology; Intensive care medicine; Biology","score_opus":0.07102304695229372,"score_gpt":0.40060935867777275,"score_spread":0.32958631172547903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595537928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058546513,0.98803675,0.00009293296,0.00082942774,0.0003294602,0.00392016,0.000042288153,0.000013968602,0.0008803369],"genre_scores_gemma":[0.016863061,0.98159605,0.0007032753,0.000098985445,0.000033413486,0.00058643747,0.000056758665,0.000034142424,0.000027873257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947297,0.0011607232,0.002660932,0.0006616064,0.00021365673,0.00057336455],"domain_scores_gemma":[0.9955252,0.0024770587,0.0011532537,0.0006437517,0.00010445286,0.00009632459],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024033396,0.0005245319,0.0055071143,0.00031464203,0.00010553644,0.000011057341,0.00036168427,0.0014826527,0.000017658662],"category_scores_gemma":[0.0013149083,0.00034319467,0.0005904796,0.00028385856,0.00089641067,0.000083974934,0.00006844519,0.0009043281,0.000006830265],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020217079,0.0011749568,0.0002464125,0.4844452,0.000043801156,0.00025460857,0.0023226745,5.5830407e-7,0.0001208522,0.02115203,0.00048571243,0.489551],"study_design_scores_gemma":[0.007832478,0.0050458345,0.00024446184,0.33394083,0.009267001,0.031145489,0.006616478,0.00007332838,0.0009234139,0.0052968184,0.5977142,0.001899641],"about_ca_topic_score_codex":0.00001737859,"about_ca_topic_score_gemma":0.000031805735,"teacher_disagreement_score":0.59722847,"about_ca_system_score_codex":0.00015896649,"about_ca_system_score_gemma":0.00036911233,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W2595812558","doi":"10.1016/j.critrevonc.2017.03.017","title":"Prognostic and predictive biomarkers in neuroendocrine tumours","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chromogranin A; Nomogram; Medicine; Biomarker; Neuroendocrine tumors; Oncology; Internal medicine; Bioinformatics; Pathology; Biology; Immunohistochemistry","score_opus":0.13984485539374347,"score_gpt":0.5008886420537874,"score_spread":0.3610437866600439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595812558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004779739,0.98641473,0.0000067814017,0.002964427,0.0005347164,0.0063798884,0.00003873832,0.000055394135,0.0035575344],"genre_scores_gemma":[0.00036285023,0.99520797,0.00067130296,0.00033179473,0.00012734653,0.0029594644,0.00006551434,0.00011714984,0.00015660762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99119407,0.0025641094,0.0025164415,0.0016748571,0.00035843946,0.0016920932],"domain_scores_gemma":[0.9907608,0.0066301036,0.00055295153,0.0012274205,0.00012628589,0.0007024234],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010707935,0.0009536114,0.008990844,0.0012140258,0.00011059198,0.000041959225,0.0007455585,0.0001755624,0.000110627196],"category_scores_gemma":[0.0602338,0.0007439797,0.0005266848,0.0005957042,0.0024258594,0.00019535658,0.000756005,0.0029593708,0.00021089811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015598611,0.0007731102,0.0031400542,0.062311232,0.00008398835,0.11276943,0.000012032322,1.659817e-8,4.3159318e-7,0.0028644167,0.0016501922,0.8162391],"study_design_scores_gemma":[0.0011342182,0.0014424213,0.0002060866,0.052376717,0.00070213916,0.071677335,0.000018889805,0.000011325993,0.0000014285957,0.00069430174,0.8713468,0.00038838826],"about_ca_topic_score_codex":0.000013968418,"about_ca_topic_score_gemma":0.00010259094,"teacher_disagreement_score":0.86969656,"about_ca_system_score_codex":0.0004956432,"about_ca_system_score_gemma":0.0011217197,"threshold_uncertainty_score":0.9995011},"labels":[],"label_agreement":null},{"id":"W2621173929","doi":"10.1016/j.critrevonc.2017.05.010","title":"Azacitidine in adult patients with acute myeloid leukemia","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Azacitidine; Myeloid leukemia; Medicine; Clinical trial; Oncology; Internal medicine; Biology","score_opus":0.08975523865005734,"score_gpt":0.4533416505009695,"score_spread":0.3635864118509121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621173929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009195124,0.9793858,0.000047744725,0.0012855654,0.00055633666,0.006326234,0.00008186584,0.00006804762,0.012156457],"genre_scores_gemma":[0.000061887535,0.9910589,0.0032989127,0.001123027,0.0002441648,0.002929879,0.0005472562,0.00020798315,0.00052798534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.989607,0.0020308748,0.0036171796,0.001942873,0.00064578635,0.002156319],"domain_scores_gemma":[0.99186426,0.0033611576,0.0008851578,0.0024801039,0.000617795,0.0007914953],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0021080675,0.0013906378,0.013939348,0.0013210586,0.00016276438,0.000049039085,0.0015037949,0.0028550758,0.00056546484],"category_scores_gemma":[0.018503387,0.0009610805,0.0008717722,0.0009479614,0.0020358346,0.00023281704,0.00075286283,0.005458633,0.0017224883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003091698,0.0007567563,0.0010065982,0.037285317,0.00022814986,0.009559429,0.000041638934,1.673577e-8,1.8044703e-7,0.010383654,0.0070327497,0.93339634],"study_design_scores_gemma":[0.004135524,0.0012468854,0.00011032419,0.077727556,0.0014084327,0.0037096615,0.000010213592,0.000007932824,0.0000010985177,0.00028624505,0.91060406,0.00075208617],"about_ca_topic_score_codex":0.00005428691,"about_ca_topic_score_gemma":0.00023330322,"teacher_disagreement_score":0.93264425,"about_ca_system_score_codex":0.0061954283,"about_ca_system_score_gemma":0.00651403,"threshold_uncertainty_score":0.9998844},"labels":[],"label_agreement":null},{"id":"W2621587943","doi":"10.1016/j.critrevonc.2017.06.001","title":"Biomarkers of response to PD-1/PD-L1 inhibition","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"U.S. Food and Drug Administration; University of Chicago; Bristol-Myers Squibb","keywords":"Medicine; PD-L1; Immunotherapy; Melanoma; Immune system; Oncology; Head and neck squamous-cell carcinoma; Lymphoma; Cytotoxic T cell; Cancer; Renal cell carcinoma; Head and neck cancer; Internal medicine; Cancer research; Antigen; Immunology; Biology","score_opus":0.17863256192961188,"score_gpt":0.5110149956100323,"score_spread":0.3323824336804204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621587943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006814058,0.9870809,0.00006448149,0.0041863234,0.0011096471,0.0035937033,0.000059390095,0.000038583097,0.0037988801],"genre_scores_gemma":[0.00009369994,0.9949277,0.001849847,0.0014219303,0.00014876162,0.0010562014,0.00007232283,0.00008119052,0.0003483659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918413,0.0026869674,0.0033266318,0.0010155647,0.00028933148,0.00084020314],"domain_scores_gemma":[0.99298567,0.003912156,0.00089529547,0.001610235,0.00020677836,0.00038986473],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053125643,0.0007416423,0.008546156,0.0009886335,0.00011042615,0.000018964822,0.00053885265,0.001752151,0.0006198515],"category_scores_gemma":[0.01863114,0.00057721196,0.001468775,0.0006683765,0.0013969555,0.000079442405,0.00026127574,0.0009984825,0.00048593842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004037524,0.00049702177,0.00001831274,0.03395081,0.0002203284,0.00090141094,0.00006746213,2.5289153e-9,0.00006702185,0.0015618207,0.013413741,0.9452645],"study_design_scores_gemma":[0.0013411961,0.0014056885,0.00003965809,0.090821646,0.00092478114,0.002766273,0.000022321006,4.0499856e-7,0.000035385638,0.00017161686,0.9020568,0.00041422818],"about_ca_topic_score_codex":0.00002635257,"about_ca_topic_score_gemma":0.000045209,"teacher_disagreement_score":0.9448503,"about_ca_system_score_codex":0.00094756635,"about_ca_system_score_gemma":0.0018187241,"threshold_uncertainty_score":0.99966794},"labels":[],"label_agreement":null},{"id":"W2766023480","doi":"10.1016/j.critrevonc.2017.10.009","title":"Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; McGill University","funders":"","keywords":"Medicine; Concomitant; Clinical trial; Internal medicine; Systematic review; MEDLINE; Oncology; Radiation therapy; Immunotherapy; Hematology; Cancer","score_opus":0.11235881203892009,"score_gpt":0.42442660713128944,"score_spread":0.31206779509236937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766023480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021142424,0.98726434,0.000007063357,0.00036999566,0.00034218357,0.011624372,0.000031358773,0.00002320897,0.00012606799],"genre_scores_gemma":[0.0002856079,0.99620956,0.0005924763,0.0006926576,0.000019834913,0.001999335,0.0000619664,0.000077848024,0.000060741237],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98896253,0.001995248,0.0069398726,0.0009647995,0.0003348972,0.00080265],"domain_scores_gemma":[0.99138,0.0037874435,0.0027428388,0.0015837534,0.0002578566,0.0002481508],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0025436012,0.0009803761,0.020146262,0.00049424043,0.00007168367,0.00003118395,0.0004781226,0.001133686,0.00010292312],"category_scores_gemma":[0.018855104,0.0005520249,0.00083848333,0.0005266151,0.0015890984,0.0001703522,0.0002774624,0.0012042123,0.000032317577],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070302514,0.0008450664,0.0006741982,0.9168569,0.00027733593,0.00077536143,0.000045068904,2.2121314e-9,6.6564775e-7,0.00032600234,0.00016252552,0.07933386],"study_design_scores_gemma":[0.0028931675,0.0021442783,0.00009979236,0.85575145,0.0034817208,0.003345291,0.000018959425,0.0000013232724,0.0000036253225,0.000021320024,0.13175012,0.00048894016],"about_ca_topic_score_codex":0.000027985056,"about_ca_topic_score_gemma":0.00011094074,"teacher_disagreement_score":0.1315876,"about_ca_system_score_codex":0.0006504523,"about_ca_system_score_gemma":0.0010616721,"threshold_uncertainty_score":0.9996931},"labels":[],"label_agreement":null},{"id":"W2768842469","doi":"10.1016/j.critrevonc.2017.11.007","title":"Biomarkers in prostate cancer – Current clinical utility and future perspectives","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Liquid biopsy; Medicine; Biomarker; Circulating tumor cell; Cancer; Prostate; Clinical Practice; Oncology; Internal medicine; Intensive care medicine; Metastasis; Biology","score_opus":0.30613549361765446,"score_gpt":0.6113364424185329,"score_spread":0.30520094880087845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768842469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033103366,0.9856697,0.0000010683567,0.006166746,0.0015013397,0.0046056057,0.000066505185,0.000025011283,0.0019309252],"genre_scores_gemma":[0.00004390912,0.9964471,0.00022317235,0.00010014859,0.00056811364,0.0023672732,0.00006583797,0.000050112863,0.000134317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924352,0.002463209,0.0023468165,0.0015055804,0.00023021769,0.0010189752],"domain_scores_gemma":[0.99619997,0.0017318506,0.00045351914,0.0009332032,0.00018133914,0.0005001167],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003468453,0.00070092094,0.007925907,0.00046612567,0.000121866826,0.000031359825,0.00039571853,0.0011709147,0.00029061525],"category_scores_gemma":[0.0052640624,0.00046029204,0.00072435604,0.00036813325,0.0027610203,0.0001001958,0.0003645397,0.0028759933,0.000081693026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019523798,0.0009528398,0.006828227,0.039242525,0.000167644,0.001210111,0.00015613712,2.3307112e-10,1.7418266e-8,0.0022875722,0.0021702596,0.94678944],"study_design_scores_gemma":[0.0017573215,0.0003674399,0.0007998581,0.042725056,0.000729829,0.00057477655,0.00015647947,0.0000029312987,9.14788e-8,0.0003590588,0.9521914,0.0003357171],"about_ca_topic_score_codex":0.000025708881,"about_ca_topic_score_gemma":0.00018057652,"teacher_disagreement_score":0.9500212,"about_ca_system_score_codex":0.00090741314,"about_ca_system_score_gemma":0.00267364,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W2769734807","doi":"10.1016/j.critrevonc.2017.11.011","title":"Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; SickKids Foundation; Pediatric Oncology Group; Hospital for Sick Children; University of Calgary; Institute for Clinical Evaluative Sciences","funders":"Pediatric Oncology Group of Ontario","keywords":"Medicine; Mindfulness; Physical therapy; Psychological intervention; Massage; Acupressure; Randomized controlled trial; Meta-analysis; Strictly standardized mean difference; Acupuncture; Internal medicine; Clinical psychology; Psychiatry; Alternative medicine","score_opus":0.2038610417729056,"score_gpt":0.47208120997224395,"score_spread":0.26822016819933836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769734807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007049274,0.98862076,0.00003472997,0.0011240835,0.00014937163,0.009737915,0.00014971728,0.000008088943,0.00010486861],"genre_scores_gemma":[0.000761486,0.99049085,0.00024360094,0.00029387616,0.000021210695,0.007874411,0.000097505894,0.00004668999,0.00017039428],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941632,0.0015004379,0.0024103064,0.0011844835,0.0002369209,0.0005046227],"domain_scores_gemma":[0.99471486,0.002067761,0.0019168187,0.00080349564,0.0002238678,0.0002732163],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002308683,0.000719476,0.017188333,0.00047211983,0.00009976537,0.000044006767,0.00021092566,0.0006718613,0.00006269269],"category_scores_gemma":[0.0013215098,0.00044429256,0.00075717043,0.00044436354,0.00047414098,0.000164383,0.00007343162,0.00070628943,0.000003115058],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070118534,0.0002887145,0.00026866,0.9711389,0.006372202,0.000060076487,0.00033811684,6.720047e-9,1.7425906e-8,0.0002678432,0.00007314381,0.021122199],"study_design_scores_gemma":[0.00090928003,0.0005449405,0.000014741984,0.22502568,0.6752047,0.0006140462,0.0000950565,0.000001826275,3.1846477e-7,0.000024450772,0.09710917,0.000455815],"about_ca_topic_score_codex":0.00008605569,"about_ca_topic_score_gemma":0.0009687707,"teacher_disagreement_score":0.74611324,"about_ca_system_score_codex":0.00023599446,"about_ca_system_score_gemma":0.00030578638,"threshold_uncertainty_score":0.99980086},"labels":[],"label_agreement":null},{"id":"W2771110982","doi":"10.1016/j.critrevonc.2017.12.009","title":"Systemic treatment in adult uterine sarcomas","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Endometrial stromal sarcoma; Uterine sarcoma; Leiomyosarcoma; Medicine; Sarcoma; Uterus; Stromal cell; Oncology; Internal medicine; Radiology; Pathology","score_opus":0.17483381086540112,"score_gpt":0.5097559825933041,"score_spread":0.334922171727903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771110982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040146042,0.98581654,0.00000889188,0.0010557023,0.0009016532,0.0045896275,0.000042818945,0.000051533756,0.0074930815],"genre_scores_gemma":[0.00024523036,0.9924388,0.001204266,0.0002782997,0.00023063133,0.004210819,0.0001712925,0.00010094812,0.0011197095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323684,0.0012123996,0.00301967,0.0012541937,0.00018327666,0.0010936249],"domain_scores_gemma":[0.9958616,0.0012835525,0.00061369967,0.0017397188,0.00010243138,0.00039901148],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066651916,0.0010988928,0.012749778,0.00062874745,0.0000834796,0.00002696752,0.0005116874,0.001417817,0.00028804105],"category_scores_gemma":[0.003085327,0.00073857274,0.0011155342,0.00027646217,0.00048820747,0.00007861381,0.00028640518,0.00093161664,0.0013685059],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044207205,0.0015667133,0.0006113403,0.046720546,0.0001572822,0.016390223,0.000036456553,3.665056e-9,2.0024552e-7,0.011519722,0.00039583122,0.9225575],"study_design_scores_gemma":[0.0022635083,0.0013541534,0.000028920234,0.08492845,0.0011698569,0.023039073,0.000008263877,0.0000032766786,6.5752846e-7,0.00014235597,0.886655,0.00040648298],"about_ca_topic_score_codex":0.000099103,"about_ca_topic_score_gemma":0.00027982375,"teacher_disagreement_score":0.92215097,"about_ca_system_score_codex":0.0021646207,"about_ca_system_score_gemma":0.0010128388,"threshold_uncertainty_score":0.9998785},"labels":[],"label_agreement":null},{"id":"W2772220088","doi":"10.1016/j.critrevonc.2017.12.011","title":"Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Pediatric Oncology Group; SickKids Foundation; Institute for Clinical Evaluative Sciences; University of Calgary; London Health Sciences Centre","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Hematopoietic stem cell transplantation; Confidence interval; Cancer; Strictly standardized mean difference; Physical activity; Physical therapy; Internal medicine; Cancer-related fatigue; Oncology; Transplantation","score_opus":0.24275538187352605,"score_gpt":0.4833647790037403,"score_spread":0.24060939713021426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772220088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004482349,0.985251,0.000022707198,0.00051670545,0.00012655274,0.013255195,0.00023949354,0.000010865647,0.00012921225],"genre_scores_gemma":[0.0068106586,0.98401725,0.00004640747,0.0001982453,0.000016413805,0.008754349,0.00005271796,0.000045388442,0.000058569287],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.983049,0.010619531,0.004297729,0.0011029564,0.0004143679,0.000516443],"domain_scores_gemma":[0.98284733,0.012738258,0.0028427935,0.0010515096,0.00024939247,0.00027072377],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008617015,0.0009153236,0.07795902,0.00067839783,0.000054576867,0.000022563723,0.00034852244,0.0006593345,0.00009496243],"category_scores_gemma":[0.005211668,0.00048842566,0.0038486694,0.00076498324,0.0010248456,0.000101707505,0.00010515182,0.00091400987,0.0000031080099],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014396649,0.00087585824,0.000040807456,0.9475827,0.02706182,0.00006772142,0.0004778401,2.1690475e-8,4.8459277e-8,0.0005147295,0.000028704486,0.021910038],"study_design_scores_gemma":[0.008815554,0.00021762936,0.0000047468848,0.24650685,0.7416168,0.000053276624,0.00002037034,0.0000028319564,0.0000015922496,0.000023187844,0.002384617,0.00035255216],"about_ca_topic_score_codex":0.00010191694,"about_ca_topic_score_gemma":0.00040294472,"teacher_disagreement_score":0.71455497,"about_ca_system_score_codex":0.00023907321,"about_ca_system_score_gemma":0.00043221455,"threshold_uncertainty_score":0.99975675},"labels":[],"label_agreement":null},{"id":"W2791371772","doi":"10.1016/j.critrevonc.2018.01.009","title":"The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Gene; Biology; SWI/SNF; Phenotype; Genetics; SMARCA4; ARID1A; Cancer; Protein subunit; Gene expression; Bioinformatics; Cancer research; Computational biology; Mutation","score_opus":0.0852170721346997,"score_gpt":0.42576139986352335,"score_spread":0.34054432772882365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791371772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010494386,0.9954716,0.00074914284,0.0005222704,0.00056094874,0.0011149681,0.000086686494,0.000013113389,0.0004318081],"genre_scores_gemma":[0.00086004013,0.9967622,0.00064839853,0.0004563252,0.00023587748,0.0007308034,0.00012679987,0.000046626763,0.00013291357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99527144,0.0017569422,0.001430994,0.00086864765,0.00010087845,0.00057112024],"domain_scores_gemma":[0.997403,0.0013066452,0.00029471796,0.00069499336,0.00011446596,0.00018616414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019947786,0.00051586377,0.0024633042,0.00014971779,0.00032913202,0.00004391692,0.00040971464,0.0011652928,0.000030113139],"category_scores_gemma":[0.002854642,0.00034712232,0.0002469633,0.00024711626,0.00068936753,0.000005183931,0.0003835896,0.00082851644,0.000024401576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000254076,0.00011930344,0.0015726764,0.0033494178,0.00013059977,0.000011973126,0.0000838111,0.0000011389137,0.000021612283,0.004591045,0.0039394936,0.98615354],"study_design_scores_gemma":[0.00034209274,0.0002907173,0.00011197311,0.0019250595,0.00020106681,0.00012129671,0.00009099036,0.00003509595,0.0000032276805,0.00052145566,0.9959905,0.0003665046],"about_ca_topic_score_codex":0.00013977378,"about_ca_topic_score_gemma":0.003634137,"teacher_disagreement_score":0.992051,"about_ca_system_score_codex":0.00021557671,"about_ca_system_score_gemma":0.00047070996,"threshold_uncertainty_score":0.9998981},"labels":[],"label_agreement":null},{"id":"W2793668795","doi":"10.1016/j.critrevonc.2018.02.010","title":"Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The King's University; University of Alberta","funders":"Li Ka Shing Foundation","keywords":"Medicine; Rivaroxaban; Randomized controlled trial; Venous thromboembolism; Low molecular weight heparin; Anticoagulant; Heparin; Meta-analysis; Anticoagulant therapy; Internal medicine; Anesthesia; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.05674974227454381,"score_gpt":0.47749433214061143,"score_spread":0.4207445898660676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793668795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110041095,0.9559918,0.00013003215,0.0004140939,0.0006700931,0.04236318,0.00013997484,0.000015606047,0.00016518385],"genre_scores_gemma":[0.0005312915,0.9922043,0.0004817146,0.00043523544,0.00008689594,0.0061060153,0.00007108138,0.000074214055,0.000009258732],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9771592,0.012329572,0.008685092,0.00082222174,0.00039251137,0.0006114195],"domain_scores_gemma":[0.9467691,0.04687565,0.0046000453,0.001019725,0.00048438396,0.00025109935],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.025525114,0.00089558435,0.07812763,0.0005017319,0.000044165503,0.0000068401655,0.00041836707,0.0008884347,0.00008487264],"category_scores_gemma":[0.12617037,0.0005033935,0.0031109678,0.00034203203,0.0011804472,0.00004555597,0.00014834592,0.00045209337,0.000015708927],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028610048,0.0020276653,0.0000015374741,0.9526794,0.0033826395,0.00005704992,0.00006401625,4.0103965e-9,0.0000016732989,0.009287997,0.001784059,0.027852934],"study_design_scores_gemma":[0.034548726,0.013117249,5.719213e-7,0.8471616,0.08823652,0.00015100939,0.000010330729,0.0000069648345,0.00007514348,0.0002461072,0.016144931,0.0003008759],"about_ca_topic_score_codex":0.0000048325,"about_ca_topic_score_gemma":8.5180653e-7,"teacher_disagreement_score":0.10551784,"about_ca_system_score_codex":0.0001342044,"about_ca_system_score_gemma":0.0004370227,"threshold_uncertainty_score":0.9997418},"labels":[],"label_agreement":null},{"id":"W2796504850","doi":"10.1016/j.critrevonc.2018.04.001","title":"The influence of genetic variation on late toxicities in childhood cancer survivors: A review","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital","funders":"KWF Kankerbestrijding; European Commission","keywords":"Candidate gene; Genome-wide association study; Medicine; Genetic variation; Genetic predisposition; Cochrane Library; Meta-analysis; Oncology; Biology; Internal medicine; Genetics; Genotype; Gene; Population; Environmental health; Single-nucleotide polymorphism; Disease","score_opus":0.07233568325606497,"score_gpt":0.4488525362974091,"score_spread":0.37651685304134414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796504850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004687923,0.9873945,0.0000098918445,0.005510678,0.0007959959,0.0049288454,0.00004265185,0.000036003752,0.00081261323],"genre_scores_gemma":[0.00011157829,0.9903605,0.00042606678,0.0060859453,0.0003178378,0.002520973,0.000027172584,0.00008743892,0.00006246981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98655224,0.005150533,0.005600527,0.0011470292,0.00055251276,0.0009971395],"domain_scores_gemma":[0.9865953,0.009748025,0.0014762081,0.0015905699,0.00033272998,0.00025718033],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005878844,0.00087360875,0.009303083,0.0004357746,0.000104205676,0.000016349133,0.00090167957,0.0011320402,0.00019538903],"category_scores_gemma":[0.027249312,0.0005923371,0.00086303527,0.001270693,0.0013213706,0.00008101535,0.00027293217,0.0018674249,0.00025483008],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007941631,0.0011900513,0.00038091728,0.2874807,0.00022034519,0.00019892301,0.0008112367,0.0000011954281,3.366388e-7,0.013208219,0.0034287155,0.69299996],"study_design_scores_gemma":[0.0004112761,0.00054632884,0.0011526662,0.3368718,0.00075037003,0.00027986977,0.000016077009,0.0000016097177,5.845916e-7,0.00093223917,0.6586917,0.00034545833],"about_ca_topic_score_codex":0.00043047324,"about_ca_topic_score_gemma":0.0034524766,"teacher_disagreement_score":0.6926545,"about_ca_system_score_codex":0.0008022972,"about_ca_system_score_gemma":0.002147434,"threshold_uncertainty_score":0.9996528},"labels":[],"label_agreement":null},{"id":"W2804629518","doi":"10.1016/j.critrevonc.2018.05.005","title":"Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Urothelial carcinoma; Meta-analysis; Medicine; Perioperative; Urology; Chemotherapy; Upper urinary tract; Urinary system; Carcinoma; Oncology; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.13255033513568734,"score_gpt":0.4548627842880608,"score_spread":0.32231244915237345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804629518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017359306,0.9801705,0.000056071767,0.0028822292,0.0001320032,0.015835127,0.00021643192,0.000012246458,0.0006936889],"genre_scores_gemma":[0.00008113855,0.9831731,0.00090607046,0.0045588124,0.00007248476,0.010521314,0.00003159367,0.00007266487,0.0005828281],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99291486,0.0022699044,0.0030902321,0.0009549642,0.00023274157,0.0005372889],"domain_scores_gemma":[0.995088,0.002303098,0.00083649234,0.0012769182,0.00029960935,0.00019589782],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0017101284,0.00084644416,0.024305178,0.0002844116,0.00010373803,0.000012169448,0.0004739768,0.00075503736,0.0008548073],"category_scores_gemma":[0.0034715317,0.0004148626,0.005598095,0.0008103395,0.00096199487,0.000050625764,0.00012966809,0.0006011652,0.000037100504],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033787433,0.0009548075,0.000029298102,0.9667274,0.026305275,0.00005311073,0.00013843791,1.6367224e-9,9.59051e-8,0.0028280385,0.00057688775,0.0023529092],"study_design_scores_gemma":[0.0006452497,0.0010706236,0.000005816017,0.06185005,0.67844963,0.0021890097,0.000018327039,0.0000012194058,0.00000231033,0.0000894084,0.25541162,0.00026670005],"about_ca_topic_score_codex":0.000009854543,"about_ca_topic_score_gemma":0.00000853765,"teacher_disagreement_score":0.9048773,"about_ca_system_score_codex":0.00026976992,"about_ca_system_score_gemma":0.0008370009,"threshold_uncertainty_score":0.9998303},"labels":[],"label_agreement":null},{"id":"W2806460677","doi":"10.1016/j.critrevonc.2018.05.006","title":"Cancer cachexia: Diagnosis, assessment, and treatment","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Medicine; Cancer cachexia; Guideline; Cancer; Quality of life (healthcare); Intensive care medicine; Standardization; Cancer treatment; Internal medicine; Pathology; Nursing","score_opus":0.3094995821127756,"score_gpt":0.6011877947690292,"score_spread":0.29168821265625355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806460677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000059111007,0.9845547,0.000021464046,0.0068797497,0.0009896768,0.003138105,0.000039724244,0.00005232871,0.004318307],"genre_scores_gemma":[0.000007936902,0.98346066,0.0041887406,0.0029533133,0.00061892846,0.008441715,0.00007896338,0.000065686654,0.00018407688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460465,0.00130589,0.0020916983,0.0009906306,0.00014891961,0.0008582362],"domain_scores_gemma":[0.99548787,0.002897828,0.00036392926,0.0005744306,0.00012027404,0.00055565283],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010993124,0.00066589296,0.0075620255,0.00040408352,0.00012883056,0.000017117276,0.00017448641,0.0012500696,0.0011215712],"category_scores_gemma":[0.0014482499,0.00047588703,0.00049080927,0.00037775096,0.0008434916,0.000048603928,0.00013093864,0.0011022935,0.00027784874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001203293,0.0007806583,0.0016020417,0.048395257,0.00007598366,0.0005552782,0.000031308133,4.443776e-10,3.870609e-8,0.018079687,0.015545199,0.91492254],"study_design_scores_gemma":[0.0010111614,0.0008680462,0.000044622702,0.071611814,0.0014361136,0.0020901277,0.000013970819,0.0000024594042,4.6524625e-7,0.00048209372,0.92213506,0.00030408622],"about_ca_topic_score_codex":0.000037381218,"about_ca_topic_score_gemma":0.00019243371,"teacher_disagreement_score":0.91461843,"about_ca_system_score_codex":0.002031622,"about_ca_system_score_gemma":0.0017629853,"threshold_uncertainty_score":0.99979156},"labels":[],"label_agreement":null},{"id":"W2808868283","doi":"10.1016/j.critrevonc.2018.06.009","title":"Imaging predictors of treatment outcomes in rectal cancer: An overview","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Colorectal cancer; Imaging biomarker; Radiology; Neoadjuvant therapy; Medical imaging; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Magnetic resonance imaging","score_opus":0.1934323487675393,"score_gpt":0.5237826760705853,"score_spread":0.3303503273030459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808868283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005849231,0.9910692,0.0000016992971,0.00043403424,0.0013549255,0.0039516385,0.00009756398,0.00005410749,0.002451882],"genre_scores_gemma":[0.00027384158,0.9945445,0.0005640734,0.0002687278,0.00020570868,0.0038326862,0.00010497487,0.00009812412,0.000107379594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99178684,0.0021019434,0.003449986,0.0013615999,0.00026892856,0.0010307105],"domain_scores_gemma":[0.9948281,0.0028851894,0.0006361968,0.0010386534,0.00014676327,0.00046508573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010605893,0.0010468441,0.013163694,0.00069924165,0.00004130315,0.000009588684,0.00043497703,0.000993769,0.00082459825],"category_scores_gemma":[0.0032235587,0.0007116247,0.0013219032,0.0009396942,0.0009791785,0.00011949555,0.00022173468,0.00082909834,0.00014360833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012072531,0.0024699064,0.036053076,0.024235517,0.00025445133,0.0014364263,0.0001108054,2.2755616e-8,1.9351872e-7,0.0018271332,0.00029505623,0.93319666],"study_design_scores_gemma":[0.0018006968,0.0029681926,0.000650983,0.05585895,0.0020575072,0.0011953779,0.000017947421,0.0000074423847,0.0000027508722,0.00025049926,0.9347414,0.00044827609],"about_ca_topic_score_codex":0.00028721307,"about_ca_topic_score_gemma":0.001091962,"teacher_disagreement_score":0.93444633,"about_ca_system_score_codex":0.004793689,"about_ca_system_score_gemma":0.002076247,"threshold_uncertainty_score":0.9995335},"labels":[],"label_agreement":null},{"id":"W2889067624","doi":"10.1016/j.critrevonc.2018.08.005","title":"The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Mitochondrion; Biology; Epigenetics; Cell biology; Function (biology); Mitochondrial DNA; Gene; Genetics; Computational biology","score_opus":0.05287255653739659,"score_gpt":0.4376379375255116,"score_spread":0.384765380988115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889067624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021831384,0.99281627,0.0008142318,0.00023116355,0.0021680163,0.0035197856,0.00002076462,0.000012970216,0.00019848825],"genre_scores_gemma":[0.00017274464,0.9961477,0.0005665292,0.0002478967,0.00038007068,0.0019458488,0.00012267115,0.00012728709,0.00028924725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99005866,0.0038536848,0.0026583513,0.0015271237,0.0003600346,0.0015421389],"domain_scores_gemma":[0.99506664,0.002348601,0.000708235,0.0012884715,0.00021461195,0.0003734561],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019280374,0.0008487066,0.004320208,0.00055416446,0.000102531754,0.00003997413,0.001518678,0.0028903012,0.00005071709],"category_scores_gemma":[0.016790789,0.0006772864,0.0007050593,0.0011523786,0.00078652194,0.000017097967,0.00061185757,0.0020174962,0.000040729083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003284666,0.0013164394,0.00014873334,0.023849685,0.00038449053,0.0012532995,0.00020766135,0.0000064084243,0.0030844558,0.0055050543,0.011711134,0.95220417],"study_design_scores_gemma":[0.0023957216,0.0017868599,0.000016350275,0.046694178,0.00042155109,0.00023419078,0.00003488793,0.000039647774,0.0026826556,0.00060755963,0.94414914,0.00093724154],"about_ca_topic_score_codex":0.0002479007,"about_ca_topic_score_gemma":0.013865537,"teacher_disagreement_score":0.95126694,"about_ca_system_score_codex":0.0010496816,"about_ca_system_score_gemma":0.0024692437,"threshold_uncertainty_score":0.9995678},"labels":[],"label_agreement":null},{"id":"W2895739306","doi":"10.1016/j.critrevonc.2018.09.017","title":"Crosstalk in cancer resistance and metastasis","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Crosstalk; Metastasis; CD44; Drug resistance; Chemotherapy; Cancer research; Medicine; Cancer; Cancer chemotherapy; Cancer treatment; Cancer cell; Tumor microenvironment; Bioinformatics; Biology; Tumor cells; Internal medicine; Cell; Genetics","score_opus":0.10951879324645543,"score_gpt":0.47477112477453154,"score_spread":0.3652523315280761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895739306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012171308,0.99647695,0.000053285785,0.00025951717,0.00058219646,0.0011829565,0.00013111865,0.000014183655,0.0011780701],"genre_scores_gemma":[0.00013056242,0.9950791,0.0017047564,0.00057574955,0.0002678113,0.0018167594,0.000103687846,0.00008099914,0.00024055205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939872,0.0017721296,0.0018085332,0.0014395195,0.0001385956,0.00085401],"domain_scores_gemma":[0.99758434,0.0007673935,0.00036330768,0.00091017614,0.00010998167,0.0002647995],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016620291,0.0006916663,0.003793176,0.00021294999,0.00007147145,0.000027567152,0.00065082405,0.0014319585,0.0001533261],"category_scores_gemma":[0.007794099,0.00060175854,0.00045401856,0.00043486553,0.0014232951,0.000007184272,0.0005020114,0.0006978067,0.000081998354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015596893,0.00080381444,0.00032902084,0.055492792,0.00019092903,0.0009624921,0.00007078814,1.31544e-7,0.00004565074,0.01179496,0.03456537,0.8955881],"study_design_scores_gemma":[0.00038915942,0.00016192181,0.0000035454755,0.015564591,0.00032848798,0.0002151884,0.000009318128,5.7879333e-7,0.00008001091,0.0007189746,0.9820005,0.0005276873],"about_ca_topic_score_codex":0.000011664262,"about_ca_topic_score_gemma":0.00074810407,"teacher_disagreement_score":0.94743514,"about_ca_system_score_codex":0.00022834618,"about_ca_system_score_gemma":0.00087724894,"threshold_uncertainty_score":0.9998644},"labels":[],"label_agreement":null},{"id":"W2906204636","doi":"10.1016/j.critrevonc.2018.12.003","title":"Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Leukemia and Lymphoma Society","keywords":"Chronic lymphocytic leukemia; Leukemia; Cancer research; Biology; Metabolism; Immunology; Biochemistry","score_opus":0.09477210235360013,"score_gpt":0.44950691634630763,"score_spread":0.3547348139927075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906204636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006542913,0.9851097,0.00006545875,0.0013437229,0.0013868214,0.0058463956,0.000024042669,0.00015431436,0.006004136],"genre_scores_gemma":[0.0002552129,0.9910253,0.0014965823,0.0006405924,0.0014429799,0.0033501342,0.000104379666,0.00034147903,0.0013433401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9830784,0.0040218774,0.004956761,0.00312558,0.0010085882,0.003808756],"domain_scores_gemma":[0.9846263,0.009755264,0.0008779969,0.003156906,0.00042721652,0.0011563478],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0059635118,0.0020208233,0.01753742,0.0022952373,0.00017004486,0.00010309421,0.0019972075,0.0048092585,0.0011547005],"category_scores_gemma":[0.025078503,0.0016090283,0.0018764243,0.0029511193,0.0030487126,0.00028527094,0.0015453823,0.0048453943,0.0034659149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000108107146,0.00025271493,0.0000030550696,0.098296866,0.00026344962,0.008172365,0.00024028485,3.980055e-7,0.0000039920533,0.025486462,0.015427236,0.85174507],"study_design_scores_gemma":[0.008008768,0.0008075283,4.6922017e-7,0.10576875,0.0016183312,0.016031286,0.00008142686,0.0005032513,0.000020314832,0.0017412261,0.8643942,0.0010244594],"about_ca_topic_score_codex":0.00009996949,"about_ca_topic_score_gemma":0.000355207,"teacher_disagreement_score":0.8507206,"about_ca_system_score_codex":0.24815796,"about_ca_system_score_gemma":0.15021254,"threshold_uncertainty_score":0.99975836},"labels":[],"label_agreement":null},{"id":"W2911141441","doi":"10.1016/j.critrevonc.2018.12.008","title":"Corrigendum to “Imaging predictors of treatment outcomes in rectal cancer: An overview” [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153–162]","year":2019,"lang":"en","type":"erratum","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Colorectal cancer; Medicine; Cancer; Philosophy; General surgery; Classics; History; Internal medicine","score_opus":0.11888211295658788,"score_gpt":0.45410568855240957,"score_spread":0.3352235755958217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911141441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037818536,0.635406,0.000032426837,0.013518728,0.1339627,0.02475621,0.00115584,0.0004355226,0.152914],"genre_scores_gemma":[0.09306267,0.6164788,0.008812551,0.01972564,0.0057569044,0.03816603,0.0037344005,0.0019090871,0.21235391],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9882269,0.0019228974,0.004425228,0.0025640447,0.0007831186,0.0020778032],"domain_scores_gemma":[0.9934592,0.0019263376,0.0009011552,0.0021241223,0.00042847492,0.0011606608],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001451118,0.0017340329,0.011681881,0.0012643469,0.000087792294,0.000028436947,0.00088294793,0.0022117856,0.0022552093],"category_scores_gemma":[0.005509982,0.0013980806,0.0012049379,0.0013447608,0.0007822576,0.0002368525,0.0005276969,0.0023336995,0.00067430036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015750413,0.0071724486,0.3785839,0.007601589,0.0005464924,0.004942159,0.0008295379,0.0000017013253,0.000035851128,0.0026240172,0.54580706,0.05028018],"study_design_scores_gemma":[0.004973329,0.007313221,0.014577333,0.014247922,0.0011144776,0.0010979931,0.00018539009,0.000102372804,0.00009036287,0.00040614663,0.9547912,0.0011002768],"about_ca_topic_score_codex":0.0010928338,"about_ca_topic_score_gemma":0.006886201,"teacher_disagreement_score":0.4089841,"about_ca_system_score_codex":0.009105057,"about_ca_system_score_gemma":0.0039232112,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W2911385124","doi":"10.1016/j.critrevonc.2019.02.005","title":"Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; CINAHL; Randomized controlled trial; Physical therapy; Chemotherapy; MEDLINE; Tolerability; Meta-analysis; Aerobic exercise; Internal medicine; Breast cancer; Clinical trial; Intensive care medicine; Psychological intervention; Cancer; Oncology; Adverse effect","score_opus":0.26506792857307904,"score_gpt":0.5635864499745943,"score_spread":0.29851852140151525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911385124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008621815,0.97433156,0.000019473197,0.0065253424,0.00081579894,0.0179755,0.0000886155,0.000011160739,0.00022394955],"genre_scores_gemma":[0.00006453341,0.9935016,0.0002691355,0.000681515,0.000098633165,0.0051569063,0.00007004903,0.000061351224,0.00009625226],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98939466,0.005478693,0.0033394133,0.00080425123,0.00036129382,0.00062168465],"domain_scores_gemma":[0.98162127,0.014407672,0.0012419348,0.0015534284,0.000977649,0.0001980731],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009256546,0.00057290494,0.012677589,0.0004564112,0.00009022133,0.0000087853,0.0006572182,0.0011137596,0.00023614819],"category_scores_gemma":[0.013621363,0.00032820663,0.0016660818,0.0011616999,0.00083474885,0.000062666215,0.00019951847,0.0015013732,0.00003808358],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015684194,0.00043150265,0.000015721116,0.7924083,0.00007573013,0.000007557284,0.00016265821,5.795431e-9,5.9372513e-7,0.004022209,0.008505763,0.19421314],"study_design_scores_gemma":[0.00043239878,0.0013810633,0.000009001831,0.6983959,0.0024515982,0.00024663907,0.00009741633,0.0000021217238,0.000001490095,0.00019569954,0.29662228,0.00016436717],"about_ca_topic_score_codex":0.000036599075,"about_ca_topic_score_gemma":0.000045629946,"teacher_disagreement_score":0.2881165,"about_ca_system_score_codex":0.0011142209,"about_ca_system_score_gemma":0.0021513859,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W2914171857","doi":"10.1016/j.critrevonc.2019.01.008","title":"Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Urinary bladder; Schistosomiasis; Carcinoma; Schistosoma; Urinary system; Internal medicine; Basal cell; Cancer research; Urology; Immunology; Cancer; Schistosoma mansoni","score_opus":0.057432181218545375,"score_gpt":0.395503240123607,"score_spread":0.3380710589050616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914171857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004344019,0.96854836,0.0000020986247,0.0013241953,0.0011198681,0.008233274,0.000043496155,0.000019025907,0.020666227],"genre_scores_gemma":[0.0019396708,0.9941477,0.00022492395,0.0016227581,0.00005493427,0.001488752,0.0000625079,0.000112237045,0.00034650203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910744,0.0024662677,0.004010443,0.0011825508,0.00032592955,0.00094044383],"domain_scores_gemma":[0.9946907,0.0022517166,0.00091585447,0.0017653727,0.00011752079,0.0002588397],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014462668,0.0009778172,0.010874972,0.0004868163,0.000053428455,0.000004876435,0.0008434633,0.001584812,0.0006465743],"category_scores_gemma":[0.0026625048,0.00062226696,0.0019182957,0.0014219052,0.00086135784,0.000056713186,0.0003823338,0.001976248,0.0005722651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010688717,0.002958044,0.0012255986,0.44937295,0.00020609988,0.0016483966,0.00010370031,2.1308217e-8,0.000001398987,0.0011110592,0.012276469,0.53098935],"study_design_scores_gemma":[0.0023750914,0.0011153691,0.00016814304,0.1532355,0.0049410397,0.0038076628,0.000016821232,0.0000021617852,0.0000052057794,0.00011520595,0.8337615,0.00045627108],"about_ca_topic_score_codex":0.000058422207,"about_ca_topic_score_gemma":0.000029999432,"teacher_disagreement_score":0.82148504,"about_ca_system_score_codex":0.00107649,"about_ca_system_score_gemma":0.0023515986,"threshold_uncertainty_score":0.99971133},"labels":[],"label_agreement":null},{"id":"W2938040477","doi":"10.1016/j.critrevonc.2019.04.009","title":"The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Glioma; Radiation therapy; Chemotherapy; Malignant transformation; Surgery; Radiology; Pathology","score_opus":0.09265330789770766,"score_gpt":0.43986332450536253,"score_spread":0.3472100166076549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938040477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078649435,0.9924561,0.0000032899748,0.0018596471,0.00078457285,0.0030525746,0.00004098319,0.000016770933,0.0009995601],"genre_scores_gemma":[0.002972782,0.9950643,0.00012016188,0.00021391641,0.00008136673,0.0013841608,0.000088929766,0.000050924293,0.000023421326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99306804,0.0018811767,0.0029377195,0.000903661,0.00029087483,0.00091854745],"domain_scores_gemma":[0.98742986,0.010519525,0.000537569,0.0011478999,0.00010616388,0.0002590094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015015223,0.0006870729,0.007846006,0.00049225596,0.00004942154,0.000016119611,0.00057053845,0.0011755319,0.00017271577],"category_scores_gemma":[0.0060084173,0.00038740394,0.0010251226,0.0008070517,0.00056574057,0.000040831863,0.00028320006,0.0013794941,0.0004064565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005839827,0.0045741233,0.0070625427,0.04102314,0.00010380458,0.003489214,0.00004821061,1.6531857e-8,3.010342e-7,0.026438199,0.0012791952,0.9159229],"study_design_scores_gemma":[0.0022776483,0.00077317556,0.00028888386,0.07692651,0.0008980731,0.0029321876,0.000028282315,0.0000073671918,0.0000032060009,0.00025521318,0.9152973,0.00031210828],"about_ca_topic_score_codex":0.000016125001,"about_ca_topic_score_gemma":0.00012418623,"teacher_disagreement_score":0.91561073,"about_ca_system_score_codex":0.00035940524,"about_ca_system_score_gemma":0.0005766308,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2949101873","doi":"10.1016/j.critrevonc.2019.06.004","title":"The microbiome and cancer for clinicians","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Microbiome; Cancer; Carcinogenesis; Disease; Pancreatic cancer; Colorectal cancer; Human microbiome; Prostate cancer; Dysbiosis; Medicine; Immunology; Bioinformatics; Biology; Cancer research; Internal medicine","score_opus":0.13038126990205112,"score_gpt":0.5173365347683865,"score_spread":0.38695526486633536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949101873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008016114,0.99358636,0.00008768087,0.0016537202,0.0014001427,0.0028194322,0.000130532,0.0000073319998,0.00030677192],"genre_scores_gemma":[0.0000048046663,0.99505097,0.0007003792,0.0015917143,0.0003305399,0.0014823369,0.0001524702,0.00006443534,0.0006223531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957391,0.0008644864,0.0015775814,0.00091918156,0.00004522148,0.0008544289],"domain_scores_gemma":[0.99696416,0.0017320699,0.00037996122,0.00067913625,0.000098887656,0.00014576699],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015883482,0.00050050276,0.0031629005,0.00009274509,0.0001808473,0.000026357555,0.0005515156,0.0015488833,0.000021190592],"category_scores_gemma":[0.0021905538,0.00032911883,0.0005660888,0.0001477947,0.00071162777,0.000002878943,0.0002961547,0.00060816406,0.000095096744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027034157,0.00008698817,0.000013396739,0.02110288,0.000060156613,0.0000071058853,0.000010989559,8.142339e-9,0.0000766674,0.007787054,0.03064593,0.9401818],"study_design_scores_gemma":[0.00035258644,0.00037967876,0.0000016366037,0.0057884096,0.00034969996,0.00037413553,0.00001247155,7.2553354e-7,0.000007696312,0.000183035,0.992217,0.0003328938],"about_ca_topic_score_codex":0.0000072581315,"about_ca_topic_score_gemma":0.00024374013,"teacher_disagreement_score":0.9615711,"about_ca_system_score_codex":0.000118550925,"about_ca_system_score_gemma":0.001053484,"threshold_uncertainty_score":0.9999161},"labels":[],"label_agreement":null},{"id":"W2949176693","doi":"10.1016/j.critrevonc.2019.06.002","title":"Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Canada; Celgene","keywords":"Myelodysplastic syndromes; Medicine; Chelation therapy; Myeloid leukemia; Anemia; Clinical trial; Randomized controlled trial; Intensive care medicine; Internal medicine; Haematopoiesis; Blood transfusion; Oncology; Stem cell; Thalassemia; Bone marrow; Biology","score_opus":0.22302558547096987,"score_gpt":0.5055964256629083,"score_spread":0.28257084019193845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949176693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014831625,0.98715603,0.003923837,0.0013692795,0.000657348,0.0063045127,0.000052118066,0.00005777284,0.00033077374],"genre_scores_gemma":[0.00070404366,0.9875753,0.009517903,0.00045534625,0.00011900443,0.00095821853,0.00048334652,0.000106186904,0.000080678445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901457,0.002637816,0.0035925426,0.002008374,0.00043015223,0.0011854122],"domain_scores_gemma":[0.99136263,0.0057237055,0.0006480675,0.0016868662,0.00014918229,0.00042953808],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005294392,0.00089797407,0.008724106,0.00083670404,0.00009491572,0.000040390525,0.0007746687,0.0021439712,0.00027619605],"category_scores_gemma":[0.008069465,0.0006055138,0.00034264353,0.0007393654,0.0009896472,0.00020751655,0.0007620765,0.0035493034,0.00032977716],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032878402,0.0011855285,0.0004322939,0.045447893,0.0002073414,0.0042172605,0.00003770695,3.6454088e-7,0.000004499006,0.03026607,0.00071210566,0.91716015],"study_design_scores_gemma":[0.008700058,0.0092974445,0.00016045842,0.10342533,0.003177557,0.02854593,0.00020869759,0.000987127,0.0000014086919,0.003195877,0.84078,0.0015200865],"about_ca_topic_score_codex":0.000020552017,"about_ca_topic_score_gemma":0.00005073714,"teacher_disagreement_score":0.91564006,"about_ca_system_score_codex":0.0013787426,"about_ca_system_score_gemma":0.0023198281,"threshold_uncertainty_score":0.99963963},"labels":[],"label_agreement":null},{"id":"W2966782162","doi":"10.1016/j.critrevonc.2019.07.017","title":"Do we still need to study palonosetron for chemotherapy-induced nausea and vomiting? A cumulative meta-analysis","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nausea and vomiting management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Palonosetron; Meta-analysis; Funnel plot; Publication bias; Medicine; Confidence interval; Odds ratio; Randomized controlled trial; Nausea; Random effects model; Odds; Internal medicine; Logistic regression; Antiemetic","score_opus":0.36153538847355216,"score_gpt":0.5372812469255104,"score_spread":0.17574585845195823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966782162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025163096,0.97708887,0.00044802294,0.0044383565,0.000261931,0.01699669,0.000048193324,0.00005902151,0.00040727414],"genre_scores_gemma":[0.0023072758,0.98423356,0.0049799182,0.0020317999,0.00013315101,0.005875108,0.00005882093,0.0001165113,0.00026384788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991076,0.0022385246,0.003274597,0.0019692918,0.00034872096,0.0010928485],"domain_scores_gemma":[0.9887494,0.008329662,0.0007564304,0.0014034364,0.00027790613,0.0004831586],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004480293,0.0011455558,0.02075525,0.001483956,0.000094027084,0.00005205234,0.0005034857,0.0009774863,0.0003797266],"category_scores_gemma":[0.0083677,0.00080330233,0.0033417698,0.0016696036,0.0001959305,0.00006303134,0.0003980298,0.0011006467,0.00019234043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027309914,0.0026300603,0.00033752102,0.04733848,0.07708203,0.00037278733,0.0007213836,2.1521895e-7,8.809934e-7,0.015049956,0.0019192689,0.85427433],"study_design_scores_gemma":[0.0017457623,0.0020883568,0.000016085336,0.0026984077,0.28936526,0.000095914824,0.0001838741,0.0000140210905,0.0000013204922,0.0004061192,0.7028732,0.00051169173],"about_ca_topic_score_codex":0.0000129835325,"about_ca_topic_score_gemma":0.000048544203,"teacher_disagreement_score":0.8537626,"about_ca_system_score_codex":0.00045624675,"about_ca_system_score_gemma":0.00030784268,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W2973482359","doi":"10.1016/j.critrevonc.2019.08.006","title":"Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Distress; Cancer; Palliative care; Cancer cachexia; Medicine; Intensive care medicine; Gerontology; Psychology; Nursing; Clinical psychology; Internal medicine","score_opus":0.07629832743797355,"score_gpt":0.4463594489996658,"score_spread":0.37006112156169224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973482359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007626032,0.98667437,0.00004546157,0.00047140702,0.00018727849,0.004093671,0.0002627171,0.000020066429,0.00061901956],"genre_scores_gemma":[0.0091645215,0.9862813,0.0020639559,0.000495575,0.00002569119,0.0011962454,0.00070390286,0.000046787198,0.000022063201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627334,0.0005952329,0.0017629274,0.00073338655,0.00017417494,0.00046094818],"domain_scores_gemma":[0.99709606,0.0013162291,0.00056955393,0.00026373437,0.00042601355,0.00032841793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003422769,0.0005167443,0.0044780797,0.0003217336,0.00006407826,0.000008836626,0.00012102887,0.00061781646,0.000087160915],"category_scores_gemma":[0.0011706757,0.00034989935,0.00018102938,0.0003774205,0.00059882423,0.00007899328,0.00009929703,0.00088252494,0.0000071740874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022356572,0.0005427262,0.025530206,0.1436294,0.00012069475,0.000045026907,0.0012057918,1.6651975e-7,0.00000269373,0.0036341841,0.00034552554,0.82472],"study_design_scores_gemma":[0.00543887,0.0023514363,0.017454443,0.367255,0.0011875298,0.00008971738,0.0014003536,0.00002452709,0.0000062139698,0.00028877772,0.60370636,0.00079675246],"about_ca_topic_score_codex":0.000034038967,"about_ca_topic_score_gemma":0.0001940023,"teacher_disagreement_score":0.8239233,"about_ca_system_score_codex":0.0004205476,"about_ca_system_score_gemma":0.0003645797,"threshold_uncertainty_score":0.9998953},"labels":[],"label_agreement":null},{"id":"W2982037555","doi":"10.1016/j.critrevonc.2019.102817","title":"Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Kingston Health Sciences Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Gemcitabine; Erlotinib; Medicine; Capecitabine; Oncology; Internal medicine; Randomized controlled trial; Meta-analysis; Pancreatic cancer; Adjuvant; Chemotherapy; Cancer; Colorectal cancer; Epidermal growth factor receptor","score_opus":0.3549700768811592,"score_gpt":0.5239913615233373,"score_spread":0.16902128464217803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982037555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.803802e-7,0.96600765,0.00031120944,0.0017360033,0.00014276974,0.030763539,0.00011000663,0.00005193152,0.00087613857],"genre_scores_gemma":[0.000008192373,0.95852464,0.0040347213,0.0016609313,0.00010784524,0.033226397,0.00037846487,0.000109501096,0.0019492857],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98374766,0.0065840753,0.005707579,0.0018882463,0.0003830957,0.0016893571],"domain_scores_gemma":[0.9712284,0.024208097,0.0012553363,0.0022265841,0.00040701425,0.0006745718],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0060397643,0.0014527969,0.072618835,0.00088424276,0.00015940522,0.00002842197,0.0005653592,0.0018042241,0.00092296733],"category_scores_gemma":[0.019461773,0.0008424135,0.006794475,0.0019972378,0.00079742575,0.00006627224,0.0002671176,0.0012162076,0.0003762939],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055312747,0.0005244697,0.00013466051,0.89862657,0.087230384,0.00046775636,0.000029586976,4.080701e-8,1.6937832e-8,0.005042174,0.0022791557,0.0056098835],"study_design_scores_gemma":[0.0007599511,0.0016778299,0.0000050101803,0.15200196,0.6455155,0.0020405496,0.000011708843,0.000041709744,2.4058336e-8,0.00022381282,0.19731772,0.00040420174],"about_ca_topic_score_codex":0.000022860375,"about_ca_topic_score_gemma":0.00009578562,"teacher_disagreement_score":0.7466246,"about_ca_system_score_codex":0.0012335771,"about_ca_system_score_gemma":0.0019045187,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W3004670172","doi":"10.1016/j.critrevonc.2020.102896","title":"A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Predictive modelling; Progression-free survival; Overall survival; Oncology; Computer science; Medicine; Machine learning","score_opus":0.09157622534961121,"score_gpt":0.4323188863312236,"score_spread":0.34074266098161243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004670172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046337555,0.97097254,0.011836802,0.007239685,0.0005381086,0.0058688438,0.0001201882,0.000053357122,0.0033241254],"genre_scores_gemma":[0.00021017929,0.9464504,0.049559418,0.0016817609,0.00016131012,0.0016092921,0.00010968986,0.0001394648,0.000078486344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99121433,0.001898921,0.003859701,0.0012565004,0.0008188986,0.0009516634],"domain_scores_gemma":[0.9902807,0.0064331046,0.00090633245,0.0014938504,0.0002938563,0.0005921845],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045876936,0.00081559963,0.0093628615,0.00051056297,0.000054390035,0.000017637449,0.0012656404,0.0011743493,0.000036221536],"category_scores_gemma":[0.07529307,0.0005213533,0.0008162903,0.0011752577,0.0014038936,0.00010282765,0.0009208144,0.003395687,0.00001758174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011646518,0.008627247,0.0019849862,0.1763745,0.0007902876,0.0011667839,0.0026094893,0.00038080703,0.00002365012,0.24252248,0.034174636,0.53018045],"study_design_scores_gemma":[0.0020467862,0.0009295366,0.000032370514,0.0560394,0.0011460405,0.00083526055,0.00008645995,0.030010441,0.0000015855276,0.0012781908,0.9071428,0.00045113973],"about_ca_topic_score_codex":0.0001013396,"about_ca_topic_score_gemma":0.000016917436,"teacher_disagreement_score":0.87296814,"about_ca_system_score_codex":0.00045152596,"about_ca_system_score_gemma":0.0019717875,"threshold_uncertainty_score":0.9997238},"labels":[],"label_agreement":null},{"id":"W3009112053","doi":"10.1016/j.critrevonc.2020.102922","title":"Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Toronto; University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Febrile neutropenia; Internal medicine; Neutropenia; Cancer; Chemotherapy","score_opus":0.07418137858785798,"score_gpt":0.44914023275501785,"score_spread":0.3749588541671599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009112053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008433552,0.9853276,0.00003617991,0.0011488281,0.000060288716,0.011863987,0.0006562106,0.0000062819518,0.00005725959],"genre_scores_gemma":[0.025011502,0.9683895,0.00041866017,0.00045203444,0.000014843866,0.005536934,0.00012971819,0.000034089906,0.000012695696],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9923043,0.0021231517,0.0042822324,0.0006731939,0.00028776855,0.0003293405],"domain_scores_gemma":[0.98952734,0.005664069,0.0030233536,0.0004977979,0.0011680082,0.000119444936],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013576931,0.00040375898,0.012272799,0.00032615365,0.000055567118,0.000008458205,0.0002798864,0.0004119115,0.00004941812],"category_scores_gemma":[0.0112629905,0.00025063078,0.0010042322,0.0014083653,0.00039117213,0.000105664345,0.00020496748,0.0007549987,9.3123236e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011728269,0.0008389173,0.1853521,0.79781187,0.008457886,0.000007443507,0.00021889899,0.0000032935657,3.2374498e-7,0.0019597753,0.00011934705,0.0051128655],"study_design_scores_gemma":[0.0060463324,0.0018920352,0.040897895,0.24243394,0.691487,0.00010674843,0.0002998949,0.00012543648,0.000004176048,0.00009206342,0.015925724,0.0006887529],"about_ca_topic_score_codex":0.00022937819,"about_ca_topic_score_gemma":0.0046771145,"teacher_disagreement_score":0.6830291,"about_ca_system_score_codex":0.00049830537,"about_ca_system_score_gemma":0.0010156772,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W3024770628","doi":"10.1016/j.critrevonc.2020.102986","title":"Oral potentially malignant disorders: A scoping review of prognostic biomarkers","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Malignant transformation; Oncology; Medicine; Podoplanin; Confounding; Internal medicine; Population; Pathology; Bioinformatics; Biology; Immunohistochemistry","score_opus":0.11784591354705722,"score_gpt":0.49325303338408716,"score_spread":0.37540711983702996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024770628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.302249e-7,0.98596513,0.0002660929,0.0014274494,0.0017275829,0.008844585,0.00009248329,0.00007913974,0.0015967094],"genre_scores_gemma":[0.0000096521235,0.99046206,0.0047280076,0.001267697,0.000089981084,0.0031194189,0.00019722914,0.0001000981,0.000025862686],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9847052,0.0064700125,0.0056850775,0.0015472039,0.00032183164,0.0012706656],"domain_scores_gemma":[0.99202585,0.004803351,0.0015490913,0.001022065,0.00015208474,0.00044758272],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0027754249,0.0010888568,0.01304259,0.00037288736,0.00012173129,0.000013648765,0.0009340623,0.0017582552,0.0010009112],"category_scores_gemma":[0.013173116,0.00084428326,0.0016175195,0.0011219484,0.0011372674,0.00010963342,0.00053356466,0.0014782574,0.0023292878],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001657779,0.00046046922,0.00007564837,0.45677277,0.00009817931,0.0027793127,0.000008210895,2.403338e-9,3.4273967e-8,0.0061061257,0.0010694619,0.5326132],"study_design_scores_gemma":[0.00033741197,0.00044681388,0.000003994394,0.5116519,0.0016636824,0.002370397,0.000005169466,7.0603323e-7,2.761007e-7,0.00036254642,0.48280716,0.0003499478],"about_ca_topic_score_codex":0.000014983707,"about_ca_topic_score_gemma":0.00024301322,"teacher_disagreement_score":0.5322633,"about_ca_system_score_codex":0.0004209056,"about_ca_system_score_gemma":0.0022117975,"threshold_uncertainty_score":0.9999123},"labels":[],"label_agreement":null},{"id":"W3034159339","doi":"10.1016/j.critrevonc.2020.102971","title":"Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canada Research Chairs","keywords":"Medicine; Systemic therapy; Intensive care medicine; Pace; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.24089697124174567,"score_gpt":0.4453458522876007,"score_spread":0.20444888104585504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034159339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002857932,0.98736805,0.000023895638,0.0022367605,0.00044375428,0.005916349,0.000008721423,0.00004752627,0.003669168],"genre_scores_gemma":[0.017036205,0.9779093,0.0005392926,0.0005027941,0.00017052212,0.0035920036,0.000049580987,0.00016316467,0.000037085592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98663443,0.0055049933,0.0042101536,0.0018406258,0.00039182237,0.0014179941],"domain_scores_gemma":[0.9917622,0.0059129433,0.0006537671,0.0011334878,0.00009966604,0.00043788657],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022579478,0.0013445973,0.013150928,0.0012408353,0.00004428694,0.000016592396,0.0006838047,0.0011659908,0.0001726443],"category_scores_gemma":[0.0022635688,0.0009984665,0.0010812219,0.001291834,0.00040119115,0.00008862965,0.00021562178,0.0028622732,0.00046876434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009282604,0.0013356926,0.00060901523,0.08154846,0.00010001206,0.013228036,0.00039793126,2.0032923e-7,0.000008381582,0.006217078,0.00008148412,0.8963809],"study_design_scores_gemma":[0.0035487355,0.0020224885,0.00017338009,0.053495575,0.0013307,0.0081426315,0.0002708876,0.000019732468,0.000012733458,0.00058623526,0.92957425,0.000822659],"about_ca_topic_score_codex":0.000059798498,"about_ca_topic_score_gemma":0.00022585559,"teacher_disagreement_score":0.9294928,"about_ca_system_score_codex":0.0027260627,"about_ca_system_score_gemma":0.0016332302,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W3080495165","doi":"10.1016/j.critrevonc.2020.103085","title":"In reply: Response to letter to the editor","year":2020,"lang":"en","type":"letter","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"Psychology; Computer science","score_opus":0.054668632550273856,"score_gpt":0.41534504348679274,"score_spread":0.36067641093651887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080495165","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013197376,0.003800924,0.00013197644,0.9800249,0.010436265,0.0028536993,0.000019920992,0.000048482416,0.0025519112],"genre_scores_gemma":[0.00024759053,0.0005903373,0.00089331204,0.9638644,0.02982959,0.0031245993,0.000018617036,0.00007404999,0.0013575417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934854,0.0026141051,0.0014985544,0.0011131524,0.00030263505,0.0009861339],"domain_scores_gemma":[0.9937344,0.004524191,0.000115542105,0.0011553821,0.00013268452,0.00033777262],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015843399,0.0004921707,0.0026347365,0.00046424265,0.00008390481,0.000023182427,0.0005795159,0.0011301504,0.0010305119],"category_scores_gemma":[0.019466102,0.00034839942,0.00032933868,0.00097073277,0.00035612204,0.0000534191,0.0003431394,0.0052336273,0.00582414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007097048,0.00011268683,0.00012762922,0.0004981306,0.00001677629,0.00928487,0.00021512006,1.5103613e-7,0.00012372194,0.0005503633,0.9870542,0.0013066143],"study_design_scores_gemma":[0.00062373467,0.0011235422,0.00007471825,0.0014143501,0.00012345861,0.0013385375,0.000018306664,8.789802e-7,0.00006501861,0.0003591224,0.99454445,0.00031386485],"about_ca_topic_score_codex":0.000030691175,"about_ca_topic_score_gemma":0.00012933518,"teacher_disagreement_score":0.019393325,"about_ca_system_score_codex":0.00080625864,"about_ca_system_score_gemma":0.0006353769,"threshold_uncertainty_score":0.9998968},"labels":[],"label_agreement":null},{"id":"W3080704689","doi":"10.1016/j.critrevonc.2020.103090","title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Breast cancer; Radiation therapy; Clinical Practice; Clinical trial; Oncology; Cancer; Medical physics; Radiology; Internal medicine; Physical therapy","score_opus":0.17953776625423248,"score_gpt":0.5333394056239898,"score_spread":0.3538016393697574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080704689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029763416,0.9643309,0.00015527067,0.030312201,0.0007199982,0.0037650566,0.0006516511,0.000010275676,0.00005168314],"genre_scores_gemma":[0.00004745062,0.9856125,0.0015637907,0.0065130047,0.00032230827,0.005647548,0.00021232381,0.000068921785,0.000012150628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904819,0.004345993,0.0032415523,0.0011156377,0.00018670973,0.00062820374],"domain_scores_gemma":[0.9842528,0.01331957,0.00077213044,0.00060300145,0.0008857945,0.00016668436],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019107005,0.000669308,0.004632882,0.000095976895,0.00014683194,0.000028700448,0.0004419486,0.0010498052,0.00004798023],"category_scores_gemma":[0.047506083,0.0004441488,0.0008891656,0.0004229081,0.001001928,0.000044887816,0.00020283682,0.00092710677,0.000021183383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005439223,0.00066183833,0.000031749914,0.008191922,0.00030702935,0.000039847604,0.000018068087,3.457743e-7,0.0000015708448,0.0048411074,0.0075397943,0.9778228],"study_design_scores_gemma":[0.0008578654,0.00056311046,0.00012135677,0.015605606,0.00074919197,0.000635484,0.000019468922,0.000015191503,0.0000036871895,0.000098106204,0.9809669,0.00036401066],"about_ca_topic_score_codex":0.000040735868,"about_ca_topic_score_gemma":0.00015114548,"teacher_disagreement_score":0.9774588,"about_ca_system_score_codex":0.00031157688,"about_ca_system_score_gemma":0.0018397041,"threshold_uncertainty_score":0.99980104},"labels":[],"label_agreement":null},{"id":"W3094603587","doi":"10.1016/j.critrevonc.2020.103125","title":"Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"Bayer","keywords":"Medicine; Edoxaban; Rivaroxaban; Apixaban; Intensive care medicine; Low molecular weight heparin; Thrombosis; Anticoagulant therapy; Clinical trial; Anticoagulant; Cancer; Observational study; Surgery; Internal medicine; Warfarin","score_opus":0.1474410475931543,"score_gpt":0.5193484276329743,"score_spread":0.37190738003982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094603587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002228245,0.9886951,0.000059587466,0.0048621846,0.0005519098,0.004441785,0.000009543763,0.000022399543,0.0011347076],"genre_scores_gemma":[0.0030268666,0.9943273,0.0009623776,0.00032605985,0.00013534287,0.0011376363,0.000026408463,0.00004333866,0.000014650311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99284977,0.0021697727,0.0033443198,0.00086096575,0.00029058053,0.00048459598],"domain_scores_gemma":[0.99305415,0.0047903755,0.0010770388,0.0006894246,0.00014635606,0.00024267199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009550445,0.00057551597,0.009867468,0.000249046,0.0000749283,0.000008631394,0.00027403113,0.0008238288,0.00006112589],"category_scores_gemma":[0.0042892452,0.00033938044,0.00086413475,0.0006130675,0.0011910286,0.000049387665,0.0003266485,0.0006349707,0.00003241912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029673281,0.0068232687,0.0015043139,0.038902394,0.001923271,0.00032311157,0.00022732563,3.3740378e-8,4.4295865e-7,0.13175113,0.0017302786,0.81678474],"study_design_scores_gemma":[0.0013140511,0.0028207663,0.0022265941,0.026738325,0.014281086,0.00009567781,0.00016958563,0.00003066127,0.0000011977534,0.00072453514,0.95134807,0.00024947114],"about_ca_topic_score_codex":0.00029933883,"about_ca_topic_score_gemma":0.0004506037,"teacher_disagreement_score":0.94961774,"about_ca_system_score_codex":0.0012079636,"about_ca_system_score_gemma":0.0007385708,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W3108540679","doi":"10.1016/j.critrevonc.2020.103185","title":"Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Janssen Biotech; Astellas Pharma; Eisai; AstraZeneca; Pfizer","keywords":"Prostate cancer; Androgen receptor; PTEN; Cancer research; Wnt signaling pathway; Signal transduction; PI3K/AKT/mTOR pathway; Medicine; Tramp; Androgen deprivation therapy; Androgen; Prostate; Cancer; Bioinformatics; Biology; Internal medicine; Hormone; Cell biology","score_opus":0.21749076504914358,"score_gpt":0.5632320503575629,"score_spread":0.3457412853084193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108540679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016895555,0.982842,0.000012456332,0.012267443,0.0003680503,0.0039422377,0.0001824427,0.000029493554,0.00018686318],"genre_scores_gemma":[0.0000834748,0.99422896,0.0008945996,0.0003434828,0.0005275541,0.0036998072,0.00015313065,0.000058271824,0.0000107473315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99491835,0.001426368,0.0019069186,0.0010147537,0.00014387834,0.00058973604],"domain_scores_gemma":[0.9971995,0.0015317412,0.0003065105,0.00034978852,0.00010357501,0.00050891354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009807542,0.00049243966,0.0042849896,0.00027641017,0.00008126331,0.000024512727,0.00017597934,0.0005813579,0.00013598237],"category_scores_gemma":[0.0010964555,0.00033771578,0.0003179019,0.00055173953,0.0006819881,0.00006148181,0.00025322652,0.0020944572,0.00004118625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000525285,0.00031103444,0.008474327,0.014419403,0.00009608836,0.0002477451,0.00010989807,2.301598e-9,0.0000018107846,0.0031290941,0.0006464631,0.9725116],"study_design_scores_gemma":[0.0009497464,0.0003832057,0.00005927918,0.029029926,0.0006677546,0.00037743762,0.000034914774,0.0000019337735,0.0000040413265,0.0004803565,0.9677519,0.0002594655],"about_ca_topic_score_codex":0.000004437487,"about_ca_topic_score_gemma":0.000013848386,"teacher_disagreement_score":0.97225213,"about_ca_system_score_codex":0.00037678523,"about_ca_system_score_gemma":0.0010755938,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W3116464343","doi":"10.1016/j.critrevonc.2020.103210","title":"The role of tumor suppressor short non-coding RNAs on breast cancer","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Piwi-interacting RNA; microRNA; Suppressor; Biology; Competing endogenous RNA; Malignancy; Metastasis; Breast cancer; Cancer research; Long non-coding RNA; Small nucleolar RNA; RNA; Angiogenesis; Context (archaeology); Tumor progression; Cancer; Non-coding RNA; Bioinformatics; RNA interference; Gene; Genetics","score_opus":0.03982867893960124,"score_gpt":0.41871137723976415,"score_spread":0.3788826983001629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116464343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027341105,0.9934436,0.0006299439,0.00082507165,0.00060849794,0.0019913777,0.00016060736,0.0000120306,0.0023261483],"genre_scores_gemma":[0.00057873665,0.99614215,0.00023044436,0.00041421384,0.00037941535,0.0020063415,0.00007805541,0.00011799785,0.00005266207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941059,0.0015074901,0.0018236719,0.0011924865,0.00033460485,0.0010358666],"domain_scores_gemma":[0.9970913,0.0009349705,0.0003548376,0.0011086403,0.00019388301,0.0003163698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012045642,0.0007083725,0.003651825,0.0001761052,0.00014456292,0.000028810633,0.0013745243,0.001203351,0.00012587318],"category_scores_gemma":[0.0033448043,0.000506244,0.0009344827,0.00047476514,0.000772121,0.000005134495,0.0007498424,0.0016182591,0.00011267627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014566426,0.00020686974,0.0000016562251,0.0057461285,0.00019210123,0.00022226006,0.000016187843,7.0855236e-7,0.0019802693,0.0134608615,0.0030036177,0.9750237],"study_design_scores_gemma":[0.00024114469,0.0004762447,5.884767e-7,0.008999437,0.00031550546,0.0009844918,0.000027972794,0.000029098734,0.0057956693,0.0002905138,0.9824189,0.00042045445],"about_ca_topic_score_codex":0.000016069464,"about_ca_topic_score_gemma":0.000077221506,"teacher_disagreement_score":0.97941524,"about_ca_system_score_codex":0.00031682206,"about_ca_system_score_gemma":0.0014431395,"threshold_uncertainty_score":0.99973893},"labels":[],"label_agreement":null},{"id":"W3116988381","doi":"10.1016/j.critrevonc.2020.103212","title":"Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Canada","keywords":"Mantle cell lymphoma; Medicine; Randomized controlled trial; Lymphoma; Internal medicine; Systematic review; Clinical trial; Oncology; Transplantation; Surgery; MEDLINE","score_opus":0.04686873006192244,"score_gpt":0.40904868239252035,"score_spread":0.3621799523305979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116988381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070590904,0.9871033,0.0000035990327,0.00068487943,0.00018602729,0.011297957,0.000074873635,0.000020078516,0.00055872626],"genre_scores_gemma":[0.00021107466,0.99601275,0.00096477475,0.00075380516,0.000047989193,0.0016014273,0.00031139507,0.00006909793,0.000027677823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99034595,0.002361079,0.00517756,0.0012063226,0.0003037783,0.0006052967],"domain_scores_gemma":[0.9915632,0.0057752156,0.0011026344,0.00092850445,0.00018228611,0.00044816948],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012427402,0.0009638076,0.01722856,0.00029390724,0.000042299453,0.000011620465,0.00029041374,0.0010963472,0.000051248247],"category_scores_gemma":[0.0056299865,0.00055700017,0.0008130981,0.00092089816,0.00044549565,0.000061187195,0.00021702723,0.0006183807,0.00011617403],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019477135,0.007511062,0.0066693584,0.6783731,0.00024405954,0.0020884383,0.00003166265,3.2174774e-9,1.0679468e-9,0.0004976203,0.00039817733,0.30399173],"study_design_scores_gemma":[0.009336159,0.0025933902,0.0007883216,0.6451543,0.0058214334,0.0006930556,0.0000028814093,0.0000010430432,8.176021e-8,0.000012341827,0.33532327,0.00027370694],"about_ca_topic_score_codex":0.0000029983821,"about_ca_topic_score_gemma":0.000015010629,"teacher_disagreement_score":0.33492512,"about_ca_system_score_codex":0.00074350124,"about_ca_system_score_gemma":0.0005355473,"threshold_uncertainty_score":0.99968815},"labels":[],"label_agreement":null},{"id":"W3124543108","doi":"10.1016/j.critrevonc.2021.103238","title":"Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Ibrutinib; Atrial fibrillation; Meta-analysis; Medicine; Internal medicine; Cardiology; Leukemia","score_opus":0.19438187720026537,"score_gpt":0.4843117483147941,"score_spread":0.2899298711145287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124543108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035795406,0.9917803,0.000089550056,0.00075193367,0.000021641094,0.006827452,0.0001197337,0.00002075442,0.00038509586],"genre_scores_gemma":[0.000071694354,0.99758947,0.0008346275,0.00013437588,0.00003216091,0.0009473225,0.00026997522,0.000043303586,0.0000770894],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990197,0.0046684914,0.0033190693,0.0009777566,0.0003179236,0.00051973836],"domain_scores_gemma":[0.98087263,0.016025046,0.0014338867,0.0009840246,0.0003981958,0.00028619595],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031708586,0.00064845517,0.026501546,0.00053989654,0.000093046474,0.000021210959,0.0001769236,0.0007514386,0.00015033524],"category_scores_gemma":[0.028098594,0.0003824238,0.0026009544,0.0018093939,0.0007659474,0.00005367402,0.00017181893,0.00056742004,0.000015805253],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000125731085,0.00011545016,0.000030438421,0.8794597,0.100149445,0.00019334434,0.000048205908,2.527865e-7,2.5203814e-8,0.006839377,0.000060521987,0.013090711],"study_design_scores_gemma":[0.0015573783,0.000423573,0.0000016184055,0.14453056,0.8116015,0.002330756,0.00001551391,0.00010930874,1.2085427e-7,0.000058430494,0.039126247,0.0002449666],"about_ca_topic_score_codex":0.0000459126,"about_ca_topic_score_gemma":0.00010723261,"teacher_disagreement_score":0.7349291,"about_ca_system_score_codex":0.00393484,"about_ca_system_score_gemma":0.0035199497,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W3143506887","doi":"10.1016/j.critrevonc.2021.103312","title":"Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Mucositis; Meta-analysis; Internal medicine; Medicine; Single-nucleotide polymorphism; Methylenetetrahydrofolate reductase; Methotrexate; Oncology; Cancer; MTRR; Gastroenterology; Bioinformatics; Genetics; Genotype; Chemotherapy; Biology; Gene","score_opus":0.2003460850781804,"score_gpt":0.4925246478094584,"score_spread":0.292178562731278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143506887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006124928,0.98802155,0.000080889586,0.0015356017,0.000059037735,0.009788847,0.00010940514,0.000033687422,0.00036485246],"genre_scores_gemma":[0.0000441874,0.97957075,0.001707261,0.0016917842,0.00002566126,0.016359234,0.00015063382,0.000119557066,0.00033094917],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9794716,0.012256794,0.004531161,0.001894827,0.00052659085,0.0013189919],"domain_scores_gemma":[0.9841924,0.0121570015,0.0010893957,0.0015553497,0.00041730393,0.00058859243],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003504579,0.0013512189,0.047775768,0.0012149826,0.000073486546,0.000037240203,0.00047819276,0.0015555797,0.0013309775],"category_scores_gemma":[0.022069415,0.0007930868,0.0027402935,0.004501223,0.00047966396,0.00007314463,0.00026382995,0.0014135435,0.00008483876],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001433912,0.0010307352,0.000025662932,0.8678477,0.09892112,0.0131620215,0.00007815459,1.249326e-7,1.4253723e-7,0.00079870655,0.00020551102,0.017915776],"study_design_scores_gemma":[0.0010227818,0.00057549734,0.0000079365955,0.25211605,0.7254778,0.0044141393,0.00001200015,0.000033676428,2.6146694e-7,0.000028278891,0.015807778,0.00050375966],"about_ca_topic_score_codex":0.00023351217,"about_ca_topic_score_gemma":0.0015694048,"teacher_disagreement_score":0.6265567,"about_ca_system_score_codex":0.005075656,"about_ca_system_score_gemma":0.004099371,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W3152748820","doi":"10.1016/j.critrevonc.2021.103324","title":"Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Impact; University of Toronto; Queen's University; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Fallopian tube; Medicine; Stage (stratigraphy); Ovary; Adjuvant therapy; Adjuvant; Gynecology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.08088353931758632,"score_gpt":0.4152486905022938,"score_spread":0.33436515118470744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152748820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002250551,0.96760285,0.0000668017,0.0026060988,0.0011130135,0.027922938,0.0003175821,0.00007434917,0.00027384792],"genre_scores_gemma":[0.00007096428,0.9595333,0.0022772907,0.0047670747,0.00039121968,0.031829413,0.00053533353,0.00020560574,0.0003898157],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98568183,0.0047204006,0.005610498,0.0021437125,0.00044499245,0.0013985534],"domain_scores_gemma":[0.9857623,0.010170788,0.0011749464,0.0017874725,0.00038567957,0.00071881583],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0037278314,0.0016517522,0.026006434,0.0004047282,0.0003180146,0.00005385177,0.000578569,0.001511973,0.00032498073],"category_scores_gemma":[0.010270092,0.0010367471,0.0020302543,0.00068680465,0.0005818217,0.00011063303,0.00039403304,0.0016935938,0.00006787427],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011204847,0.0013288734,0.00004867782,0.77547044,0.0004258274,0.0058171293,0.00012618145,9.535022e-9,4.4730072e-7,0.004409576,0.002882073,0.2093787],"study_design_scores_gemma":[0.0030180418,0.0018633327,0.00000699359,0.4990993,0.006233297,0.009955565,0.000055155535,0.000003673276,6.48335e-7,0.000017541704,0.47921526,0.00053118536],"about_ca_topic_score_codex":0.00003551467,"about_ca_topic_score_gemma":0.0000763039,"teacher_disagreement_score":0.47633317,"about_ca_system_score_codex":0.0017537152,"about_ca_system_score_gemma":0.0040409574,"threshold_uncertainty_score":0.9997843},"labels":[],"label_agreement":null},{"id":"W3154004164","doi":"10.1016/j.critrevonc.2021.103336","title":"Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; University of Toronto; Hamilton Health Sciences; Impact","funders":"Cancer Care Ontario","keywords":"Fallopian tube; Ovary; Consolidation (business); Medicine; Gynecology; Ovarian carcinoma; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.09736373348610841,"score_gpt":0.4254258861202621,"score_spread":0.3280621526341537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154004164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000100258,0.9599208,0.00026361932,0.0028454815,0.0014314186,0.034609307,0.00041183233,0.00009286407,0.00041462918],"genre_scores_gemma":[0.000054633998,0.9372781,0.0031006597,0.0067312643,0.00045616977,0.04908698,0.0007893666,0.00019761865,0.0023052078],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9845762,0.004710425,0.0065755257,0.002124752,0.0004914388,0.0015216068],"domain_scores_gemma":[0.9801324,0.014961563,0.0016559452,0.0020011615,0.00064217893,0.00060672854],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004053446,0.0016573777,0.023867583,0.000409565,0.00033921844,0.00006007284,0.00076633727,0.0016035776,0.0015975777],"category_scores_gemma":[0.021312336,0.0009088663,0.0020453155,0.0010789616,0.000601474,0.00014520058,0.0003026828,0.0016064908,0.00009972876],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000710476,0.001847638,0.000017709719,0.8588281,0.00055919023,0.008725786,0.00013719812,2.2111523e-8,4.1390103e-7,0.0044712825,0.013875089,0.11082709],"study_design_scores_gemma":[0.004282684,0.0021299806,0.0000015594114,0.48275748,0.005087476,0.010650175,0.00008212856,0.00000451078,0.000001110734,0.000011101106,0.49447015,0.0005216439],"about_ca_topic_score_codex":0.000036603178,"about_ca_topic_score_gemma":0.00018592403,"teacher_disagreement_score":0.48059505,"about_ca_system_score_codex":0.002928638,"about_ca_system_score_gemma":0.008486874,"threshold_uncertainty_score":0.99969256},"labels":[],"label_agreement":null},{"id":"W3165799328","doi":"10.1016/j.critrevonc.2021.103367","title":"Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Centre for Blood Research, University of British Columbia; University of British Columbia","keywords":"Oxidative stress; Reactive oxygen species; Myelodysplastic syndromes; DNA damage; Haematopoiesis; Stem cell; Cell biology; Biology; Hematopoietic stem cell; Cellular respiration; Senescence; Oxidative phosphorylation; Membrane permeability; Mitochondrion; Biochemistry; Immunology; Bone marrow; DNA","score_opus":0.12375963500328774,"score_gpt":0.4527460638293274,"score_spread":0.3289864288260397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165799328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087654707,0.99168605,0.0000247335,0.0011282505,0.0005618202,0.0038710781,0.000053338346,0.00004504791,0.001753135],"genre_scores_gemma":[0.00080129807,0.9958096,0.0006945644,0.00037969337,0.0001609412,0.0015117058,0.00025515,0.00013630693,0.00025071634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884797,0.0044967732,0.0030538377,0.0018888189,0.00045063463,0.0016302401],"domain_scores_gemma":[0.98784864,0.0097851595,0.00043266793,0.0009928809,0.00025840578,0.0006822348],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002209985,0.0011342752,0.011960854,0.0010994019,0.00008511149,0.00003594273,0.00060105347,0.0027539595,0.00085856195],"category_scores_gemma":[0.02698125,0.0009280016,0.00061276834,0.0014221999,0.00069412595,0.00014824163,0.0008693285,0.0047186953,0.000588972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007822537,0.0013183155,0.00012876639,0.17091885,0.00024078866,0.04523309,0.0002207225,8.575922e-8,0.00012209384,0.041005373,0.0015933915,0.7391403],"study_design_scores_gemma":[0.0018524922,0.001022637,0.000012401162,0.13904291,0.0013652506,0.012125662,0.00018195313,0.0000495999,0.00010604854,0.00026171713,0.84307706,0.0009022451],"about_ca_topic_score_codex":0.000019155363,"about_ca_topic_score_gemma":0.000067914996,"teacher_disagreement_score":0.8414837,"about_ca_system_score_codex":0.0025781922,"about_ca_system_score_gemma":0.003373577,"threshold_uncertainty_score":0.99931705},"labels":[],"label_agreement":null},{"id":"W3170899709","doi":"10.1016/j.critrevonc.2021.103391","title":"The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Dalhousie University","funders":"Cancer Research UK","keywords":"Medicine; Radiation therapy; Bolus (digestion); Breast cancer; Medical physics; Mastectomy; Oncology; Radiology; Cancer; Internal medicine","score_opus":0.0864038647895065,"score_gpt":0.4349867527343321,"score_spread":0.3485828879448256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170899709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020693908,0.99083275,0.000039707582,0.0017953977,0.00041765833,0.0066174082,0.00026673925,0.0000066196135,0.000021628552],"genre_scores_gemma":[0.000012416766,0.98430765,0.00027324556,0.0010346579,0.000103809194,0.014007918,0.00017106907,0.000059304766,0.00002991791],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99313307,0.002635963,0.002665671,0.0008057075,0.00014206127,0.00061750086],"domain_scores_gemma":[0.99442315,0.0033605357,0.00090570585,0.00094023434,0.0002852427,0.00008510671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013789412,0.00061960844,0.00698583,0.00012373716,0.00008723265,0.000018623025,0.00051198533,0.00071048347,0.000020638043],"category_scores_gemma":[0.007057245,0.00039118272,0.00096659514,0.00047357706,0.00034594734,0.00000916026,0.00020027591,0.0003712244,0.0000075922044],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004109124,0.00023591917,0.000036405025,0.45446116,0.0002694553,0.00002134178,0.000012957024,8.5112525e-8,7.529482e-7,0.0016156073,0.0029861853,0.540319],"study_design_scores_gemma":[0.0004955673,0.00011811125,0.000009508012,0.31394118,0.0009078344,0.0005381232,0.000008504929,0.0000010500858,0.000003331692,0.000025571066,0.6837047,0.0002465145],"about_ca_topic_score_codex":0.000027507274,"about_ca_topic_score_gemma":0.0002565885,"teacher_disagreement_score":0.6807185,"about_ca_system_score_codex":0.00033727044,"about_ca_system_score_gemma":0.00093423034,"threshold_uncertainty_score":0.999854},"labels":[],"label_agreement":null},{"id":"W3188155770","doi":"10.1016/j.critrevonc.2021.103430","title":"Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Eusko Jaurlaritza","keywords":"Oncology; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Disease; Clinical trial; Germline mutation; Aggressive lymphoma; Mutation; Bioinformatics; Rituximab; Biology; Genetics; Gene","score_opus":0.05634092512945823,"score_gpt":0.4154295717266789,"score_spread":0.3590886465972207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188155770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006651377,0.9884577,0.000018774514,0.00061910454,0.00016629146,0.010138733,0.000029635963,0.000024281411,0.00047896334],"genre_scores_gemma":[0.00097268645,0.98843575,0.0007447919,0.0011134307,0.000021898628,0.008483506,0.00012702426,0.00006830843,0.00003263051],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98970115,0.0038042036,0.004530257,0.00091161276,0.0002858938,0.0007668724],"domain_scores_gemma":[0.9880358,0.009650088,0.00089427567,0.0009985227,0.00014259895,0.00027869188],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019235845,0.0008118625,0.015989993,0.00047155435,0.00005148215,0.00001499378,0.00028020205,0.00082856126,0.00007863818],"category_scores_gemma":[0.011630401,0.0005556307,0.0009712468,0.0008692465,0.00039463947,0.000044875713,0.00020333256,0.0004571827,0.0001481837],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034708144,0.013480021,0.00022800436,0.9026913,0.00017966631,0.0018535153,0.000090988375,3.1441534e-9,6.799318e-8,0.024057472,0.000087115346,0.05732835],"study_design_scores_gemma":[0.0047451085,0.00042225575,0.000031279003,0.90712905,0.015102664,0.0052757785,0.000066076886,0.000017153594,8.685325e-7,0.00039708242,0.066436484,0.00037620394],"about_ca_topic_score_codex":0.000007793262,"about_ca_topic_score_gemma":0.000024907766,"teacher_disagreement_score":0.066349365,"about_ca_system_score_codex":0.0007534895,"about_ca_system_score_gemma":0.0013556847,"threshold_uncertainty_score":0.9996895},"labels":[],"label_agreement":null},{"id":"W3189960204","doi":"10.1016/j.critrevonc.2021.103433","title":"Exercise for individuals with bone metastases: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; Canada Research Chairs; University of Toronto; BC Cancer Agency","funders":"Astellas Pharma; Astellas Pharma Canada","keywords":"Medicine","score_opus":0.09813424377026841,"score_gpt":0.46271266712299436,"score_spread":0.36457842335272594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189960204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.5741523e-8,0.9627867,0.0009862173,0.0019101675,0.00028262998,0.032850884,0.0001899358,0.00007557337,0.00091787806],"genre_scores_gemma":[1.7316644e-7,0.92974627,0.0283086,0.0050151427,0.00006200883,0.03525405,0.0009706105,0.00017325184,0.00046991557],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9861595,0.0040402734,0.006125718,0.0017258414,0.00066546886,0.0012832114],"domain_scores_gemma":[0.98734164,0.0073986235,0.0016573712,0.002399183,0.00045585088,0.0007473433],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0075974474,0.0013986182,0.032615505,0.00073558674,0.000091339236,0.000044679247,0.00068594445,0.00078639766,0.00089028693],"category_scores_gemma":[0.035075083,0.0009217613,0.00238701,0.0013853307,0.0005873501,0.00011741753,0.00036582188,0.0011951004,0.00048610088],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022827999,0.0010564589,0.0000011700665,0.80760676,0.00057485665,0.0026533597,0.000015815098,3.1202922e-9,6.250098e-9,0.01761049,0.021451512,0.14900674],"study_design_scores_gemma":[0.00075046817,0.0002983565,2.7655247e-8,0.48099276,0.044085328,0.0022690664,0.000036423193,0.0000010880636,8.915197e-8,0.00011412058,0.471077,0.00037528036],"about_ca_topic_score_codex":0.0000014981492,"about_ca_topic_score_gemma":0.000005192902,"teacher_disagreement_score":0.4496255,"about_ca_system_score_codex":0.00048044606,"about_ca_system_score_gemma":0.0018691127,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W3216204715","doi":"10.1016/j.critrevonc.2021.103540","title":"The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Ottawa Hospital; University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Lomustine; Temozolomide; Bevacizumab; Oncology; Randomized controlled trial; Internal medicine; Regimen; Progression-free survival; Overall survival; Population; Chemotherapy; Cyclophosphamide; Vincristine","score_opus":0.0924226103081859,"score_gpt":0.47382605870762773,"score_spread":0.38140344839944185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216204715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.27598e-7,0.9348383,0.00005386027,0.0010072159,0.0014483287,0.062458098,0.000063023224,0.000015801443,0.000114543625],"genre_scores_gemma":[0.00002153514,0.92543375,0.00019628293,0.0001422297,0.00013127584,0.07391941,0.00008185955,0.00005967337,0.000013968909],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9548617,0.025053926,0.018070135,0.00082722004,0.00050520094,0.00068182056],"domain_scores_gemma":[0.8285453,0.15936218,0.008828801,0.0016915939,0.0013141297,0.0002580368],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.041135266,0.0010154478,0.0989853,0.00047546715,0.00007537454,0.000018002824,0.0005466341,0.00066959055,0.00008286409],"category_scores_gemma":[0.25930446,0.0003921148,0.01367454,0.00070541614,0.0005915821,0.00002795333,0.00012346885,0.0007697809,0.000027214914],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005545193,0.0011642703,4.654619e-7,0.6731421,0.0018462293,0.000054632856,0.000017893788,4.1983896e-9,7.003342e-8,0.015258465,0.001883164,0.3010875],"study_design_scores_gemma":[0.061330564,0.00096674863,1.1691626e-8,0.7129556,0.03288678,0.0010692516,0.000018554454,0.0000046550845,0.0000019047936,0.00016383354,0.1904055,0.00019658387],"about_ca_topic_score_codex":8.0123334e-7,"about_ca_topic_score_gemma":0.0000048988763,"teacher_disagreement_score":0.30089092,"about_ca_system_score_codex":0.0003164476,"about_ca_system_score_gemma":0.0017042999,"threshold_uncertainty_score":0.9998531},"labels":[],"label_agreement":null},{"id":"W3217756212","doi":"10.1016/j.critrevonc.2021.103534","title":"Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atezolizumab; Pembrolizumab; Durvalumab; Medicine; Oncology; Regimen; Internal medicine; Avelumab; Adverse effect; Immunotherapy; Cancer","score_opus":0.2226408354437612,"score_gpt":0.5032529699975057,"score_spread":0.28061213455374445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217756212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.5910222e-7,0.98426485,0.00004516255,0.003340916,0.00032074293,0.0109989345,0.00007070749,0.00003536102,0.00092308654],"genre_scores_gemma":[0.000005064974,0.9654556,0.0015038573,0.009218965,0.00008725627,0.023193158,0.00016472541,0.00011037755,0.0002609957],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98041844,0.010341347,0.0058557848,0.0017255761,0.00035355779,0.0013052975],"domain_scores_gemma":[0.98993254,0.0065352665,0.0012157424,0.0016174505,0.00027233455,0.00042669594],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0044936473,0.0014289868,0.056590572,0.0007643978,0.00009110339,0.000030931664,0.000532538,0.0011735449,0.0031812878],"category_scores_gemma":[0.004216064,0.0009082599,0.0050975243,0.0033087824,0.000627471,0.00009045597,0.00026744674,0.0017076527,0.000112757516],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026134234,0.0010108614,0.000020620695,0.77934355,0.11354358,0.0026936724,0.00008216827,2.2214739e-7,3.5782847e-8,0.0030220514,0.0023254314,0.097931705],"study_design_scores_gemma":[0.00063286436,0.00041680026,7.4610284e-7,0.12312422,0.46779338,0.0020092698,0.000019378578,0.000001789604,9.339406e-8,0.00015611012,0.4054676,0.0003777634],"about_ca_topic_score_codex":0.00011962575,"about_ca_topic_score_gemma":0.00072390825,"teacher_disagreement_score":0.6562193,"about_ca_system_score_codex":0.0011431054,"about_ca_system_score_gemma":0.0024620288,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W4200071516","doi":"10.1016/j.critrevonc.2021.103566","title":"Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Radioresistance; Systemic therapy; Oncology; Cancer; Disease; Internal medicine","score_opus":0.04894730476087189,"score_gpt":0.5086703591717768,"score_spread":0.45972305441090494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200071516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013072675,0.98994035,0.0007411673,0.00604829,0.00019894108,0.002656547,0.000046469228,0.000018834653,0.00033633038],"genre_scores_gemma":[0.000046164205,0.9920353,0.0041719675,0.0014216547,0.00013109737,0.0019570298,0.00016206576,0.000046324658,0.000028351666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961062,0.0010285082,0.0015735558,0.00082153693,0.00009313322,0.00037705124],"domain_scores_gemma":[0.99769676,0.0013497634,0.00022082674,0.00037510713,0.000102536906,0.0002549823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062564993,0.00038478913,0.0044771913,0.00025396107,0.000050180195,0.00001543111,0.000083479514,0.0007945291,0.00008894578],"category_scores_gemma":[0.00060102285,0.00031032457,0.00027138594,0.00046553972,0.0005164849,0.00004452723,0.00006502116,0.00070618244,0.000009532045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009844757,0.00045887486,0.0012727734,0.0082406,0.00015745079,0.00066151714,0.00003360561,4.428531e-8,4.9205585e-7,0.022980211,0.00043351756,0.96575105],"study_design_scores_gemma":[0.0012086876,0.000120892735,0.00023585033,0.016841898,0.0016412917,0.00516562,0.000018655217,0.000019149746,2.2446078e-7,0.00032068783,0.97418565,0.00024141841],"about_ca_topic_score_codex":0.0000233208,"about_ca_topic_score_gemma":0.00005990625,"teacher_disagreement_score":0.9737521,"about_ca_system_score_codex":0.0005864024,"about_ca_system_score_gemma":0.0009860796,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W4210423715","doi":"10.1016/j.critrevonc.2022.103620","title":"A scoping review to map the evidence of physical activity interventions in post-treatment adolescent and young adult cancer survivors","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CINAHL; Psychological intervention; Medicine; Cochrane Library; MEDLINE; Systematic review; Cancer survivor; Gerontology; Alternative medicine; Cancer; Psychiatry; Internal medicine","score_opus":0.2363290025921716,"score_gpt":0.5449011887916535,"score_spread":0.3085721861994819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210423715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023875711,0.972245,0.000025421281,0.016131518,0.0006837456,0.010520401,0.00005106284,0.000023227478,0.0000809036],"genre_scores_gemma":[0.00022721221,0.98832273,0.00016767628,0.0027917917,0.00013672268,0.008248315,0.00001889087,0.000057305195,0.000029344179],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9890748,0.0058872956,0.0027165182,0.001171337,0.0004294539,0.0007205815],"domain_scores_gemma":[0.98986185,0.0076793307,0.00080339104,0.0011433507,0.00019193612,0.0003201302],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033347888,0.0007347298,0.009230892,0.00035737996,0.000096381475,0.000012199443,0.0005420824,0.00035261616,0.00034462087],"category_scores_gemma":[0.017411053,0.0005029683,0.001415208,0.0009497297,0.0006076322,0.00009486307,0.00066291087,0.001529084,0.000043155032],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058175454,0.0013862365,0.00024854578,0.46316352,0.000078705845,0.000112030604,0.0004478793,4.479374e-8,3.4419546e-7,0.0010472243,0.0002745781,0.53318274],"study_design_scores_gemma":[0.00034949317,0.0012003436,0.00010833664,0.80797434,0.001651653,0.0005036511,0.00010221347,0.0000023284642,0.0000014775271,0.000027297101,0.1877549,0.00032397074],"about_ca_topic_score_codex":0.0022270158,"about_ca_topic_score_gemma":0.034015976,"teacher_disagreement_score":0.5328587,"about_ca_system_score_codex":0.0016318946,"about_ca_system_score_gemma":0.0018384472,"threshold_uncertainty_score":0.9997422},"labels":[],"label_agreement":null},{"id":"W4213232123","doi":"10.1016/j.critrevonc.2022.103638","title":"A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Atomic Energy Agency; Terry Fox Foundation; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Accuray","keywords":"Meta-analysis; Medicine; Publication bias; Funnel plot; Internal medicine; Oncology; Hazard ratio; Randomized controlled trial; Subgroup analysis; Cervical cancer; Adjuvant; Cancer; Confidence interval","score_opus":0.12417699816296195,"score_gpt":0.47165265665990086,"score_spread":0.3474756584969389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213232123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.4473475e-7,0.98554844,0.000102465594,0.002393677,0.0001276977,0.011332858,0.00033125482,0.000020283711,0.0001427644],"genre_scores_gemma":[0.000013330274,0.9476143,0.0011607927,0.006449439,0.000032369768,0.044330858,0.00021772551,0.000064790496,0.0001163715],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9925434,0.0014866549,0.004006416,0.0010474887,0.0003430166,0.00057305204],"domain_scores_gemma":[0.9918857,0.0056581367,0.0011324004,0.00083130214,0.0001973493,0.00029508898],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019117068,0.0007714071,0.03267353,0.0006930234,0.000047727666,0.000007702167,0.000318727,0.0006125497,0.0051394342],"category_scores_gemma":[0.006135384,0.00048476338,0.004644821,0.0022347334,0.00028301709,0.000054952787,0.0001400414,0.00064652506,0.000013686259],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013164635,0.00051053223,0.000004399365,0.8495055,0.041613363,0.000065389715,0.000022033457,6.247644e-8,4.0874603e-8,0.00095805,0.000114125214,0.1070749],"study_design_scores_gemma":[0.0009840622,0.0005147397,0.0000019141723,0.04731145,0.6321152,0.0001264488,0.0000065443955,0.0000060105217,4.2370908e-7,0.00009723614,0.31856975,0.0002662113],"about_ca_topic_score_codex":0.000015769741,"about_ca_topic_score_gemma":0.000059882805,"teacher_disagreement_score":0.802194,"about_ca_system_score_codex":0.00074360095,"about_ca_system_score_gemma":0.0005597283,"threshold_uncertainty_score":0.9997604},"labels":[],"label_agreement":null},{"id":"W4221123017","doi":"10.1016/j.critrevonc.2022.103660","title":"Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Lung cancer; Internal medicine; Adverse effect; Meta-analysis; Hazard ratio; Chemotherapy; Randomized controlled trial; Cancer; Immunotherapy; Confidence interval","score_opus":0.13754416683348544,"score_gpt":0.4488775729735346,"score_spread":0.3113334061400491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221123017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.034768e-7,0.9732391,0.0009092142,0.002676802,0.00016462409,0.022657666,0.000114838855,0.000039520386,0.00019793097],"genre_scores_gemma":[0.0000011381686,0.9328341,0.005723767,0.010412741,0.00006921044,0.04996701,0.0001706414,0.00014871635,0.00067269016],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9893395,0.003086011,0.004603441,0.0014948014,0.0003482195,0.0011280377],"domain_scores_gemma":[0.9879335,0.008424202,0.0017404133,0.0014012487,0.00017049986,0.00033012158],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0051271454,0.0012981937,0.03990662,0.0005386826,0.00019548587,0.000032801086,0.0006059747,0.00054445793,0.0036910698],"category_scores_gemma":[0.0017412236,0.00072121236,0.004656217,0.0026384806,0.0004927338,0.000060201262,0.00015094416,0.0011183782,0.000010578983],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004846135,0.00039645482,0.0000028667887,0.8917565,0.08275133,0.0003313206,0.00004674659,2.1284089e-7,4.6936297e-8,0.0002639682,0.004500274,0.01946568],"study_design_scores_gemma":[0.0014466814,0.00070286973,1.1060323e-7,0.097208284,0.4763707,0.001717238,0.000016382199,0.00001852575,1.328392e-7,0.0000142342415,0.42209986,0.0004050153],"about_ca_topic_score_codex":0.00003984507,"about_ca_topic_score_gemma":0.00031135324,"teacher_disagreement_score":0.7945482,"about_ca_system_score_codex":0.000862745,"about_ca_system_score_gemma":0.0018329484,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W4224320263","doi":"10.1016/j.critrevonc.2022.103678","title":"Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Bayer Corporation; Bayer","keywords":"Perspective (graphical); Medicine; Intensive care medicine; Family medicine; Pediatrics; Computer science","score_opus":0.24861790735082723,"score_gpt":0.5435150600523989,"score_spread":0.2948971527015717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224320263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066557106,0.96229684,0.0000024886044,0.023904156,0.0007020461,0.012651294,0.00008217174,0.000021052525,0.0002733717],"genre_scores_gemma":[0.00017028088,0.9898299,0.0011024472,0.0017077946,0.00039909338,0.0065534557,0.00012346702,0.00007678016,0.000036790974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98692405,0.0059626075,0.0038927696,0.0018308997,0.0004209863,0.0009686744],"domain_scores_gemma":[0.96560013,0.031708047,0.00056131155,0.001234374,0.0005888341,0.0003072769],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005880648,0.00080531294,0.012060063,0.00027653272,0.00016920401,0.000009025512,0.0005853022,0.00079309894,0.00010934274],"category_scores_gemma":[0.1559771,0.0004601285,0.001147491,0.0010094682,0.0032023164,0.00007001243,0.0006488325,0.0028057382,0.00003575021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029691283,0.0033031898,0.00027723832,0.1425809,0.00044950616,0.00041301976,0.00025641767,1.0449734e-9,6.6296444e-8,0.025889374,0.0057612415,0.8207721],"study_design_scores_gemma":[0.0020742558,0.0047741337,0.000135569,0.21688868,0.0025886898,0.0005753832,0.0005594151,0.0000018197205,5.56271e-7,0.0045269155,0.7674336,0.00044101843],"about_ca_topic_score_codex":0.000038686183,"about_ca_topic_score_gemma":0.000043123877,"teacher_disagreement_score":0.8203311,"about_ca_system_score_codex":0.00068826176,"about_ca_system_score_gemma":0.0019427645,"threshold_uncertainty_score":0.99978507},"labels":[],"label_agreement":null},{"id":"W4280628647","doi":"10.1016/j.critrevonc.2022.103711","title":"Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Clinical endpoint; Medicine; Surrogate endpoint; Overall survival; Oncology; Internal medicine; Clinical trial; Malignancy; Intensive care medicine","score_opus":0.16917668507141453,"score_gpt":0.5136750876270089,"score_spread":0.34449840255559433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280628647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055679087,0.98101074,0.00002683478,0.011534406,0.00052862003,0.005747673,0.00013728041,0.000027061355,0.00093172357],"genre_scores_gemma":[0.00015995312,0.995061,0.0013624814,0.0014842813,0.000034574474,0.0016705736,0.00010743672,0.000065595494,0.000054134325],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9823545,0.008904991,0.005348796,0.0013305824,0.00085196196,0.0012091452],"domain_scores_gemma":[0.9888209,0.0066547473,0.0016536466,0.0022852544,0.000258721,0.00032672545],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0098947035,0.0008329993,0.013873652,0.00088136096,0.0000890387,0.000008122906,0.001660759,0.0016154698,0.0006585186],"category_scores_gemma":[0.04080244,0.00052759517,0.000998444,0.0031646348,0.001889658,0.0000636211,0.0027795916,0.003883197,0.000019776091],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007841812,0.0014272087,0.0011388023,0.6213305,0.000109725304,0.002534834,0.00006943547,1.3291001e-8,5.3534495e-7,0.08728929,0.0036942705,0.28232697],"study_design_scores_gemma":[0.0013249886,0.0011953681,0.000047622696,0.3397607,0.00045762677,0.009198898,0.000041783456,0.0000030136823,0.0000029951575,0.0052018636,0.64249796,0.0002671588],"about_ca_topic_score_codex":0.000028454895,"about_ca_topic_score_gemma":0.000063452775,"teacher_disagreement_score":0.6388037,"about_ca_system_score_codex":0.002108278,"about_ca_system_score_gemma":0.0067935004,"threshold_uncertainty_score":0.99971753},"labels":[],"label_agreement":null},{"id":"W4281931702","doi":"10.1016/j.critrevonc.2022.103728","title":"Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review","year":2022,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CINAHL; Medicine; Psychological intervention; Anxiety; Needs assessment; Distress; Gerontology; MEDLINE; Depression (economics); Social support; Psycho-oncology; Cancer; Family medicine; Nursing; Psychiatry; Psychology; Clinical psychology; Psychotherapist","score_opus":0.09233959939078881,"score_gpt":0.4705893985035747,"score_spread":0.3782497991127859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281931702","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03767397,0.956357,0.00013380025,0.001609042,0.00013942759,0.0029619988,0.000035602174,0.000015055086,0.0010740786],"genre_scores_gemma":[0.6117427,0.38172585,0.0017124284,0.0020327626,0.000021924281,0.0026861536,0.000028779403,0.000030527168,0.00001891621],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973875,0.000736422,0.0010968687,0.0002868766,0.00016748202,0.0003248302],"domain_scores_gemma":[0.99727833,0.0015795596,0.00038543716,0.0003429294,0.00030023765,0.00011348359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006558024,0.00023552707,0.0034060164,0.0001887,0.000054623033,0.0000016598384,0.00015302256,0.000097021024,0.00019238795],"category_scores_gemma":[0.003393772,0.00016398863,0.00014669138,0.00061867415,0.00038885832,0.000053653454,0.00015535479,0.0003385374,0.0000023449709],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002331052,0.00027069877,0.022324499,0.9370685,0.00014261613,0.00020112885,0.025798555,0.000001742496,0.00013116516,0.0073372303,0.00046443185,0.006026294],"study_design_scores_gemma":[0.0019235362,0.0024970968,0.0001104635,0.9184307,0.00081413984,0.0007095431,0.06978106,0.000012252624,0.0009143565,0.00011795873,0.0043956507,0.00029325797],"about_ca_topic_score_codex":0.00004393011,"about_ca_topic_score_gemma":0.00015930874,"teacher_disagreement_score":0.57463115,"about_ca_system_score_codex":0.00026118467,"about_ca_system_score_gemma":0.00050802174,"threshold_uncertainty_score":0.6687262},"labels":[],"label_agreement":null},{"id":"W4282961610","doi":"10.1016/j.critrevonc.2022.103747","title":"Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Lung cancer; Clinical trial; Inclusion and exclusion criteria; MEDLINE; Randomized controlled trial; Internal medicine; Systematic review; Oncology; Intensive care medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.7253479304992632,"score_gpt":0.6936135107392718,"score_spread":0.03173441975999136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002083969,0.9835829,0.0010318877,0.0020778594,0.0005041915,0.011587363,0.00008820453,0.000018472198,0.0010882538],"genre_scores_gemma":[0.00013609954,0.9829296,0.0037356976,0.0017103992,0.000080046986,0.0111976,0.000120208795,0.00005204773,0.000038292506],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93804324,0.04639571,0.013391343,0.0009959062,0.0005065973,0.00066723506],"domain_scores_gemma":[0.8679545,0.12284306,0.0067510568,0.0017963365,0.00035005002,0.00030503265],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03849065,0.00079581636,0.03292875,0.00046920584,0.00011662989,0.000015714195,0.0007446681,0.0007988488,0.0010119383],"category_scores_gemma":[0.16994914,0.00042791673,0.0027419575,0.001688382,0.00059740344,0.00007658484,0.00032830925,0.0016529165,0.000010370965],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035443107,0.0011412528,0.00018298597,0.96196747,0.0006201087,0.00008490068,0.00014726058,0.0000011784296,0.0000011317519,0.0035114891,0.0002857256,0.03202108],"study_design_scores_gemma":[0.00191797,0.0003636368,0.00004729566,0.83049864,0.030023808,0.00016445472,0.0003931621,0.000021613258,0.0000023212333,0.00033645637,0.13572629,0.0005043384],"about_ca_topic_score_codex":0.00037580144,"about_ca_topic_score_gemma":0.0003223348,"teacher_disagreement_score":0.13544056,"about_ca_system_score_codex":0.0012229532,"about_ca_system_score_gemma":0.0033669746,"threshold_uncertainty_score":0.9999013},"labels":[],"label_agreement":null},{"id":"W4293516714","doi":"10.1016/j.critrevonc.2022.103797","title":"Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University","funders":"Fonds de Recherche du Québec - Santé; Merck Canada; GlaxoSmithKline","keywords":"Genetic testing; Genetic counseling; Confidentiality; Medicine; Mainstream; Informed consent; Service (business); Health care; Family medicine; Alternative medicine; Business; Political science; Genetics; Pathology; Biology","score_opus":0.11370886842590748,"score_gpt":0.476170785487023,"score_spread":0.3624619170611155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293516714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016890923,0.99336547,0.00033055525,0.0036649532,0.0008132255,0.0009805401,0.000042371343,0.000019363364,0.00061460334],"genre_scores_gemma":[0.0001880755,0.9619472,0.034537986,0.0013955248,0.00070139114,0.0010784337,0.000057860132,0.00008389033,0.000009614896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991874,0.0035526368,0.0021294968,0.0016248953,0.00019665298,0.0006223218],"domain_scores_gemma":[0.9918789,0.0065554827,0.00055161567,0.00053550553,0.00017368855,0.00030476358],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003867463,0.0006603606,0.0028958968,0.00015864252,0.00026895164,0.000054952798,0.00035390974,0.0021359762,0.000055237473],"category_scores_gemma":[0.012812708,0.0005951602,0.00017839247,0.00025126466,0.0015446433,0.000014973496,0.0004801382,0.0029913737,0.0000039367715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003113526,0.00011032124,0.000073347976,0.007853625,0.000118186406,0.0003630518,0.00012305824,2.97654e-7,0.0000031095567,0.0061242995,0.0005932222,0.9846063],"study_design_scores_gemma":[0.00043126725,0.0005780951,0.000017770635,0.0051629217,0.0007033659,0.018268136,0.00034339348,0.00005911848,6.900882e-7,0.0010444518,0.97286063,0.0005301635],"about_ca_topic_score_codex":0.00008942035,"about_ca_topic_score_gemma":0.0005849515,"teacher_disagreement_score":0.9840762,"about_ca_system_score_codex":0.00022068337,"about_ca_system_score_gemma":0.0013962492,"threshold_uncertainty_score":0.99965},"labels":[],"label_agreement":null},{"id":"W4294993163","doi":"10.1016/j.critrevonc.2022.103804","title":"Cancer-related fatigue in childhood cancer survivors: A systematic scoping review on contributors of fatigue and how they are targeted by non-pharmacological interventions","year":2022,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cancer-related fatigue; Psychological intervention; Checklist; Childhood cancer; Medicine; Physical activity; Intervention (counseling); Cancer; Depression (economics); Systematic review; Clinical psychology; Psychology; Gerontology; MEDLINE; Psychiatry; Physical therapy; Internal medicine","score_opus":0.09497476390225923,"score_gpt":0.45557816698080744,"score_spread":0.3606034030785482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294993163","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09977759,0.8332397,0.000116168485,0.054554828,0.0010313321,0.010800342,0.00022945297,0.00008431019,0.00016632467],"genre_scores_gemma":[0.8374465,0.14712101,0.00018082204,0.006712464,0.000045164477,0.008350505,0.000068382054,0.000048912225,0.00002626307],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895172,0.0053800847,0.0029465216,0.0009020183,0.00048557122,0.00076861755],"domain_scores_gemma":[0.9938185,0.004041959,0.0011206977,0.00050628727,0.00019717713,0.00031533177],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049787113,0.0005089202,0.0053449697,0.00036507734,0.00015173346,0.000012626619,0.0004255602,0.00035565248,0.00079252553],"category_scores_gemma":[0.011509269,0.00043213659,0.00047626105,0.000873296,0.0003954035,0.00009754276,0.00032697126,0.0015538447,0.0000064301425],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040949802,0.009756706,0.047440298,0.9103322,0.00089604425,0.0008583031,0.004137623,0.000027164202,0.00028580223,0.007817468,0.015201434,0.00283748],"study_design_scores_gemma":[0.0063199275,0.0021680952,0.003668935,0.9819583,0.0014848788,0.0004760232,0.0013162897,0.00020954097,0.00026613014,0.00042327534,0.0009426445,0.00076595676],"about_ca_topic_score_codex":0.00050441833,"about_ca_topic_score_gemma":0.0033416445,"teacher_disagreement_score":0.7376689,"about_ca_system_score_codex":0.0008776665,"about_ca_system_score_gemma":0.00055974413,"threshold_uncertainty_score":0.999813},"labels":[],"label_agreement":null},{"id":"W4297878040","doi":"10.1016/j.critrevonc.2022.103822","title":"Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health; University Health Network; Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"National Institutes of Health; University of Toronto; National Institute of Nursing Research; Oncology Nursing Foundation","keywords":"PsycINFO; Medicine; MEDLINE; Cancer; Extant taxon; Meta-analysis; Cognition; Systematic review; Breast cancer; Oncology; Bioinformatics; Internal medicine; Psychiatry","score_opus":0.07113327747756361,"score_gpt":0.45638476611455703,"score_spread":0.38525148863699343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297878040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006229527,0.9726112,0.000014423265,0.0013030232,0.0017440491,0.022733564,0.00024959873,0.00011952026,0.0011623357],"genre_scores_gemma":[0.00024652548,0.97045696,0.00020487409,0.0012631789,0.000106763655,0.027334165,0.00020631075,0.00015893081,0.000022274311],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98527294,0.003785674,0.0065691466,0.0018151423,0.00064393383,0.0019131763],"domain_scores_gemma":[0.99007404,0.0062448643,0.002081411,0.00075883267,0.0003474718,0.00049339083],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030137284,0.0014394907,0.016390402,0.0012413517,0.00015463786,0.000010272771,0.00057157094,0.0012019429,0.0017822296],"category_scores_gemma":[0.0054191686,0.001246788,0.0017939539,0.00306035,0.0011073212,0.000081408,0.00047821694,0.0027003556,0.000058698883],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017503832,0.0017067377,0.00068043394,0.5952628,0.0011273839,0.0022228814,0.00010278196,5.032309e-7,2.6589842e-7,0.00019465151,0.0008074522,0.3977191],"study_design_scores_gemma":[0.0043811765,0.001492039,0.00008092455,0.86032945,0.01541248,0.0012624741,0.00016231638,0.000035453817,0.00000417254,0.0000078016665,0.116014935,0.0008167986],"about_ca_topic_score_codex":0.0004898349,"about_ca_topic_score_gemma":0.0006755914,"teacher_disagreement_score":0.39690226,"about_ca_system_score_codex":0.0058195763,"about_ca_system_score_gemma":0.007103727,"threshold_uncertainty_score":0.9998355},"labels":[],"label_agreement":null},{"id":"W4306761162","doi":"10.1016/j.critrevonc.2022.103860","title":"A systematic review of contemporary phase I trials in patients with lymphoma","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Adverse effect; Clinical trial; Internal medicine; Oncology","score_opus":0.153472054092088,"score_gpt":0.47553061678527725,"score_spread":0.3220585626931892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306761162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010005863,0.9774598,0.000003128102,0.0003527467,0.0003051828,0.01963659,0.00011767477,0.000023224706,0.0020916592],"genre_scores_gemma":[0.00006383739,0.9826511,0.0003114255,0.0015919124,0.00003015904,0.014688173,0.0005653776,0.00007573925,0.000022233002],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9765432,0.011462313,0.009817248,0.0010011389,0.00053011504,0.0006459754],"domain_scores_gemma":[0.9757665,0.019169692,0.0031194384,0.0014310178,0.00018291698,0.00033043814],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009094412,0.00093527895,0.036931336,0.0007170892,0.000042965843,0.000008005822,0.00046116472,0.00068237423,0.00085881294],"category_scores_gemma":[0.051530804,0.0005532131,0.0018562992,0.0011254128,0.0004077138,0.000072779105,0.00022413621,0.0005598662,0.00011214678],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014502207,0.008219857,0.00020131055,0.7902773,0.00035093128,0.0014854966,0.000020087571,8.5392643e-10,2.4797748e-9,0.0030468476,0.0018820255,0.19437113],"study_design_scores_gemma":[0.0060531893,0.0020123401,0.0000063854,0.5593463,0.0048238575,0.0005165972,0.000010336342,1.7120284e-7,1.3288052e-7,0.0000262478,0.42696747,0.00023694264],"about_ca_topic_score_codex":0.0000137789875,"about_ca_topic_score_gemma":0.000005680185,"teacher_disagreement_score":0.42508543,"about_ca_system_score_codex":0.0018422436,"about_ca_system_score_gemma":0.0026458267,"threshold_uncertainty_score":0.99969196},"labels":[],"label_agreement":null},{"id":"W4309643713","doi":"10.1016/j.critrevonc.2022.103867","title":"Patient reported outcome measure domains and tools used among adolescents and young adults with cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"CINAHL; PsycINFO; Patient-reported outcome; MEDLINE; Young adult; Medicine; Cancer survivor; Clinical psychology; Cancer; Gerontology; Quality of life (healthcare); Psychiatry; Nursing; Psychological intervention","score_opus":0.15569345566373136,"score_gpt":0.45209914620607505,"score_spread":0.29640569054234367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309643713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040489787,0.98461586,0.00001961294,0.0015429342,0.0007251854,0.012233018,0.000041868978,0.0000876354,0.00032900888],"genre_scores_gemma":[0.0002568702,0.98940486,0.00058418815,0.0039473823,0.00011969016,0.0054336586,0.00010615385,0.00013492117,0.000012265541],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98736465,0.0036186287,0.0052890377,0.0019076454,0.00077406917,0.0010459855],"domain_scores_gemma":[0.99349016,0.0025011734,0.001805984,0.0012911749,0.00018979631,0.0007216974],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037349802,0.0011347404,0.01336104,0.0003566974,0.0002022267,0.00004452145,0.00032770322,0.0008596703,0.0003126862],"category_scores_gemma":[0.01435232,0.00086856465,0.00059989915,0.0008263563,0.0010885282,0.00020019559,0.0005415236,0.0025535508,0.000011846417],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089344176,0.00031404523,0.010389985,0.48488888,0.00014458422,0.0016026782,0.0002716711,4.6764868e-9,2.3705509e-8,0.00022094332,0.00040041827,0.5016774],"study_design_scores_gemma":[0.0014202482,0.0006458533,0.00033553978,0.6740739,0.0027221022,0.0063041826,0.00011220123,5.646154e-7,8.796753e-8,0.000013068204,0.31377205,0.0006002332],"about_ca_topic_score_codex":0.00017862755,"about_ca_topic_score_gemma":0.0020283426,"teacher_disagreement_score":0.5010772,"about_ca_system_score_codex":0.0009091438,"about_ca_system_score_gemma":0.0017282973,"threshold_uncertainty_score":0.9997476},"labels":[],"label_agreement":null},{"id":"W4310018701","doi":"10.1016/j.critrevonc.2022.103880","title":"Three-year disease-free survival in randomized trials of neoadjuvant chemotherapy and HER2-targeted therapy in breast cancer: A meta-analysis","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Trastuzumab; Adjuvant therapy; Neoadjuvant therapy; Sample size determination; Targeted therapy; Randomized controlled trial; Meta-analysis; Trastuzumab emtansine; Chemotherapy; Cancer","score_opus":0.15403272796396347,"score_gpt":0.44466289712837276,"score_spread":0.2906301691644093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310018701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008119452,0.99207085,0.000049795293,0.0030514277,0.00023585065,0.0035671638,0.0008462432,0.000009241049,0.00008821866],"genre_scores_gemma":[0.0004865399,0.98947066,0.0004788559,0.00040001769,0.00008636619,0.0087138405,0.00028270535,0.00007128735,0.000009708535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98332024,0.0099939015,0.0042839567,0.0014126095,0.00028042175,0.00070888957],"domain_scores_gemma":[0.9909925,0.0063398476,0.0012228636,0.0011683048,0.00009383882,0.00018267545],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008776674,0.0009573898,0.026952956,0.0007114979,0.000053157877,0.000012663517,0.00075552677,0.000721677,0.0012615372],"category_scores_gemma":[0.00740608,0.0006579596,0.004861957,0.0011759034,0.0009882048,0.000008397055,0.00047178648,0.0006522902,0.0000029782266],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029214703,0.0032096547,0.0047355397,0.011174593,0.09377151,0.00042148322,0.00019885774,0.000004547012,0.000005416038,0.006614945,0.0012453108,0.84940344],"study_design_scores_gemma":[0.07932739,0.0003934132,0.00069376116,0.00223435,0.1389414,0.00016157006,0.0000839879,0.000012916941,0.000007495531,0.0033269112,0.77336085,0.0014559178],"about_ca_topic_score_codex":0.0005848132,"about_ca_topic_score_gemma":0.0031167408,"teacher_disagreement_score":0.84794754,"about_ca_system_score_codex":0.00026913703,"about_ca_system_score_gemma":0.0007624311,"threshold_uncertainty_score":0.99965143},"labels":[],"label_agreement":null},{"id":"W4311461682","doi":"10.1016/j.critrevonc.2022.103896","title":"Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Malignancy; Intensive care medicine; Cancer; Immunodeficiency; Hematological malignancy; Oncology; Human immunodeficiency virus (HIV); Clinical Practice; Internal medicine; Cancer therapy; Immune system; Immunology; Family medicine","score_opus":0.06335652969341639,"score_gpt":0.37866124238427595,"score_spread":0.3153047126908596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311461682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055279717,0.9820435,0.000039551127,0.00038089353,0.0010709101,0.0027879064,0.000054979297,0.000023630262,0.013045834],"genre_scores_gemma":[0.019675836,0.977246,0.00018558801,0.0002685979,0.0000029253017,0.0023222433,0.0001891829,0.000048111742,0.00006149893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9826611,0.008535809,0.005914976,0.0012082654,0.00017922634,0.0015006186],"domain_scores_gemma":[0.9903487,0.006818681,0.0013585241,0.0013921034,0.000064031745,0.00001795192],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006498757,0.0009384641,0.008951561,0.00086282863,0.0001640137,0.000008187418,0.002852848,0.0019851888,0.0018099485],"category_scores_gemma":[0.0017051763,0.00067975663,0.0011132895,0.00189427,0.002816324,0.00011387834,0.0010707907,0.004984764,0.00014861517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009538613,0.0033370587,0.000028261804,0.017218797,0.00009444022,0.00082484283,0.0012581572,0.0000017833049,0.00001609496,0.117961645,0.00010968423,0.85905385],"study_design_scores_gemma":[0.0015816849,0.00080933387,0.00007922458,0.014209958,0.00036751915,0.0023070085,0.0024835186,0.0000027679578,0.000012697589,0.005211013,0.97233546,0.00059981935],"about_ca_topic_score_codex":0.000062731815,"about_ca_topic_score_gemma":0.000030215231,"teacher_disagreement_score":0.9722258,"about_ca_system_score_codex":0.00054112857,"about_ca_system_score_gemma":0.0010164352,"threshold_uncertainty_score":0.9998974},"labels":[],"label_agreement":null},{"id":"W4317935107","doi":"10.1016/j.critrevonc.2023.103914","title":"Financial toxicity among adolescent and young adult cancer survivors: A systematic review of educational attainment, employment, and income","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Institute for Work & Health; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Socioeconomic status; Educational attainment; Survivorship curve; Population; Cancer; Medicine; Quality of life (healthcare); Gerontology; Demography; Psychology; Environmental health; Economics; Internal medicine; Nursing; Economic growth","score_opus":0.07469456629543393,"score_gpt":0.39044283192372475,"score_spread":0.31574826562829084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317935107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013523868,0.9931133,0.00003898212,0.0009264192,0.0009956273,0.003458064,0.00038283385,0.000016100354,0.0009334784],"genre_scores_gemma":[0.0001332505,0.99552554,0.00011400242,0.0010042338,0.00015636053,0.0027349943,0.00003301201,0.000067690155,0.00023091046],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99278706,0.00046648938,0.004972481,0.0010176835,0.00006690958,0.00068938505],"domain_scores_gemma":[0.9952294,0.0016524376,0.00217966,0.00059163943,0.00011461876,0.00023219874],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026214214,0.00065127056,0.010004997,0.00046872697,0.00008696519,0.00003103941,0.00047583296,0.0008039116,0.000219247],"category_scores_gemma":[0.016166197,0.00061585905,0.0005047524,0.00049190386,0.0007668315,0.00020288704,0.00034078985,0.00073619804,0.00018333827],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036483527,0.00013174204,0.0053383973,0.7276497,0.000060898827,0.000009879753,0.000043426608,1.1418821e-8,5.40565e-9,0.2584725,0.0010591273,0.0072306995],"study_design_scores_gemma":[0.0003110583,0.00013335688,0.0007519294,0.85696864,0.00055519614,0.00014630701,0.000011134961,0.000007408396,1.1711043e-7,0.011512509,0.12890133,0.00070099847],"about_ca_topic_score_codex":0.0005858524,"about_ca_topic_score_gemma":0.0024046039,"teacher_disagreement_score":0.24695998,"about_ca_system_score_codex":0.0007555248,"about_ca_system_score_gemma":0.00046576068,"threshold_uncertainty_score":0.99962926},"labels":[],"label_agreement":null},{"id":"W4365452464","doi":"10.1016/j.critrevonc.2023.103987","title":"KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"KRAS; Colorectal cancer; Microsatellite instability; Targeted therapy; ARID1A; Medicine; Mutation; Cancer research; Oncology; Cancer; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Microsatellite","score_opus":0.15457283951959125,"score_gpt":0.5159820336971392,"score_spread":0.361409194177548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365452464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055964093,0.9923141,0.000015175172,0.0013738106,0.0006286472,0.0044977977,0.000049952152,0.0000772106,0.00048368608],"genre_scores_gemma":[0.00012937933,0.99464047,0.001207433,0.0005041577,0.00021600677,0.0030732874,0.000109400506,0.000078604346,0.000041231822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99566334,0.0006656511,0.0019032456,0.00090557424,0.00022334649,0.0006388425],"domain_scores_gemma":[0.99665606,0.002128856,0.0003895682,0.00032071664,0.00020293868,0.000301844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007293118,0.00075185264,0.0063889143,0.00027742644,0.00013440718,0.000026815182,0.00014660685,0.00079607556,0.00004497674],"category_scores_gemma":[0.0010708643,0.00042388524,0.00029528522,0.00066285586,0.0019800132,0.00006087536,0.00015430221,0.0013191508,0.000031569285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045499485,0.0002548936,0.0013401068,0.023180857,0.00058449584,0.0011863012,0.00024965606,9.079437e-9,4.9549392e-8,0.0032550322,0.00023654757,0.96925706],"study_design_scores_gemma":[0.001992233,0.003476912,0.00012933266,0.022917967,0.00419741,0.0032721108,0.00031096634,0.00002021945,6.4418674e-7,0.00031327162,0.962913,0.00045594177],"about_ca_topic_score_codex":0.000015547923,"about_ca_topic_score_gemma":0.0005289096,"teacher_disagreement_score":0.96880114,"about_ca_system_score_codex":0.00043434004,"about_ca_system_score_gemma":0.002191098,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W4372231823","doi":"10.1016/j.critrevonc.2023.104018","title":"The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","keywords":"Meta-analysis; Oncology; Internal medicine; Colorectal cancer; Publication bias; Hazard ratio; Confidence interval; Medicine; Cancer","score_opus":0.13262410147093504,"score_gpt":0.4664700693060231,"score_spread":0.333845967835088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372231823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022092202,0.9845671,0.0000398905,0.001505967,0.00010192242,0.013473395,0.000121808516,0.000035349618,0.00015232479],"genre_scores_gemma":[0.00004236471,0.97443485,0.0004721225,0.00035879828,0.000011269876,0.024455173,0.000088200875,0.00007893512,0.000058295693],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98764914,0.005033346,0.005289712,0.00092767726,0.00035677844,0.00074336916],"domain_scores_gemma":[0.98328525,0.013951128,0.0013301929,0.0009207296,0.00027368957,0.0002389939],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0045648767,0.00074633514,0.026128048,0.000897283,0.00008235133,0.000017197177,0.00046892854,0.0005879488,0.0001464451],"category_scores_gemma":[0.034851942,0.00043920396,0.002978556,0.0039641266,0.0009179456,0.00004195951,0.00022523137,0.0013774405,0.000104699226],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008168341,0.00023596878,0.000007630918,0.9467702,0.034884185,0.00044230866,0.00007020325,4.700473e-7,3.2960247e-7,0.009427478,0.00013674857,0.008016323],"study_design_scores_gemma":[0.00023747754,0.00021499267,0.0000019559025,0.16958898,0.78456306,0.0011742504,0.00006102827,0.000035093606,6.695788e-7,0.00073280884,0.043101862,0.00028784078],"about_ca_topic_score_codex":0.0000641466,"about_ca_topic_score_gemma":0.0015875929,"teacher_disagreement_score":0.7771812,"about_ca_system_score_codex":0.0005432949,"about_ca_system_score_gemma":0.0013990055,"threshold_uncertainty_score":0.999806},"labels":[],"label_agreement":null},{"id":"W4379013481","doi":"10.1016/j.critrevonc.2023.104041","title":"Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Bristol-Myers Squibb","keywords":"Pomalidomide; Lenalidomide; Medicine; Multiple myeloma; Thalidomide; Combination therapy; Drug; Mechanism of action; Pharmacology; Immunology","score_opus":0.2681742536432019,"score_gpt":0.4716844319718877,"score_spread":0.2035101783286858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379013481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004344773,0.99110556,0.001486356,0.0015034643,0.00023700533,0.005150558,0.000065378656,0.00007784274,0.00033036532],"genre_scores_gemma":[0.0031662653,0.9831571,0.00751247,0.00036854442,0.00003064271,0.0052193366,0.0003431627,0.0001258603,0.0000766008],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9915647,0.0027513872,0.0027693454,0.001137776,0.0005818622,0.0011949474],"domain_scores_gemma":[0.9816528,0.015873581,0.0005507341,0.0011038316,0.0003189206,0.0005001323],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002060611,0.00080830004,0.007778289,0.0016181278,0.00008125526,0.000014222503,0.0005652342,0.0011363849,0.000293718],"category_scores_gemma":[0.024775665,0.00057349965,0.0007837069,0.0019702334,0.0009491987,0.00008963077,0.00017142225,0.0013550723,0.00044956472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056726794,0.0054065944,0.0010278067,0.13514891,0.000306481,0.010785824,0.000026364032,0.0000033230394,0.000008467805,0.043982815,0.0005189958,0.8022171],"study_design_scores_gemma":[0.014760199,0.006762377,0.00044812515,0.6099537,0.0027604366,0.0011853154,0.00007413516,0.0017889504,0.00019369897,0.002228354,0.3585394,0.0013053223],"about_ca_topic_score_codex":0.00009647398,"about_ca_topic_score_gemma":0.0007207271,"teacher_disagreement_score":0.80091184,"about_ca_system_score_codex":0.0011282951,"about_ca_system_score_gemma":0.003311715,"threshold_uncertainty_score":0.99967164},"labels":[],"label_agreement":null},{"id":"W4386947175","doi":"10.1016/j.critrevonc.2023.104143","title":"Evaluation of clinical decision support systems in oncology: An updated systematic review","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Guideline; Medicine; Clinical decision support system; Clinical Practice; Systematic review; Decision support system; Medical physics; MEDLINE; Oncology; Family medicine; Computer science; Data mining; Pathology","score_opus":0.7183757448227174,"score_gpt":0.712091054110527,"score_spread":0.006284690712190399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000142209465,0.97148657,0.00017608803,0.0011982565,0.0027367084,0.023453943,0.000052061398,0.00008566432,0.0007964994],"genre_scores_gemma":[0.000026125625,0.98821336,0.0026908664,0.0018498045,0.0002803647,0.0054147504,0.0013379861,0.00014880669,0.00003794741],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.90993446,0.047846124,0.0368722,0.0021529407,0.0020188312,0.0011754339],"domain_scores_gemma":[0.9186794,0.06595632,0.008350379,0.0031644667,0.0030140805,0.00083532295],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.15715675,0.0009897957,0.029238429,0.0011784937,0.0000515162,0.000019891104,0.0009417237,0.00313472,0.0008576307],"category_scores_gemma":[0.45223543,0.000746473,0.0016580865,0.0023235853,0.0006639352,0.0002993209,0.00042239757,0.0032704,0.0017885452],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005963092,0.0013786966,0.000029432746,0.52844584,0.0001758729,0.00053823495,0.000016685133,2.5981842e-7,7.446052e-8,0.001586366,0.007616628,0.46015227],"study_design_scores_gemma":[0.0019585933,0.0015506635,0.000007824443,0.5388378,0.019890126,0.0020312115,0.00010807367,0.0004274761,4.242447e-8,0.0004447138,0.4343862,0.0003572893],"about_ca_topic_score_codex":0.00006885161,"about_ca_topic_score_gemma":0.0004570503,"teacher_disagreement_score":0.45979497,"about_ca_system_score_codex":0.002303034,"about_ca_system_score_gemma":0.009572979,"threshold_uncertainty_score":0.9994986},"labels":[],"label_agreement":null},{"id":"W4387166184","doi":"10.1016/j.critrevonc.2023.104147","title":"Prevalence, patterns, and determinants of multimorbidity among childhood and adult cancer survivors: A systematic review.","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Universiteit Utrecht; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Cancer; Multimorbidity; Ethnic group; Quality of life (healthcare); Childhood cancer; Demography; Gerontology; Comorbidity; Internal medicine","score_opus":0.09849578975415026,"score_gpt":0.4694744504830365,"score_spread":0.37097866072888624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387166184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037385832,0.98883957,0.0000046583086,0.00016990221,0.0002867542,0.009907578,0.00013292575,0.000057663303,0.00022707685],"genre_scores_gemma":[0.00017327658,0.99462485,0.00008457089,0.00033677174,0.00006700482,0.004478801,0.000049731414,0.00008005741,0.00010493973],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99244404,0.0018402633,0.0036499517,0.0010801197,0.00029990493,0.00068571186],"domain_scores_gemma":[0.99472445,0.0027527895,0.0010936472,0.0009384089,0.0001681171,0.0003225874],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019773885,0.0007844499,0.011981137,0.00039535362,0.000050529336,0.00001782826,0.00038145372,0.00067908556,0.0001616727],"category_scores_gemma":[0.013626744,0.0005688696,0.00053014595,0.000486667,0.0009524693,0.000108095635,0.0005081974,0.00078576873,0.000053227042],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000047797425,0.00027265653,0.004403415,0.94584405,0.00015222972,0.00051717134,0.00003497126,2.4590694e-9,6.9552017e-9,0.0013188306,0.00053971604,0.046912193],"study_design_scores_gemma":[0.0005230478,0.00020787571,0.0011006775,0.9748157,0.01070083,0.00076992554,0.000045555338,0.00001595341,1.336853e-7,0.0000961158,0.0113114305,0.0004127164],"about_ca_topic_score_codex":0.0001785313,"about_ca_topic_score_gemma":0.0010218113,"teacher_disagreement_score":0.046499476,"about_ca_system_score_codex":0.00024306837,"about_ca_system_score_gemma":0.0004886132,"threshold_uncertainty_score":0.9996763},"labels":[],"label_agreement":null},{"id":"W4392591746","doi":"10.1016/j.critrevonc.2024.104319","title":"Physical activity for cancer prehabilitation: A scoping review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"Canadian Cancer Society","keywords":"Prehabilitation; Medicine; Observational study; Psychological intervention; Psychosocial; Physical therapy; MEDLINE; Intervention (counseling); Cancer; Oncology; Internal medicine; Nursing","score_opus":0.1676790120443535,"score_gpt":0.5618419671473927,"score_spread":0.3941629551030391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392591746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017504186,0.9789593,0.0001345171,0.0058165356,0.0021411183,0.011666353,0.000083226456,0.0000873655,0.0011098296],"genre_scores_gemma":[0.000005676075,0.9694702,0.00046684526,0.0015404599,0.0007700338,0.02740099,0.00006298588,0.00010898465,0.0001738071],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947232,0.0012207209,0.0016712613,0.0013428965,0.00024124947,0.00080066954],"domain_scores_gemma":[0.99243844,0.005871116,0.00032769397,0.0008262127,0.00023232154,0.00030419393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015253823,0.000792784,0.010857784,0.00026365952,0.00006269229,0.000018956602,0.00032352936,0.0009153599,0.0002707745],"category_scores_gemma":[0.008331278,0.0005737257,0.0021900476,0.0008624769,0.0005257774,0.00008268551,0.00019113033,0.0015380017,0.00032244148],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014887795,0.000214935,0.0000011142156,0.47394553,0.0000466509,0.0000615382,0.000047207646,2.1306408e-9,7.099585e-8,0.0042997827,0.0051572896,0.516211],"study_design_scores_gemma":[0.00014266762,0.00025952238,1.5002924e-7,0.47338608,0.0033543126,0.00028608902,0.0000061386677,0.0000040185105,5.215586e-7,0.00032133024,0.52199596,0.0002432001],"about_ca_topic_score_codex":0.00002225632,"about_ca_topic_score_gemma":0.0005117382,"teacher_disagreement_score":0.51683867,"about_ca_system_score_codex":0.0010872021,"about_ca_system_score_gemma":0.0029570449,"threshold_uncertainty_score":0.9996714},"labels":[],"label_agreement":null},{"id":"W4392648433","doi":"10.1016/j.critrevonc.2024.104326","title":"Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer","year":2024,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Réseau de Recherche en Santé Buccodentaire et Osseuse; McGill University","keywords":"Medicine; Radiation therapy; Oncology; Head and neck cancer; Chemoradiotherapy; De-escalation; Internal medicine; Immunotherapy; Adverse effect; Cancer; Chemotherapy; Neoadjuvant therapy; Disease; Intensive care medicine; Breast cancer","score_opus":0.09938930778067546,"score_gpt":0.4523643395442973,"score_spread":0.3529750317636218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392648433","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47916678,0.49621332,0.000065376465,0.020279072,0.00020144545,0.0006653958,0.0000044201065,0.000031761487,0.0033724394],"genre_scores_gemma":[0.7244711,0.27261117,0.0010095004,0.0013882981,0.000071411836,0.00040591182,0.0000039165016,0.0000138668975,0.000024858335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982401,0.000320623,0.000527372,0.00043940946,0.000069213806,0.0004032869],"domain_scores_gemma":[0.9985609,0.0011385686,0.000031506715,0.00011980617,0.00003125654,0.00011797807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048053756,0.00021926475,0.0011874825,0.00013785761,0.000058252997,0.000024670382,0.000035665216,0.00025594965,0.000052329833],"category_scores_gemma":[0.00034593433,0.0001563625,0.00005883477,0.00019219324,0.00041267386,0.0001025747,0.000031572094,0.00036091032,0.0000065924423],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003358884,0.0003550976,0.038098406,0.0010376539,0.000077370525,0.0015927354,0.011258671,6.6181315e-7,0.0002693121,0.16498882,0.00047630424,0.7815091],"study_design_scores_gemma":[0.012903377,0.014724377,0.43066758,0.03298331,0.00058480765,0.005890486,0.0035060437,0.0046026553,0.001192137,0.14358187,0.34806508,0.0012982673],"about_ca_topic_score_codex":0.00022009153,"about_ca_topic_score_gemma":0.0014100563,"teacher_disagreement_score":0.7802108,"about_ca_system_score_codex":0.00047144888,"about_ca_system_score_gemma":0.00039529402,"threshold_uncertainty_score":0.6376277},"labels":[],"label_agreement":null},{"id":"W4396776569","doi":"10.1016/j.critrevonc.2024.104364","title":"Mapping inter-professional collaboration in oncogenetics: Results from a scoping review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université Laval; Hôpital du Saint-Sacrement","funders":"Fonds de Recherche du Québec - Santé; Merck Canada; GlaxoSmithKline","keywords":"Computer science; Field (mathematics); Grey literature; Set (abstract data type); Quality (philosophy); Data science; Knowledge management; MEDLINE","score_opus":0.08392000603911168,"score_gpt":0.4880002146719081,"score_spread":0.40408020863279637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396776569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007553289,0.9894744,0.00023633923,0.0021400538,0.0029870586,0.0036838872,0.00026626803,0.000024705645,0.0011796891],"genre_scores_gemma":[0.0000161056,0.98817533,0.004566554,0.0016870936,0.0005346327,0.0032112775,0.0015317237,0.000104321334,0.00017293138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903256,0.00270338,0.0041621053,0.0018518441,0.00022001183,0.00073703536],"domain_scores_gemma":[0.9965297,0.0013145844,0.0006492732,0.0011392033,0.0001947414,0.00017247218],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025298258,0.000804516,0.004485594,0.00047811033,0.00006495052,0.000039818475,0.0008148848,0.001801132,0.0001381959],"category_scores_gemma":[0.011651226,0.0006948493,0.00057194184,0.0012295721,0.000436675,0.000012362328,0.00074623013,0.0013429257,0.0005274885],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039599327,0.00023326528,0.000007272138,0.14248097,0.00010333806,0.000319263,0.00016639626,5.6063567e-7,0.000022237755,0.00085304806,0.044385236,0.8113888],"study_design_scores_gemma":[0.00027575507,0.00008928607,2.8909503e-7,0.39815438,0.00024242495,0.00013884423,0.000045176163,0.0000051578536,0.000011399659,0.00032645112,0.6003356,0.0003752276],"about_ca_topic_score_codex":0.000013765455,"about_ca_topic_score_gemma":0.00094153825,"teacher_disagreement_score":0.8110136,"about_ca_system_score_codex":0.0009556726,"about_ca_system_score_gemma":0.0044420674,"threshold_uncertainty_score":0.9995503},"labels":[],"label_agreement":null},{"id":"W4399070680","doi":"10.1016/j.critrevonc.2024.104401","title":"Rediscovering immunohistochemistry in lung cancer","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lung cancer; Immunohistochemistry; Medicine; Pathology; Oncology","score_opus":0.0617392239826426,"score_gpt":0.5304947154319777,"score_spread":0.4687554914493351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399070680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000071565637,0.9826637,0.000015344433,0.001256164,0.0013795398,0.0020861472,0.000046270816,0.000047286405,0.012498393],"genre_scores_gemma":[0.00003954877,0.99265635,0.0005404965,0.00035077005,0.00023362848,0.0049924357,0.0001282115,0.00008286756,0.0009756756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960382,0.00030098777,0.001932009,0.00090132374,0.00014491788,0.0006825658],"domain_scores_gemma":[0.99821424,0.00076072157,0.00019727487,0.0005866856,0.00005228969,0.00018876488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005054801,0.00060497096,0.0053751944,0.00039392617,0.00004022789,0.000017985281,0.00024839994,0.0010185136,0.0004651357],"category_scores_gemma":[0.0015902247,0.00044269473,0.000668116,0.00068710773,0.0003279546,0.00005977846,0.00017897354,0.0016665288,0.00023460151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019362671,0.00045042517,0.00008751378,0.1885002,0.00027966715,0.003915978,0.0001596935,8.628387e-8,0.0000028715406,0.010422638,0.012709454,0.7834521],"study_design_scores_gemma":[0.00045398725,0.00007488687,0.0000022212048,0.14574637,0.0038723757,0.00144207,0.000021826858,0.000009085537,0.0000012308441,0.00022935023,0.8478646,0.0002819644],"about_ca_topic_score_codex":0.0000615371,"about_ca_topic_score_gemma":0.00004949097,"teacher_disagreement_score":0.8351552,"about_ca_system_score_codex":0.0036575126,"about_ca_system_score_gemma":0.0024673268,"threshold_uncertainty_score":0.9998025},"labels":[],"label_agreement":null},{"id":"W4399274269","doi":"10.1016/j.critrevonc.2024.104407","title":"Comprehensive approach to cancer immunotherapy – Simultaneous targeting of myeloid-derived suppressor cells and cancer cells with AFP conjugates","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Cancer Technologies; MaRS; Alpha Technologies (Canada)","funders":"","keywords":"Cancer; Cancer immunotherapy; Immunotherapy; Cancer research; Suppressor; Myeloid-derived Suppressor Cell; Conjugate; Medicine; Cancer cell; Immunology; Internal medicine; Mathematics","score_opus":0.04542090664708075,"score_gpt":0.3782622840863666,"score_spread":0.3328413774392858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399274269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015951376,0.99093986,0.000105923085,0.0002832163,0.0034170381,0.004125598,0.00039308376,0.00011522147,0.00046053756],"genre_scores_gemma":[0.00042411886,0.99181825,0.0024499437,0.00078072096,0.0001064052,0.003637692,0.00010630211,0.0002849037,0.00039164833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910394,0.002475389,0.0029825803,0.001865294,0.00011901257,0.0015183571],"domain_scores_gemma":[0.9915999,0.0061631044,0.00080645876,0.0009196661,0.00037377301,0.00013707388],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0008118819,0.0014638853,0.009459178,0.00053401757,0.00014072336,0.000034875327,0.0010676091,0.0022570007,0.0005289809],"category_scores_gemma":[0.00059771136,0.0010536724,0.0005986966,0.00073814264,0.0026996038,0.00008070205,0.0006292942,0.002556044,0.00032848772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063484436,0.0010703854,0.000008283706,0.13663712,0.002273614,0.0004390438,0.00217072,0.00004850509,0.048449304,0.0029119933,0.02230119,0.783055],"study_design_scores_gemma":[0.0009592961,0.0005026015,2.4633786e-7,0.027707232,0.0015985833,0.0005317623,0.00022387301,0.000009702275,0.010667277,0.00006384691,0.95672673,0.0010088583],"about_ca_topic_score_codex":0.00020705373,"about_ca_topic_score_gemma":0.00004651892,"teacher_disagreement_score":0.93442553,"about_ca_system_score_codex":0.0005800524,"about_ca_system_score_gemma":0.0010513973,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W4400605478","doi":"10.1016/j.critrevonc.2024.104444","title":"Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nausea and vomiting management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Antiemetic; Nausea; Vomiting; Chemotherapy-induced nausea and vomiting; Intensive care medicine; Acupressure; Physical therapy; Discontinuation; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.0517135168120171,"score_gpt":0.4647491555672196,"score_spread":0.4130356387552025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400605478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027631153,0.9694939,0.00009524255,0.009382151,0.0011117664,0.0061928798,0.0000105579575,0.00009643758,0.013589426],"genre_scores_gemma":[0.00037175216,0.99003744,0.0022465533,0.0020553702,0.00068009825,0.003987707,0.00006758803,0.00010146951,0.00045201046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943514,0.00095175306,0.002085753,0.0013447969,0.00036222654,0.0009040804],"domain_scores_gemma":[0.99726987,0.0011716671,0.00025876355,0.00081854576,0.000121314566,0.00035984404],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021151227,0.00083721505,0.0057775644,0.0006864494,0.00019384747,0.00009476111,0.0006426624,0.0006139811,0.00010388302],"category_scores_gemma":[0.0015127296,0.0005293385,0.000767171,0.001363397,0.0007152226,0.00007705488,0.0007503481,0.0017297895,0.0009289067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025263147,0.0005126554,0.0000072203106,0.09635705,0.00012867933,0.0006328267,0.00041057522,1.4773339e-9,1.3333299e-7,0.11176515,0.033695914,0.75646454],"study_design_scores_gemma":[0.0005593704,0.0003703681,0.0000047347003,0.08666984,0.0048744287,0.0004184563,0.0003316956,0.000006064858,6.688778e-7,0.0061354227,0.90022105,0.00040791987],"about_ca_topic_score_codex":0.000014733893,"about_ca_topic_score_gemma":0.000019518415,"teacher_disagreement_score":0.8665251,"about_ca_system_score_codex":0.00040095957,"about_ca_system_score_gemma":0.0002091184,"threshold_uncertainty_score":0.99984896},"labels":[],"label_agreement":null},{"id":"W4401024204","doi":"10.1016/j.critrevonc.2024.104455","title":"The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Clinical trial; Medicine; Breast cancer; Metastatic breast cancer; Oncology; Overall survival; Internal medicine; Cancer; Medical physics","score_opus":0.43042100573632724,"score_gpt":0.6349239968568318,"score_spread":0.20450299112050452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401024204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000816614,0.978354,0.00018771413,0.0043496354,0.0013945579,0.015188565,0.0003610605,0.00003870085,0.000117643416],"genre_scores_gemma":[0.00008941947,0.98724496,0.00041450342,0.00075435214,0.0006025063,0.010564273,0.00010221055,0.00013751262,0.000090246365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97670954,0.010769233,0.010024606,0.0012329591,0.00036768385,0.00089598435],"domain_scores_gemma":[0.9664227,0.028986536,0.00264942,0.0012640806,0.0004049889,0.00027231892],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.023097899,0.0010622478,0.019655285,0.0003393588,0.000060397317,0.000022971142,0.00061797973,0.00091297575,0.00012997352],"category_scores_gemma":[0.031717494,0.00053361163,0.0039395574,0.00080887054,0.0008495528,0.00007690458,0.000091355294,0.0020842468,0.000056596444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092270586,0.0006631865,0.000014816138,0.14487204,0.00074304396,0.00013262693,0.000024741434,5.0357744e-7,9.1859226e-7,0.00914777,0.002583688,0.840894],"study_design_scores_gemma":[0.0022849047,0.0018317553,0.000008654765,0.3867327,0.0034798014,0.0029410913,0.000009994407,0.000018742783,3.363061e-7,0.001675922,0.6006734,0.0003427446],"about_ca_topic_score_codex":0.000045956123,"about_ca_topic_score_gemma":0.000085896405,"teacher_disagreement_score":0.8405512,"about_ca_system_score_codex":0.001624974,"about_ca_system_score_gemma":0.0036509237,"threshold_uncertainty_score":0.9997115},"labels":[],"label_agreement":null},{"id":"W4401474245","doi":"10.1016/j.critrevonc.2024.104467","title":"The burden of pediatric critical illness among pediatric oncology patients in low- and middle-income countries: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"Health Science Center, University of Tennessee; College of Dentistry, University of Tennessee; American Lebanese Syrian Associated Charities; Le Bonheur Children's Hospital","keywords":"Medicine; CINAHL; Confidence interval; Odds ratio; Meta-analysis; MEDLINE; Mechanical ventilation; Emergency medicine; Intensive care medicine; Internal medicine; Psychological intervention","score_opus":0.13617625793305577,"score_gpt":0.45921593443317676,"score_spread":0.323039676500121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401474245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009393911,0.98780787,0.0000031276697,0.0033348538,0.00030740467,0.008173542,0.000099779965,0.00002566914,0.00015384139],"genre_scores_gemma":[0.0009436174,0.9897772,0.00015291065,0.0006267514,0.00012781398,0.008203887,0.000045543777,0.00007766338,0.000044616445],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9857104,0.0046477094,0.006663765,0.0014721944,0.00049936195,0.0010065766],"domain_scores_gemma":[0.970996,0.025779989,0.0011271937,0.0011935479,0.000431739,0.00047150743],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005033257,0.00116261,0.028272927,0.0013502081,0.00012856169,0.00004866044,0.00050847826,0.00139254,0.00017636803],"category_scores_gemma":[0.025262568,0.00062119536,0.002626104,0.0026426348,0.001281098,0.00009509594,0.0004975404,0.0014846267,0.00011842364],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011345631,0.00067690975,0.001268809,0.97994137,0.009937312,0.0007262278,0.00013090852,2.5276611e-8,2.2457552e-10,0.0060556796,0.00032107308,0.00093032944],"study_design_scores_gemma":[0.00053048105,0.00064616185,0.000058979906,0.12897243,0.84117967,0.00040066827,0.00006463258,0.0000068328436,2.303123e-8,0.00028534135,0.027370097,0.00048467563],"about_ca_topic_score_codex":0.000051518902,"about_ca_topic_score_gemma":0.00013531276,"teacher_disagreement_score":0.85096896,"about_ca_system_score_codex":0.0007068116,"about_ca_system_score_gemma":0.0007365968,"threshold_uncertainty_score":0.99990386},"labels":[],"label_agreement":null},{"id":"W4401665421","doi":"10.1016/j.critrevonc.2024.104483","title":"Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American-Italian Cancer Foundation","keywords":"Circulating tumor cell; Liquid biopsy; Prostate cancer; Biomarker discovery; Medicine; Clinical Practice; Precision oncology; Biomarker; Cancer; Cancer research; Internal medicine; Biology; Metastasis; Proteomics","score_opus":0.15045267554137565,"score_gpt":0.5690888837702326,"score_spread":0.41863620822885694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401665421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022734667,0.99451554,0.00004865117,0.00010963819,0.0005232222,0.0018511642,0.00005460906,0.0000086135215,0.0006150977],"genre_scores_gemma":[0.009183396,0.98917824,0.0010761588,0.000119123666,0.00013423004,0.00021283503,0.000019881347,0.00005535722,0.00002078498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923406,0.0014276018,0.0046350136,0.0007890933,0.00019418003,0.0006134578],"domain_scores_gemma":[0.9933564,0.004928893,0.00083973916,0.0006077745,0.00008382567,0.00018337218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035579419,0.0005473504,0.008754413,0.00038939013,0.00002682384,0.0000122774545,0.00029768498,0.00039736278,0.00008216212],"category_scores_gemma":[0.0059851767,0.00031162886,0.0014089171,0.00073449634,0.0011756324,0.00007610954,0.0003278103,0.0016222306,0.000022164479],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008191852,0.000805071,0.0014695319,0.09152906,0.00030688432,0.0009635126,0.00010278599,0.000001415626,0.000017405524,0.0039642598,0.00037186884,0.9003863],"study_design_scores_gemma":[0.0030358862,0.002438165,0.00014729066,0.36814797,0.008139314,0.0047965455,0.00033294948,0.0001755867,0.00006468057,0.0022886437,0.60955685,0.00087612576],"about_ca_topic_score_codex":0.00007486392,"about_ca_topic_score_gemma":0.00007053338,"teacher_disagreement_score":0.89951015,"about_ca_system_score_codex":0.00039842748,"about_ca_system_score_gemma":0.0013949389,"threshold_uncertainty_score":0.9999336},"labels":[],"label_agreement":null},{"id":"W4404450071","doi":"10.1016/j.critrevonc.2024.104555","title":"First-line treatments for advanced or recurrent endometrial cancer: Systematic literature review of clinical evidence","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Endometrial cancer; Medicine; Systematic review; Oncology; Internal medicine; MEDLINE; Cancer; Biology","score_opus":0.3202241178932936,"score_gpt":0.5916982964525532,"score_spread":0.27147417855925965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404450071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.745469e-7,0.9702964,0.000051629173,0.001862255,0.0054197614,0.021694608,0.0004300791,0.000058764446,0.00018601581],"genre_scores_gemma":[0.000001995581,0.97076994,0.002523865,0.0009956232,0.0009220817,0.023952782,0.00024662443,0.000119397075,0.00046768406],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9836056,0.002936025,0.0101219155,0.0017962422,0.0005621915,0.0009780304],"domain_scores_gemma":[0.96070284,0.034688015,0.0020353813,0.0013167529,0.00063187245,0.0006251394],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.005069535,0.0013142515,0.028030068,0.0009046886,0.00006736213,0.000023479271,0.00070190214,0.0017261439,0.0004690352],"category_scores_gemma":[0.14008923,0.0006994363,0.004486477,0.0036054098,0.0004618554,0.00012780263,0.00028432175,0.0017507306,0.00021183207],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007459348,0.0008787809,0.0000049048817,0.5536179,0.0006616936,0.0005697353,0.000009681526,6.044084e-9,1.7106874e-8,0.00090360484,0.0018478136,0.44075996],"study_design_scores_gemma":[0.0024265163,0.003771622,2.362233e-7,0.534108,0.020825092,0.0007344225,0.0000022572608,0.0000020592975,4.6932874e-7,0.00013654142,0.4377309,0.0002618769],"about_ca_topic_score_codex":0.000005051114,"about_ca_topic_score_gemma":0.000043435393,"teacher_disagreement_score":0.44049808,"about_ca_system_score_codex":0.0013630072,"about_ca_system_score_gemma":0.002305292,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W4405802125","doi":"10.1016/j.critrevonc.2024.104603","title":"The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Immunohistochemistry; Serous fluid; Pathology; Serous carcinoma; Ovarian carcinoma; Medicine; Biology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.06427543056132641,"score_gpt":0.42297873160860705,"score_spread":0.35870330104728065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405802125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035779685,0.98103595,0.0000056107283,0.013383873,0.0004976481,0.004329877,0.000055383527,0.00003631171,0.00061954715],"genre_scores_gemma":[0.0015696592,0.9919366,0.00094226346,0.0020377876,0.00008260088,0.0032019892,0.00010139092,0.00007811143,0.00004958819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941344,0.0013601001,0.0022729975,0.0012078697,0.00028686205,0.0007377357],"domain_scores_gemma":[0.9937107,0.004278476,0.00042255144,0.0011938331,0.000104792096,0.0002896495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010081177,0.00088607863,0.0077069686,0.00018980306,0.0000953393,0.000021722099,0.00043654747,0.0011640092,0.00007086202],"category_scores_gemma":[0.0059432564,0.00047391493,0.0010485844,0.00051915605,0.0011944956,0.000021473987,0.0003276446,0.0019305542,0.00013941994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077603974,0.0013067245,0.00002708746,0.16263421,0.00037049133,0.008088229,0.000028365259,9.227669e-9,0.000007782949,0.061699376,0.03261687,0.73314327],"study_design_scores_gemma":[0.0007775799,0.0009534508,0.000022610782,0.15135813,0.00429681,0.008954928,0.000007886043,7.0043825e-7,0.00001710488,0.0008761131,0.83241946,0.00031524946],"about_ca_topic_score_codex":0.000036159992,"about_ca_topic_score_gemma":0.000015692725,"teacher_disagreement_score":0.79980254,"about_ca_system_score_codex":0.00064918154,"about_ca_system_score_gemma":0.0005541205,"threshold_uncertainty_score":0.99977124},"labels":[],"label_agreement":null},{"id":"W4405942046","doi":"10.1016/j.critrevonc.2024.104610","title":"MAVS: The next STING in cancers and other diseases","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Sting; Medicine; Intensive care medicine; Engineering","score_opus":0.12491320668893004,"score_gpt":0.44986374964252157,"score_spread":0.32495054295359155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405942046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021990707,0.99286014,0.0000055182213,0.0009338266,0.002061406,0.0014017187,0.000060493814,0.000049722297,0.0026052077],"genre_scores_gemma":[0.00021339724,0.9963238,0.00004070785,0.0012822609,0.00007115401,0.0011665294,0.000029670307,0.00007214185,0.00080032233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99163157,0.004463959,0.0019762632,0.0009055949,0.000041506617,0.0009810993],"domain_scores_gemma":[0.9926493,0.006388423,0.00025453974,0.00061370735,0.000034937628,0.000059093112],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014322457,0.00072516844,0.0045969062,0.0004770682,0.000121774094,0.000044023203,0.00069949805,0.0013756416,0.0006810593],"category_scores_gemma":[0.005783587,0.00042843874,0.0005207526,0.00048544133,0.0018659974,0.0000737726,0.0005072522,0.0023751007,0.002016354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072535564,0.00014929648,0.00003695049,0.015564987,0.00014939444,0.00032083935,0.0002534698,2.044574e-8,0.0000064028904,0.06158918,0.012263588,0.90959334],"study_design_scores_gemma":[0.00030691584,0.00019746504,0.0000036971533,0.03481328,0.00074318395,0.0022415603,0.0002227214,0.0000011197549,0.0000024762123,0.0008241642,0.9602599,0.00038350513],"about_ca_topic_score_codex":0.00009261595,"about_ca_topic_score_gemma":0.00026545132,"teacher_disagreement_score":0.9479963,"about_ca_system_score_codex":0.00055679923,"about_ca_system_score_gemma":0.0008233626,"threshold_uncertainty_score":0.99992645},"labels":[],"label_agreement":null},{"id":"W4406788256","doi":"10.1016/j.critrevonc.2025.104631","title":"Future directions in the evaluation and management of newly diagnosed metastatic cancer","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health; Siemens Healthineers; Society of Nuclear Medicine and Molecular Imaging","keywords":"Cancer; Medicine; Oncology; Intensive care medicine; General surgery; Internal medicine","score_opus":0.10333730852043564,"score_gpt":0.5364956610348124,"score_spread":0.43315835251437673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000069275593,0.98546743,0.000024634304,0.0038406947,0.00054943335,0.0053951177,0.000029135506,0.000008065541,0.00467853],"genre_scores_gemma":[0.000029449911,0.9874638,0.0013968188,0.00053328107,0.00005643532,0.010331977,0.00007923698,0.0000139981885,0.00009502921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644834,0.0014711967,0.001186474,0.00043724893,0.0001825755,0.0002741628],"domain_scores_gemma":[0.99687755,0.002355449,0.00021435822,0.00038937666,0.00010343711,0.00005982552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012772945,0.0002952909,0.0028251961,0.0003347444,0.000050113766,0.000006998722,0.00015017464,0.00026283323,0.00014819317],"category_scores_gemma":[0.001056578,0.00017603538,0.00025465264,0.00081683096,0.00022268407,0.00003434972,0.000059451155,0.00044398295,0.000009705612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071543723,0.00044711254,0.000053592343,0.052641507,0.00019902755,0.00019897395,0.00019619142,8.267309e-8,9.266913e-9,0.027215695,0.0014238666,0.9176168],"study_design_scores_gemma":[0.0010946806,0.00012406374,0.00018083438,0.05139132,0.009346345,0.00019983697,0.00027383034,0.000005429967,5.9313283e-8,0.00074925786,0.93652505,0.00010928824],"about_ca_topic_score_codex":0.00004960257,"about_ca_topic_score_gemma":0.0004848978,"teacher_disagreement_score":0.9351012,"about_ca_system_score_codex":0.00052309927,"about_ca_system_score_gemma":0.00081279833,"threshold_uncertainty_score":0.71785146},"labels":[],"label_agreement":null},{"id":"W4409879933","doi":"10.1016/j.critrevonc.2025.104751","title":"Revolutionizing immunotherapy: The next frontier in CAR T-cell engineering","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mount Royal University","keywords":"Chimeric antigen receptor; Immunotherapy; Tumor microenvironment; Cell therapy; Cancer immunotherapy; Medicine; Cytokine release syndrome; Cancer; T cell; Clinical trial; Immunology; Cancer research; Biology; Cell; Immune system; Internal medicine","score_opus":0.09647313472189277,"score_gpt":0.4360006391393491,"score_spread":0.3395275044174563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409879933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004688399,0.9834156,0.0002797546,0.0016436706,0.0010704069,0.004254344,0.0000073533215,0.00005194241,0.009272237],"genre_scores_gemma":[0.000009996786,0.9918429,0.0018867962,0.00084100675,0.00024773186,0.002244036,0.00003911028,0.00010372026,0.0027846934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924005,0.0022978503,0.002671908,0.0010096991,0.00031157152,0.00130847],"domain_scores_gemma":[0.9908478,0.007098333,0.000247242,0.0014686999,0.00013686894,0.00020103013],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003631167,0.0007829797,0.0073397704,0.00094503735,0.000092450915,0.00003574734,0.0008920748,0.0015828379,0.0014306204],"category_scores_gemma":[0.007786778,0.00054754235,0.0010954558,0.0016072132,0.0005679201,0.000081408376,0.0003486179,0.0039444407,0.0003397108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050409737,0.00037787302,0.00004505628,0.05164036,0.00008332484,0.0006782036,0.00009874298,2.9200604e-7,0.000027862072,0.00712942,0.004843087,0.9350254],"study_design_scores_gemma":[0.0008666306,0.00018188245,0.000004532856,0.05380655,0.00034747508,0.0009234315,0.000043391123,0.00004418519,0.000004426256,0.00020184499,0.94321865,0.00035700062],"about_ca_topic_score_codex":0.000037770442,"about_ca_topic_score_gemma":0.000045856505,"teacher_disagreement_score":0.93837553,"about_ca_system_score_codex":0.0019096911,"about_ca_system_score_gemma":0.0018433827,"threshold_uncertainty_score":0.9997133},"labels":[],"label_agreement":null},{"id":"W4410246272","doi":"10.1016/j.critrevonc.2025.104742","title":"Preoperative neoadjuvant chemotherapy or immunotherapy in head and neck cancer: A systematic review and meta-analysis of surgical risk and pathologic response","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Meta-analysis; Head and neck cancer; Chemotherapy; Oncology; Head and neck; Immunotherapy; Neoadjuvant therapy; Cancer; Internal medicine; Radiology; Surgery; Breast cancer","score_opus":0.11799637163461243,"score_gpt":0.4915903480977219,"score_spread":0.37359397646310943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410246272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001355831,0.9881569,0.0000071714408,0.004359286,0.000047947415,0.00702405,0.00013970124,0.00001621418,0.000113133574],"genre_scores_gemma":[0.00004246537,0.99127674,0.0006339345,0.0023078413,0.000009907481,0.005483058,0.000011888769,0.000031485753,0.00020268175],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98644775,0.007918978,0.0037597602,0.0011375215,0.00018020862,0.000555786],"domain_scores_gemma":[0.9855306,0.012627568,0.0007652967,0.0007228604,0.00016739636,0.00018623668],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005290251,0.0008519758,0.037403286,0.0008066652,0.00007595401,0.000012824178,0.00021030984,0.0008030861,0.00025481085],"category_scores_gemma":[0.008486015,0.0004617867,0.0012370534,0.0016952362,0.0009950085,0.000050288167,0.00019151827,0.001052818,0.0000026648545],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006387017,0.0003874613,0.00019849076,0.91567856,0.017962666,0.0010524561,0.00037076662,1.6713868e-8,1.7674857e-7,0.0007960859,0.00020781947,0.06270678],"study_design_scores_gemma":[0.0020350865,0.0016432464,0.00008730037,0.340016,0.46522567,0.0019090975,0.000061613624,0.000006206121,4.2899748e-7,0.000070573704,0.18845165,0.0004931337],"about_ca_topic_score_codex":0.00005718498,"about_ca_topic_score_gemma":0.00038761753,"teacher_disagreement_score":0.57566255,"about_ca_system_score_codex":0.0002578638,"about_ca_system_score_gemma":0.0007704821,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W4410529901","doi":"10.1016/j.critrevonc.2025.104768","title":"Immunotherapy in primary hormone-receptor positive breast cancer: A systematic review","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; National and Kapodistrian University of Athens; McGill University","keywords":"Breast cancer; Oncology; Hormone receptor; Medicine; Immunotherapy; Internal medicine; Cancer","score_opus":0.03134749409604915,"score_gpt":0.41323372093724725,"score_spread":0.3818862268411981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410529901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.893144e-7,0.97687083,0.000019290956,0.0050636264,0.0008446862,0.014163269,0.00024052874,0.00006155126,0.0027356083],"genre_scores_gemma":[0.0000011386819,0.97480094,0.00035907107,0.012145738,0.00011498931,0.011807071,0.00024546043,0.000099279125,0.000426334],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9873708,0.0040039034,0.005785338,0.0013270396,0.00036094585,0.0011519837],"domain_scores_gemma":[0.99268067,0.0044756844,0.0010306614,0.0013511748,0.00022492502,0.00023689326],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003508282,0.0012500344,0.021226298,0.00088131684,0.00007815854,0.00002298423,0.00082026643,0.0016651874,0.0006875551],"category_scores_gemma":[0.002844165,0.0009034337,0.002110281,0.00206487,0.00073255424,0.0001117896,0.00020340548,0.0020772824,0.00027491315],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025529062,0.0005265691,0.000006746266,0.6357394,0.00029786534,0.00033241895,0.000028020315,1.4087511e-9,0.000002413631,0.0008432079,0.006447019,0.35552105],"study_design_scores_gemma":[0.0010966576,0.00023962972,0.000012176338,0.59629935,0.0021268171,0.0025743155,0.000009541737,2.8775213e-7,3.5140667e-7,0.000027511678,0.39718378,0.0004295935],"about_ca_topic_score_codex":0.00007394631,"about_ca_topic_score_gemma":0.00005481841,"teacher_disagreement_score":0.39073676,"about_ca_system_score_codex":0.004028348,"about_ca_system_score_gemma":0.0037638885,"threshold_uncertainty_score":0.999795},"labels":[],"label_agreement":null},{"id":"W4410726164","doi":"10.1016/j.critrevonc.2025.104777","title":"Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brachytherapy; Medicine; Toxicity; Radiation therapy; Radiology; Stereotactic radiotherapy; Medical physics; Nuclear medicine; Radiosurgery; Internal medicine","score_opus":0.10522495851178826,"score_gpt":0.49787892677158885,"score_spread":0.3926539682598006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410726164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012886791,0.9799473,0.001991267,0.0027533567,0.00034952557,0.014507853,0.00030900261,0.000028201384,0.00011216566],"genre_scores_gemma":[0.0000051591305,0.98118633,0.008083271,0.0040378654,0.000049260914,0.0060152886,0.00033484495,0.00005982273,0.00022815794],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9878567,0.004945514,0.0053982446,0.0009388534,0.0002545092,0.0006061965],"domain_scores_gemma":[0.97879964,0.018364495,0.0013038624,0.001007702,0.0002704074,0.00025386483],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005228279,0.000847615,0.0177041,0.0005873033,0.00006056923,0.0000150299575,0.00035375578,0.00067001133,0.00036648163],"category_scores_gemma":[0.03156446,0.0005645432,0.0023547343,0.0006768091,0.00048354047,0.00006782045,0.00013226693,0.0007235097,0.000012023126],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000566445,0.0010747979,0.000011364261,0.85678965,0.0009581602,0.00016866133,0.000008862176,2.2385034e-9,1.9827075e-7,0.026933856,0.0020630194,0.11193479],"study_design_scores_gemma":[0.001310054,0.0012676952,8.8123124e-7,0.6560952,0.008089628,0.0017832803,0.000005948987,0.000002884481,8.0212175e-7,0.00028598247,0.33091524,0.0002423803],"about_ca_topic_score_codex":0.000003945888,"about_ca_topic_score_gemma":0.000013854613,"teacher_disagreement_score":0.3288522,"about_ca_system_score_codex":0.00052997295,"about_ca_system_score_gemma":0.0005670715,"threshold_uncertainty_score":0.9996806},"labels":[],"label_agreement":null},{"id":"W4410800208","doi":"10.1016/j.critrevonc.2025.104776","title":"Cancer in a drop: Advances in liquid biopsy in 2024","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Liquid biopsy; Drop (telecommunication); Biopsy; Medicine; General surgery; Radiology; Internal medicine; Engineering; Mechanical engineering","score_opus":0.030878205246571186,"score_gpt":0.43631667121600226,"score_spread":0.40543846596943106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410800208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059376966,0.9918284,0.00005416226,0.0005307492,0.0013160898,0.0015708724,0.000104759536,0.000005821481,0.0045297747],"genre_scores_gemma":[0.000105665655,0.9952794,0.00044558622,0.00069729896,0.00018467435,0.0029735093,0.00010543359,0.000047537153,0.0001609145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99420846,0.0010098835,0.0024084465,0.0013029039,0.00010047723,0.0009698163],"domain_scores_gemma":[0.9974772,0.0013707537,0.0002723248,0.0006806913,0.00005985451,0.00013922599],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011379,0.0006687746,0.0043829433,0.00074636546,0.000024112245,0.000015294763,0.00070091645,0.0016932755,0.00014976929],"category_scores_gemma":[0.0063756187,0.0006257839,0.00040901062,0.0010579309,0.0004127273,0.000009534728,0.0005301328,0.0011800083,0.000049531518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001295296,0.0006377546,0.00060284097,0.027643025,0.0000224036,0.0009092095,0.000034708053,0.000005016225,0.00001909261,0.01292017,0.0022098941,0.95486635],"study_design_scores_gemma":[0.000627126,0.00027907203,0.0000095078585,0.032882616,0.00008522629,0.00015405928,0.000021451338,0.0000065664503,0.000014009631,0.0008102029,0.96458477,0.0005253853],"about_ca_topic_score_codex":0.0001081459,"about_ca_topic_score_gemma":0.011740508,"teacher_disagreement_score":0.96237487,"about_ca_system_score_codex":0.0006587785,"about_ca_system_score_gemma":0.0020033375,"threshold_uncertainty_score":0.99961936},"labels":[],"label_agreement":null},{"id":"W4410954716","doi":"10.1016/j.critrevonc.2025.104787","title":"Adverse effect of trastuzumab deruxtecan in solid tumours: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; NOSM University; Lakeshore General Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Trastuzumab; Meta-analysis; Oncology; Adverse effect; Medicine; Systematic review; Internal medicine; MEDLINE; Cancer; Chemistry; Breast cancer","score_opus":0.1405847298912986,"score_gpt":0.5463202509195888,"score_spread":0.4057355210282902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410954716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.009751e-7,0.98150873,0.00004486641,0.0014040164,0.000095097326,0.015557834,0.00006423332,0.000026436554,0.0012979853],"genre_scores_gemma":[0.000048548958,0.98573124,0.00051167636,0.001004422,0.000020530657,0.012335123,0.000055228807,0.00006250407,0.00023071443],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97618186,0.014022814,0.0066389577,0.0014911339,0.0005365444,0.0011286818],"domain_scores_gemma":[0.97729427,0.019059243,0.001035535,0.0018892757,0.00027411128,0.00044755396],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.012339171,0.0011495245,0.058592394,0.0022523825,0.000044005672,0.000010689932,0.0008044095,0.0013123727,0.0008520249],"category_scores_gemma":[0.056226674,0.00073006266,0.004978558,0.004162306,0.0009959553,0.000060435792,0.00042414194,0.002392018,0.00011225771],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021097527,0.00029690773,0.000022107643,0.963779,0.015599049,0.00095056044,0.000025710855,3.431319e-8,4.8818837e-8,0.0012010074,0.00051867386,0.017585836],"study_design_scores_gemma":[0.000402325,0.0006691672,8.8358524e-7,0.39479047,0.55992424,0.000999115,0.000010884771,0.000002685123,0.0000011589232,0.000061914696,0.042841785,0.00029535664],"about_ca_topic_score_codex":0.00003738585,"about_ca_topic_score_gemma":0.00024528423,"teacher_disagreement_score":0.5689885,"about_ca_system_score_codex":0.001139336,"about_ca_system_score_gemma":0.00194902,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4412391632","doi":"10.1016/j.critrevonc.2025.104841","title":"Navigating the challenges of immunotherapy as a neoadjuvant treatment for locally advanced squamous cell carcinoma of the head and neck: A review of the evidence from the literature","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sociedad Española de Oncología Médica","keywords":"Medicine; Immunotherapy; Oncology; Clinical trial; Head and neck squamous-cell carcinoma; Internal medicine; Disease; Chemoradiotherapy; Radiation therapy; Clinical endpoint; Stage (stratigraphy); Intensive care medicine; Head and neck cancer; Cancer","score_opus":0.08041838939580993,"score_gpt":0.4568789641555294,"score_spread":0.3764605747597195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412391632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036078496,0.96918434,0.000005285324,0.022453127,0.00038439714,0.007254722,0.000086615386,0.000005384893,0.00026531532],"genre_scores_gemma":[0.0019091724,0.99318576,0.0003606597,0.0022386822,0.00006865971,0.002173261,0.0000061193114,0.00002882598,0.000028871258],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99411803,0.0023394094,0.002299009,0.00059425563,0.00023462363,0.00041467499],"domain_scores_gemma":[0.9789461,0.018203698,0.0009928934,0.0014568929,0.00034313145,0.000057281904],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014815142,0.00056661677,0.0064032567,0.000029567556,0.00014761982,0.0000048035763,0.0007958402,0.00046148978,0.000013740966],"category_scores_gemma":[0.010896358,0.00020388892,0.00125655,0.00051577174,0.0013329702,0.000030239265,0.00031440562,0.0010691038,0.0000011896163],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000952625,0.00024469523,0.00006970624,0.16819145,0.00007927906,0.000011416707,0.0014540906,1.7972479e-8,0.000005900784,0.0028185607,0.00029913825,0.8267305],"study_design_scores_gemma":[0.000895245,0.0013184904,0.000066229535,0.66248685,0.00116544,0.00016896159,0.00020288688,0.0000010953544,0.00005387959,0.00040262894,0.33311534,0.00012295268],"about_ca_topic_score_codex":0.00006395972,"about_ca_topic_score_gemma":0.0001442612,"teacher_disagreement_score":0.8266075,"about_ca_system_score_codex":0.00020416638,"about_ca_system_score_gemma":0.0014490448,"threshold_uncertainty_score":0.9974353},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4413094060","doi":"10.1016/j.critrevonc.2025.104879","title":"Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Covenant University Centre for Research, Innovation and Discovery; Association Canadienne des Ergotherapeutes; Covenant University","keywords":"Microbiome; Breast cancer; Dysbiosis; Medicine; Bioinformatics; Carcinogenesis; Cancer; Oncology; Biology; Internal medicine","score_opus":0.06876031565237745,"score_gpt":0.49031169209630354,"score_spread":0.4215513764439261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032181968,0.99407727,0.00006729982,0.0025675169,0.0004290968,0.0019712802,0.0002572906,0.000011016124,0.0005870638],"genre_scores_gemma":[0.00018810549,0.99674207,0.00059136533,0.0011082471,0.00009963864,0.00078146276,0.00025533425,0.00006104186,0.00017275961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921808,0.0032254197,0.0017153472,0.001328154,0.0001224794,0.0014277569],"domain_scores_gemma":[0.99762774,0.0010239288,0.00023188668,0.00066969707,0.00017610325,0.000270621],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003144775,0.0006657306,0.0039187535,0.0007968168,0.0001294553,0.000034617176,0.00071370817,0.0023357356,0.0000756192],"category_scores_gemma":[0.0011517293,0.0005648047,0.00033670125,0.00091552536,0.0008045616,0.000007137489,0.00069866766,0.001775786,0.000053553507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070459566,0.00056387007,0.00013748948,0.09186239,0.00008523769,0.00021228322,0.000034121444,2.6655822e-8,0.0009637432,0.07227018,0.0053664893,0.8284337],"study_design_scores_gemma":[0.00049021,0.0002726416,0.000035169505,0.035024542,0.00017034507,0.0018899105,0.00004205956,0.000003368316,0.000019216784,0.0017359768,0.9598139,0.00050266256],"about_ca_topic_score_codex":0.00011406833,"about_ca_topic_score_gemma":0.0023424523,"teacher_disagreement_score":0.9544474,"about_ca_system_score_codex":0.0010347492,"about_ca_system_score_gemma":0.0026652836,"threshold_uncertainty_score":0.99968034},"labels":[],"label_agreement":null},{"id":"W4413110716","doi":"10.1016/j.critrevonc.2025.104880","title":"Corrigendum to “First-line treatments for advanced or recurrent endometrial cancer: Systemic literature review of clinical evidence” [Crit. Rev. Oncol./Hematol. 206 (2025) 104555]","year":2025,"lang":"en","type":"erratum","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; First line; Cancer; Gynecology","score_opus":0.2035360627894469,"score_gpt":0.5347310634199487,"score_spread":0.3311950006305018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413110716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019182356,0.8784472,0.00021668104,0.013599953,0.08330859,0.018459257,0.0010969094,0.00008788552,0.004764349],"genre_scores_gemma":[0.00007291781,0.91327393,0.004655539,0.008321458,0.0034130865,0.01739781,0.0011157556,0.00013057842,0.05161891],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9819733,0.0025256185,0.009781715,0.0028852022,0.0010433944,0.0017908012],"domain_scores_gemma":[0.97713494,0.014791291,0.002251792,0.0021390226,0.0023713147,0.0013116145],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.005014953,0.001712978,0.018023333,0.0015176262,0.0001739293,0.000034128538,0.0012439181,0.0037566195,0.00139282],"category_scores_gemma":[0.17129707,0.0011895122,0.002805359,0.004859753,0.00055338035,0.00018721502,0.00056357455,0.0034528547,0.00016323416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009439522,0.0025254749,0.00035404053,0.16775875,0.00066413416,0.00097215286,0.000036871414,8.370193e-8,0.0000027863364,0.001167673,0.6086691,0.20840943],"study_design_scores_gemma":[0.008513985,0.007998769,0.000020329357,0.40634516,0.004004485,0.00045489427,0.000014749169,0.0000057574825,0.000029211662,0.00020476225,0.5718983,0.0005096139],"about_ca_topic_score_codex":0.00005375136,"about_ca_topic_score_gemma":0.0004207077,"teacher_disagreement_score":0.23858641,"about_ca_system_score_codex":0.0027851406,"about_ca_system_score_gemma":0.005883701,"threshold_uncertainty_score":0.99975204},"labels":[],"label_agreement":null},{"id":"W4413111232","doi":"10.1016/j.critrevonc.2025.104892","title":"Long non-coding RNAs as immune landscape regulators in cancer: A spotlight on HEIH in immuno-oncology","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Association for the Study of the Liver; European Society for Medical Oncology; Science and Technology Development Fund; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Royal Society of Canada; Deutscher Akademischer Austauschdienst; Ministry of Higher Education; Bundesministerium für Bildung und Forschung","keywords":"Metastasis; Immune system; Biology; Tumor microenvironment; microRNA; Tumor progression; Cancer research; Cancer; Long non-coding RNA; Oncogene; Immunology; Downregulation and upregulation; Gene; Cell cycle; Genetics","score_opus":0.0347366302628015,"score_gpt":0.4378099555949207,"score_spread":0.4030733253321192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052402444,0.98661643,0.00055801176,0.0011099706,0.0016514191,0.003497796,0.000042125197,0.000023986653,0.006447876],"genre_scores_gemma":[0.0006058901,0.9930361,0.00031656245,0.0008574563,0.00022489637,0.003999986,0.00032567236,0.00014456615,0.0004888963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.988873,0.0033124092,0.0034156584,0.0021522488,0.00034604457,0.0019006268],"domain_scores_gemma":[0.99588543,0.0014961574,0.0005748626,0.0015900264,0.00015709226,0.0002964288],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0031275013,0.0011860327,0.0068574664,0.0016682391,0.00010555752,0.000036746584,0.0015547216,0.0042641633,0.00035620414],"category_scores_gemma":[0.0066225417,0.0011101211,0.0010060018,0.0018060884,0.0005681216,0.000014172901,0.0010915274,0.0030437207,0.00021166122],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004111336,0.0011365464,0.000026869231,0.019781724,0.00018529888,0.0032355313,0.00007289694,0.000008107758,0.00043747865,0.014016622,0.0031147746,0.957573],"study_design_scores_gemma":[0.001773035,0.001136448,0.0000090418225,0.0447494,0.00022449715,0.0008605724,0.000044405962,0.000022628272,0.001279117,0.00047513953,0.9485306,0.00089511706],"about_ca_topic_score_codex":0.0001587015,"about_ca_topic_score_gemma":0.0021730398,"teacher_disagreement_score":0.9566779,"about_ca_system_score_codex":0.0018875751,"about_ca_system_score_gemma":0.0045792884,"threshold_uncertainty_score":0.9992563},"labels":[],"label_agreement":null},{"id":"W4413270584","doi":"10.1016/j.critrevonc.2025.104894","title":"Current insights on transglutaminase 2: Exploring its functions, mechanisms, and therapeutic potential in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"McGill University Health Centre","keywords":"Glioblastoma; Tissue transglutaminase; Current (fluid); Computational biology; Neuroscience; Cancer research; Medicine; Biology; Enzyme; Biochemistry; Engineering","score_opus":0.07463592517043743,"score_gpt":0.36649547279493133,"score_spread":0.2918595476244939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55092335,0.42722553,0.004905226,0.011888512,0.0019157963,0.0018716293,0.0000024465558,0.00007153861,0.0011959808],"genre_scores_gemma":[0.9816918,0.015871832,0.00021163234,0.0016155682,0.000044285734,0.00050960586,0.0000027525286,0.000012870695,0.00003967554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980222,0.00041268184,0.00069394655,0.00042905653,0.00010378391,0.00033835383],"domain_scores_gemma":[0.9992421,0.00034530993,0.000042716416,0.00021454299,0.000057271962,0.00009804588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037053478,0.00020590471,0.00088703155,0.0003607042,0.00006926342,0.000008875498,0.000077457844,0.00023540789,0.00007280419],"category_scores_gemma":[0.00056995265,0.00016254152,0.00008618866,0.00035223976,0.00013870932,0.00006801036,0.000046147245,0.00055009365,0.000053814474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009138702,0.0013030587,0.00066298177,0.0014451782,0.000030417541,0.0002898188,0.00031737852,0.0000039109946,0.0013646216,0.38446093,0.00019564493,0.6090122],"study_design_scores_gemma":[0.025446735,0.015623764,0.027349295,0.03562993,0.0023104586,0.0022648415,0.0026096583,0.012805948,0.024682814,0.122319914,0.7268816,0.0020750072],"about_ca_topic_score_codex":0.0000039961687,"about_ca_topic_score_gemma":0.00006741663,"teacher_disagreement_score":0.726686,"about_ca_system_score_codex":0.00013317009,"about_ca_system_score_gemma":0.00011672463,"threshold_uncertainty_score":0.66282505},"labels":[],"label_agreement":null},{"id":"W4417123736","doi":"10.1016/j.critrevonc.2025.105078","title":"Pseudogenes in breast cancer pathogenesis and their clinical utility","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St Joseph's Health Care; Western University","funders":"Western University; Breast Cancer Society of Canada; Academic Medical Organization of Southwestern Ontario","keywords":"Pseudogene; Breast cancer; Cancer; Pathogenesis; Immune system; Gene; Function (biology)","score_opus":0.07719988009940319,"score_gpt":0.4513517857029197,"score_spread":0.37415190560351647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417123736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010114448,0.99402004,0.00014685765,0.00053832383,0.0029999628,0.0014016576,0.00033814958,0.00001378024,0.00044010626],"genre_scores_gemma":[0.00008066432,0.99553967,0.00045344216,0.0010744651,0.0010724962,0.0015005915,0.00010938958,0.000049943526,0.00011932235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916984,0.003087989,0.0026303139,0.001630084,0.000095558265,0.0008576408],"domain_scores_gemma":[0.99698174,0.0013018578,0.00035784877,0.0009542124,0.00012724829,0.00027706774],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025932563,0.00080637826,0.0060964776,0.00026850545,0.000068224566,0.00001821506,0.00062487926,0.0024176156,0.00011047849],"category_scores_gemma":[0.0033253252,0.0006211235,0.00090815785,0.00046785147,0.0012123821,0.000007154422,0.0006413063,0.0009416053,0.000020208303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048868835,0.00033470846,0.00082779565,0.012752134,0.00006308117,0.000025539679,0.000010713288,2.5295675e-8,0.000013353683,0.0013518956,0.003910988,0.9806609],"study_design_scores_gemma":[0.0005251481,0.00009958692,0.0002598907,0.009574527,0.00036160945,0.0006792744,0.000017927003,0.000002480195,0.0000057080383,0.00030880523,0.98765653,0.00050849275],"about_ca_topic_score_codex":0.000033187087,"about_ca_topic_score_gemma":0.0005017014,"teacher_disagreement_score":0.9837456,"about_ca_system_score_codex":0.000101993865,"about_ca_system_score_gemma":0.0017642794,"threshold_uncertainty_score":0.999624},"labels":[],"label_agreement":null}]}